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Abstract 
This thesis encompasses a novel methodology enabling the diastereoselective addition of 
heteroatom-centered nucleophiles to the conjugated double bond of in situ-generated α,β – 
unsaturated cyclopropenyl amides.  The methodology is presented as a means of activating the 
relatively poorly electrophilic double bond of conjugated amides via release of the ring strain 
which is inherent to cyclopropenes.  Through strain-release activation it was demonstrated that 
oxygen, sulfur and nitrogen-centered nucleophilic adducts of cyclopropylcarboxamides can be 
efficiently synthesized.  The thesis is divided into three chapters which discuss not only the 
development and elaboration of our chemistry, but also other methods of activating α,β – 
unsaturated amides and why our method will benefit the synthetic community.   
 Chapter one is a review of activation methods which are commonly employed to 
facilitate nucleophilic addition to α,β – unsaturated amides.  The utility of directly 
functionalizing conjugated amides through nucleophilic addition is discussed, as well as why 
activation is necessary.  The discussion is organized as a comparison of the reactivity of 
unactivated systems to that of activated systems; meanwhile providing an overview of what the 
synthetic community has done to develop this area of chemistry. 
 Chapter two focuses on the development of the strain-release activation method and 
addresses the problems and solutions associated with using inherently unstable cyclopropenes.  
Elaboration of the methodology to include addition of alkoxide, phenoxide and thiolate 
nucleophiles, both inter- and intramolecularly, to in situ generated, conjugated 
cyclopropenylcarboxamides is then presented and discussed.  Chapter three follows up with 
discussion of the benefits of nitrogen-centered nucleophilic addition and the challenges we faced  
iv 
 
Abstract (Continued) 
 
in accomplishing this task.  Utilization of anilines, carboxamides and sulfonamides as 
nucleophilic amine-surrogates are presented as a viable means facilitating the addition of 
nitrogen-centered nucleophiles to conjugated cyclopropenes, thereby accessing biologically 
interesting β-aminocyclopropanecarboxylic acid derivatives.   
 
  
v 
 
Table of Contents 
Chapter 1. Activation methods for conjugate addition to α,β-unsaturated amides. ................................... 1 
1.1. Introduction ....................................................................................................................................... 1 
1.2. Carbon nucleophiles and unactivated systems ................................................................................. 1 
1.3. Carbon nucleophiles and activated systems ...................................................................................... 5 
1.4. Nitrogen-centered nucleophiles and unactivated systems ............................................................. 10 
1.5. Nitrogen-centered nucleophiles and activated systems ................................................................. 12 
1.6. Oxygen-centered nucleophiles and unactivated systems ............................................................... 17 
1.7. Oxygen-centered nucleophiles and activated systems.................................................................... 19 
1.8. Conclusions ...................................................................................................................................... 21 
Chapter 2. Strain-Release activation of unsaturated amides and oxygen-centered nucleophiles............. 22 
2.1. Introduction ..................................................................................................................................... 22 
2.2. In situ generation and trapping of cyclopropene with alkoxide nucleophiles ................................. 23 
2.3. Phenoxide addition .......................................................................................................................... 34 
2.4. Thiolate addition .............................................................................................................................. 40 
2.5. Conclusions ...................................................................................................................................... 41 
2.6. Experimental .................................................................................................................................... 42 
2.6.1. General Information ................................................................................................................. 42 
2.6.2. Synthesis of 2,2-Dibromocyclopropanecarboxylic acid derivatives.......................................... 43 
2.6.3. Synthesis of 2-bromocyclopropanecarboxamide derivatives ................................................... 47 
2.6.4. Preparation of Nucleophiles ..................................................................................................... 54 
2.6.5. Alkoxide adducts ....................................................................................................................... 55 
2.6.6. Phenoxide adducts .................................................................................................................... 68 
2.6.7. Thiolate Adducts ....................................................................................................................... 81 
2.6.8. Cyclization precursors ............................................................................................................... 87 
2.6.9. Cyclization products .................................................................................................................. 99 
Chapter 3. Nitrogen-centered nucleophile ............................................................................................... 104 
3.1. Introduction ................................................................................................................................... 104 
3.2. Carbonyl activation of nitrogen nucleophiles. ............................................................................... 105 
3.3. Sulfonyl activation of nitrogen nucleophiles. ................................................................................ 119 
3.4. Aromatic activation of nitrogen nucleophiles................................................................................ 122 
vi 
 
3.4. Conclusions .................................................................................................................................... 125 
3.5. Experimentals ................................................................................................................................ 129 
3.5.1. Synthesis of carbonyl-activated nucleophiles ......................................................................... 129 
3.5.4: Synthesis of sulfonamide nucleophiles ................................................................................... 141 
3.5.2. Synthesis of β-ACC derivatives ................................................................................................ 142 
3.5.5. Adducts Resulting from Nucleophilic Attack by Sulfonamides. .............................................. 162 
3.5.6. Aniline Adducts ....................................................................................................................... 178 
Appendix ................................................................................................................................................... 184 
A.1. Assignment of Relative Configurations by 1H NMR ....................................................................... 184 
A.2. Crystallographic Data ..................................................................................................................... 186 
Cited Literature ......................................................................................................................................... 190 
 
  
vii 
 
List of Schemes 
Scheme 1 ....................................................................................................................................................... 2 
Scheme 2 ....................................................................................................................................................... 2 
Scheme 3 ....................................................................................................................................................... 3 
Scheme 4 ....................................................................................................................................................... 5 
Scheme 5 ....................................................................................................................................................... 6 
Scheme 6 ....................................................................................................................................................... 6 
Scheme 7 ....................................................................................................................................................... 7 
Scheme 8 ....................................................................................................................................................... 8 
Scheme 9 ....................................................................................................................................................... 9 
Scheme 10 ................................................................................................................................................... 10 
Scheme 11 ................................................................................................................................................... 10 
Scheme 12 ................................................................................................................................................... 11 
Scheme 13 ................................................................................................................................................... 11 
Scheme 14 ................................................................................................................................................... 12 
Scheme 15 ................................................................................................................................................... 13 
Scheme 16 ................................................................................................................................................... 14 
Scheme 17 ................................................................................................................................................... 14 
Scheme 18 ................................................................................................................................................... 15 
Scheme 19 ................................................................................................................................................... 15 
Scheme 20 ................................................................................................................................................... 16 
Scheme 21 ................................................................................................................................................... 17 
Scheme 22 ................................................................................................................................................... 17 
Scheme 23 ................................................................................................................................................... 18 
Scheme 24 ................................................................................................................................................... 19 
Scheme 25 ................................................................................................................................................... 20 
Scheme 26 ................................................................................................................................................... 20 
Scheme 27 ................................................................................................................................................... 24 
Scheme 28 ................................................................................................................................................... 25 
Scheme 29 ................................................................................................................................................... 26 
Scheme 30 ................................................................................................................................................... 27 
Scheme 31.  Test on Reversibility of the Nucleophilic Addition of Alkoxide Species .............................. 33 
Scheme 32 ................................................................................................................................................... 38 
Scheme 33 ................................................................................................................................................... 39 
Scheme 34 ................................................................................................................................................. 105 
Scheme 35 ................................................................................................................................................. 106 
Scheme 36 ................................................................................................................................................. 107 
Scheme 37 ................................................................................................................................................. 108 
Scheme 38 ................................................................................................................................................. 108 
Scheme 39 ................................................................................................................................................. 109 
Scheme 40 ................................................................................................................................................. 113 
viii 
 
Scheme 41 ................................................................................................................................................. 116 
Scheme 42 ................................................................................................................................................. 120 
Scheme 43 ................................................................................................................................................. 123 
  
ix 
 
List of Figures 
 
Figure 1: Strain-release activation of unsaturated amides. ......................................................................... 22 
Figure 2: Potential electronic and steric challenges to nucleophilic addition. ............................................ 31 
Figure 3.  Swain-Lupton LFER studies of the formal nucleophilic substitution of bromocyclopropane 70a 
with aryloxides. ........................................................................................................................................... 37 
Figure 4: 
1
H NMR showing evidence for product mixture potentially containing 96a-d. ........................ 114 
Figure 5.   ORTEP drawing of diamide 95bmg showing 50% probability amplitude displacement 
ellipsoids. .................................................................................................................................................. 118 
Figure 6 ..................................................................................................................................................... 126 
Figure 7 ..................................................................................................................................................... 127 
Figure 8: Potential Future directions ......................................................................................................... 128 
Figure 9.   ORTEP drawing of diamide 95bmg molecule, showing the atom numbering scheme; 50% 
probability amplitude displacement ellipsoids are shown. ....................................................................... 189 
Figure 10.   Packing of diamide 95bmg molecules in the crystalline lattice cell. ..................................... 189 
 
  
x 
 
List of Tables 
Table 1 .......................................................................................................................................................... 4 
Table 2: Addition of amines to silica-activated unsaturated amides ........................................................... 16 
Table 3: Addition of alkoxides to steric controlled system ......................................................................... 24 
Table 4: Addition of alkoxides to cyclopropenes bearing directing groups ............................................... 25 
Table 5: Addition of alkoxides to conjugated cyclopropenyl carboxamides .............................................. 28 
Table 6: Epimerization protocol ................................................................................................................. 32 
Table 7: Phenoxide addition ....................................................................................................................... 35 
Table 8.  Formal nucleophilic substitution of bromocyclopropanes with thiolates and thiophenols
a ......... 41 
Table 9.  Steric effect in the formal substitution of bromocyclopropane 70a with secondary amides ..... 110 
Table 10.   Electronic effect in the formal substitution of bromocyclopropane 1a with secondary 
benzamides ................................................................................................................................................ 112 
Table 11.  Convergent approach to conformationally constrained trans-cyclopropyl amino acid 
derivatives via formal substitution of bromocyclopropanes with nucleophilic carboxamides ................. 116 
Table 12.  Convergent approach to conformationally constrained trans-cyclopropyl amino acid 
derivatives via formal substitution of bromocyclopropanes with nucleophilic sulfonamides .................. 120 
Table 13.   Convergent approach to conformationally constrained trans-cyclopropyl amino acid 
derivatives via formal substitution of bromocyclopropanes with nucleophilic anilines. .......................... 124 
Table 14 Atomic coordinates (Å) and equivalent isotopic factors (Å
2
) for diamide 95bmg.   U(eq) is 
defined as one third of the trace of the orthogonalized U
ij
 tensor. ............................................................ 188 
 
1 
 
 
Chapter 1. Activation methods for conjugate addition to α,β-unsaturated amides. 
1.1. Introduction 
 
The conjugate addition reaction has been known for over a century and has received vast 
attention from the synthetic community.
1a,2
 The overwhelming majority of publications on the 
subject have focused on nucleophilic addition to α,β-unsaturated aldehyde, ketone and ester 
derivatives.  Early in the 20
th
 century, it was demonstrated that α,β-unsaturated amides could also 
undergo conjugate addition
1b-d
, however, it was quickly recognized that this class of molecule 
suffers from poor electrophilicity as compared to analogous aldehydes, ketones or esters.
3,4
 
Despite having relatively poor reactivity, conjugate addition to unsaturated amides has received a 
great deal of attention over the past several decades, granting synthetic access to a number of 
valuable products including alkaloids,
 5
 polyamines,
6
 β-peptides
7
 and biologically interesting 
heterocycles.
8
  Efforts leading to this development will be discussed in this review, which is 
organized into three sections based on the class of nucleophile; with each section being 
subdivided into two groups: unactivated amides, and activated amides. 
1.2. Carbon nucleophiles and unactivated systems 
 
Many classes of carbon-based nucleophiles have been demonstrated as viable candidates 
for addition to α,β–unsaturated amides which have no activating groups.  For example in 1973, 
Schlessinger demonstrated that the enolate anion generated from 1 is a viable nucleophile for 
conjugate addition to lactam 2, en route to the total synthesis of vincamine (Scheme 1).
9
 
2 
 
Scheme 1 
 
 
Interestingly, it was found that when a sterically hindered acyclic version of thioacetal 1, bearing 
S-ethyl substituents, was employed under similar conditions; the reaction did not occur.  In 1980, 
Baldwin demonstrated that alkyl and phenyl lithium reagents could be added to secondary 
amides, in a 1,4-fashion.
10
  Concurrently Snieckus published that alkyl and aryl Grignards, alkyl, 
aryl and vinyl lithium reagents as well as cyclic and acyclic lithium enolates can be successfully 
added in a 1,4 fashion to unsaturated tertiary amides.  He further demonstrated that many of the 
anionic conjugate addition intermediates can be trapped with carbon-based electrophiles 
(Scheme 2).
 11
   
Scheme 2 
 
 
3 
 
Nitroalkanes also react with unactivated amides as carbon nucleophiles.  It was 
demonstrated that bicyclic lactam 4 in the presence of DBU and nitropropane as solvent, readily 
forms 1,4-adduct 5 (Scheme 3).
5
   
Scheme 3 
 
 
It is noteworthy that in the case of sterically demanding substrates such as substituted lactam 6 
(Table 1, eq 1, entry 1) bearing a butyl group at the δ-position, reaction with nitromethane in the 
presence of DBU results in poor yields.
 12
  Steric factors play a defining role in this reaction as 
evidenced by the fact that the only nitroalkane adducts that were formed, were products of 
relatively unhindered nitromethane (entry 1) in contrast to nitropropane (entry 3) where only 
trace ammounts of products were observed.  Also the substituents on unsaturated lactam 6 play a 
pivotal role.  The best yields were obtained when the δ-substituent was hydrogen (entry 7), in 
which case, a more bulky nitro-cyclopentane was added in 37% yield.  In contrast, the 
complementary thiolactam 6, bearing various substituents at the δ-position, was found to be more 
reactive and accepts a variety of different alkyl-nitro nucleophiles under identical conditions to 
form thiolactam derivatives 8 in excellent yields (Table 1, entries 2, 4, 6 and 8). 
4 
 
Table 1 
 
Entry X R
1
 R
3
 R
2
 yield (%) dr 
1 O H H n-Bu 17 - 
2 S H H n-Bu 88 >99:1 
3 O Me H n-Bu trace - 
4 S Me H n-Bu 88 >99:1 
5 O Me Bn Allyl trace - 
6 S Me Bn Allyl 90 >99:1 
7 O (CH2)5 Ph H 37 na 
8 S (CH2)5 Ph H 72 na 
 
One other example of 1,4-addition of nitroalkanes to an unsaturated lactam was published in 
2006 and demonstrates the viability of an intramolecular approach (Scheme 4).
13
  It was 
demonstrated that pentacyclic lactam 11 can be synthesized through 6-endo-trig cyclization of 
unsaturated amide 9. 
5 
 
Scheme 4 
 
 
With the exception of the above examples (Scheme 3) which gave only poor yields of 
nitroalkane adducts, nitroalkane-substituted amides, synthesized by intermolecular nucleophilic 
addition, are formed by addition to the more reactive thiolactam followed by subsequent 
transformation into lactams.
4
 
1.3. Carbon nucleophiles and activated systems 
 
While Grignard, organolithium and stabilized enolate-type reagents are viable 
nucleophiles for unactivated systems, organocuprates are not well tolerated.
10,11
  These less 
reactive nucleophiles necessitate activation of the olefin by various methods.  It was shown that 
the addition of a tosyl group to the amide nitrogen of lactam 12 can enhance selectivity towards 
conjugate addition and grant access to products like β-substituted lactam 14.  The tosyl-group 
effectively diminishes the electron donating ability of the nitrogen, and subsequently enhances 
the electrophilicity of the conjugated olefin; enabling weaker nucleophiles to add. 
In the absence of this activating substituent, deprotonation of the γ-carbon is favored and 
β,γ-unsaturated lactam 13 is formed (Scheme 5).
14
  This activation-method was also 
demonstrated to work on acyclic systems allowing access to amides 16.   
6 
 
Scheme 5 
 
Scheme 6 
 
In the case of five and six membered-lactams bearing a tertiary nitrogen, it was found that 
substitution of the α-carbon with an alkoxycarbonyl group activates the molecule towards 
addition of organocuprates.
15,16
  Bosch and coworkers have shown that an ester substituent on the 
α–carbon activates bicyclic α,β-unsaturated amides 17 towards addition of alkyl and aryl-
7 
 
cuprates (Scheme 6).  It was established that the angular position of the C-O bond at the δ- 
position determines the facial selectivity of the incoming nucleophile.   
Scheme 7 
 
Utilizing a similar α-carbon activated system, investigations into the effects of γ and δ 
substituents on the lactam ring on the facial selectivity of cuprate addition were conducted 
(Scheme 7)
17,18,19,20
 and it was determined that neither γ-(19b)
21
 nor δ-(19a) substituents 
influence facial selectivity under kinetic control. 
8 
 
Scheme 8 
 
Under thermodynamic control however (Scheme 8),
22,6
 a stabilized enolate could be added to 
either isomer of 21 and it was found that the γ-substituent could influence the stereochemical 
outcome of the reaction.  It is thought that enolate addition is reversible and in the case of 21b 
the ethyl group likely forces the appended ester into a cis configuration with respect to the δ-CO 
bond as a result of thermodynamic equilibration. 
9 
 
Scheme 9 
 
 
Aside from olefin isomerization, adding organocuprates to unsaturated lactams can have other 
chemoselectivity issues.
23,24,25 
 It was that demonstrated chemoselectivity can be enhanced by the 
addition of TMSCl, which traps the enolate ion until acidic workup, thereby affording vinyl 
adduct 24 in good yield (Scheme 9).  In the absence of TMSCl, lactam 23 undergoes cuprate 
addition, but also significant dimerization via intermediate 25 reacting with 23 to form mixtures 
of dimerized adduct 26 as the major product.  It is likely that TMSCl also enhances the 
electrophilicity of the double bond through interaction with the carbonyl-oxygen of the 
unsaturated lactam. 
 
10 
 
1.4. Nitrogen-centered nucleophiles and unactivated systems  
 
Unactivated α,β-unsaturated amides have been shown to react with several classes of 
nitrogen-based nucleophiles.  Similar to carbon-based nucleophiles, stronger nitrogen-based 
nucleophiles readily add to unactivated amides while activation is often employed for weaker 
nucleophiles.   
Scheme 10 
 
For example, acyclic unsaturated amides can react with secondary lithium amide nucleophiles 
with good to high yields (Scheme 10).
26,27,28
  This example also demonstrates that the chiral 
auxiliary on 64 can lead to a high degree of enantio-induction. 
Scheme 11 
 
11 
 
Intramolecular cyclization reactions between amine-derivatives and conjugated amides can also 
be realized for several substrates.
29,30,31
  An intramolecular 5-exo-trig cyclization between 
weakly nucleophilic amide-derivative 30 and its appended β-carbon has been demonstrated as 
part of a Heck-Michael cascade reaction (Scheme 11).
30
 
Scheme 12 
 
Similarly, Scheme 12 highlights a reaction sequence beginning with removal of the FMOC group 
from silica-supported amide 32, initiating 6-exo-trig cyclization, followed by N-acylation with 
benzoyl chloride and subsequent cleavage from the silica support with TFA/H2O to yield 33 as a 
3:1 mixture of diastereomers.  HPLC was utilized for determination of diastereomeric ratio and 
products were isolated by semi-preparative HPLC.  However, NMR resonances of 33 were broad 
and therefore assignments of major/minor diastereomeric products were not reported.
31
 
Scheme 13 
 
Dehydroalanine derivatives are an attractive candidates for 1,4-addition despite being 
notoriously poor Michael acceptors.
32
  This is likely due to the deactivation of the β-carbon by 
12 
 
both the amide nitrogen of the conjugated amide, and further deactivation by the amide nitrogen 
attached to the α-carbon.  Despite these drawbacks, several papers have been published showing 
that through optimization of reaction conditions (solvent, temperature, etc…), several nitrogen-
based nucleophiles can be added to this class of molecule.  For example, dehydroalanine 
derivative 34 can accept benzyl amine to yield functionalized alanine 35 (Scheme 13).
33
 It should 
be noted that reactions require protic solvents (water, methanol), have reaction times on the order 
of days and require a 5-20 fold excess of amine.   
Scheme 14 
 
 
Given the observation that poor Michael acceptors like dehydroalanine can react with amines, it 
is no surprise that simple α,β-unsaturated amides like 36 can readily react with similar amine 
substrates (Scheme 14).
34
 However, this reaction required refluxing toluene for 32 hours to 
complete.  A similar system used ethanol as a solvent and required 24 hours to achieve a modest 
60% yield.
35
  Even large aza-crown ethers have been demonstrated to react with unsaturated 
amides, but require similar reaction times and a large excess of substrate.
36
  
1.5. Nitrogen-centered nucleophiles and activated systems 
 
The poor elecrophilicity of α,β-unsaturated amides further manifests itself when less 
reactive nitrogen nucleophiles are employed.  A single example demonstrating addition of 
13 
 
pyrrole was present in the literature (Scheme 15).
37
  Although pyrrole adds to 38 in high yield, it 
takes three days for the reaction to complete, compared to stronger Michael acceptors such as 
α,β-unsaturated esters and nitriles which take only 18 hours to achieve comparable yields under  
Scheme 15 
 
 
identical reaction conditions.  However, using various modes of activation, the addition of 
several amine derivatives, including aromatic amines, can be achieved for a variety of substrates 
under comparatively mild conditions and shorter reaction times. 
N-acyl activation is a viable approach for promoting the addition of nitrogen-based 
nucleophiles to unsaturated amides.
 38,39,40,41
  For example N-phenylmaleimide 40, which can be 
viewed as an unsaturated amide with an N-carbonyl activating group, readily accepts aromatic 
heterocyclic nucleophile 41; forming succinimide-derivative 42 (Scheme 16).
42
 
14 
 
Scheme 16 
 
 
The utility of N-carbonyl activation is further showcased in Scheme 17, which illustrates the 
reaction of weakly nucleophilic Cbz-protected amine with activated amide 43 to yield glycine 
derivative 44 in good yield.
43
 
Scheme 17 
 
 
Lewis acids are sufficient activators for nucleophilic addition of weak nitrogen 
nucleophiles.  Utilizing Cu(OTf)2 as a Lewis acid catalyst enables highly deactivated Cbz-
protected aromatic amine 45 to react cleanly with amide 46 to form adduct 47 in good to 
excellent yield (Scheme 18).
44
 
15 
 
Scheme 18 
 
Scheme 19 
 
Similarly, the above system utilizes catalytic ytterbium(III) triflate to enhance the reaction rate
7
 
of unsaturated amide 48 with alkyl amines.  While examples involving unactivated amides 
(Scheme 13, Scheme 14, Scheme 15) sometimes require days of reaction time, 5-22 fold excess 
of amine, and/or harsh conditions, this particular case utilizes only a 1:1 ratio of starting 
materials, is performed in an aprotic solvent and requires only 12 hours to complete at room 
temperature yielding amine derivative 49 (Scheme 19).   
  
16 
 
Scheme 20 
 
Table 2: Addition of amines to silica-activated unsaturated amides 
Entry R
3
 R
1
,R
2
 Time (h) yield (%) 
1 H n-Bu, H 3 92 
2 H R
1
=R
2
= CH2CH3 5 89 
3 H R
1
=R
2
= (CH2)5 5 93 
4 H R
1
=R
2
= (CH2CH2)2O 5 92 
5 CH2CH3 n-Bu, H 5 94 
6 CH2CH3 R
1
=R
2
= CH2CH3 10 88 
7 CH2CH3 R
1
=R
2
= (CH2)5 10 72 
8 CH2CH3 R
1
=R
2
= (CH2CH2)2O 10 84 
9 CH2CH3 Ph, H 24 62 
 
A weak Lewis acid like silica
45
 and even alumina
46
 can be used to promote amine addition to 
unsaturated amides (Table 2, entries 1-8) in aprotic MeCN on the timescale of several hours 
(Scheme 20); even allowing access to an adduct of weakly nucleophilic aniline within a 
reasonable amount of time and in good yield (Table 2, entry 9). 
17 
 
Collin demonstrated the effectiveness of SmI2, in conjunction with an N-acyl group, at 
activating amide 50 towards 1,4-addition of a variety of aromatic amines in good to excellent 
yields under base-free conditions (Scheme 21).
 47
 
Scheme 21 
 
 
1.6. Oxygen-centered nucleophiles and unactivated systems 
 
The literature provides scarce examples of oxygen-based conjugate addition to unactivated 
amides.  One example demonstrates an elimination-addition pathway to add hydroxyl, alkoxyl 
and amino substituents to bicyclic amide 52 (Scheme 22).
48
 
 
Scheme 22 
 
 
18 
 
Scheme 23 
 
 
Paolucci demonstrated that unsaturated lactam 62 is capable of accepting methoxide as a 
nucleophile without activation (Scheme 23).
49
  This paper also demonstrates that azides,
50
 as 
well as sulfur-based nucleophiles can be added to this system.  Other similar reports confirm that 
alkoxides are indeed viable nucleophiles for these unactivated amide systems.
51
 
  
19 
 
1.7. Oxygen-centered nucleophiles and activated systems 
 
Scheme 24 
 
 
However when activated with an electron-withdrawing group on the amide-nitrogen,
52
 
oxygen-based nucleophiles add under relatively mild conditions
, 
(Scheme 24).
53
  In this example, 
PMB-protected glycine is added to aldehyde 54 to form iminium-adduct 56 which undergoes 
decarboxylation to form an azomethine ylide which is protonated in the presence of water to 
form iminium intermediate 57.  This imminium is in conjugation with the amide nitrogen, 
activating the olefin towards nucleophilic addition of water.  This is the start of a Michael-
Mannich cascade which produces product 55 in 90% yield. 
20 
 
Scheme 25 
 
 
In another example, the amide nitrogen of 58 is substituted with either an aryl or acyl group to 
allow access to 6-membered cycle 59 under mild conditions (Scheme 25).
8
  Note that when 
amide 58 has an alkyl substituent, no reaction occurs.   
Scheme 26 
 
 
Conjugated olefins can be activated towards nucleophilic addition by electron 
withdrawing groups on the β-carbon.
54,55,56
  Nitrogen, sulfur, oxygen and carbon nucleophiles 
were successfully added to acrylamide-derivative 60, accompanied by reformation of the double 
bond via chlorine elimination, yielding conjugated amide 61 (Scheme 26).
57
  
21 
 
 
1.8. Conclusions 
 
α,β-unsaturated amides can readily react with carbon and nitrogen-based nucleophiles 
given that the nucleophile is sufficiently strong or that the reaction conditions are relatively 
harsh.  Through various methods of activation including Lewis acidic catalysis, installation of 
electron withdrawing groups on the amide nitrogen, or installation of electron withdrawing 
groups on the α or β position of the appended olefin; the scope of nucleophilic addition to 
unsaturated amides can be greatly enhanced to encompass weaker organocuprates, deactivated 
amine-derivatives as well as oxygen-based nucleophiles.  Work done in this area has allowed 
conjugate addition into unsaturated amides to grow into a valuable synthetic tool allowing access 
to a large number of valuable molecules.    
22 
 
Chapter 2. Strain-Release activation of unsaturated amides and oxygen-centered 
nucleophiles 
2.1. Introduction 
 
An alternative approach to activating α,β-unsaturated amides could be accessed through 
ring-strain release.  It is known that cyclopropene is accompanied by large amounts of strain 
energy because of the fact that it contains sp
2
 bonds which are locked at 60
o
 bond angles.  This 
has several implications including instability but also that cyclopropene can serve as an effective 
energy reserve for driving otherwise unfavorable reactions.
58,59
  We envisioned utilizing the 
strain-energy inherent to conjugated cyclopropenyl carboxamides as a means of both activating 
the amide and accessing a variety of interesting and useful cyclopropanecarboxamide derivatives 
(Figure 1).   
 
Figure 1: Strain-release activation of unsaturated amides. 
 
Indeed the products of these reactions belong to the general class of molecules called 
donor-acceptor cyclopropanes (DAC’s).  DAC’s have found widespread application in organic 
synthesis as equivalents of C3-electrophiles or all-carbon 1,3-dipoles.
60
 A number of useful 
protocols employing DACs have been developed, including various nucleophilic additions,
61
 [3 
+ 2],
62
 [3 + 3],
63
 and [3 + 4] cycloaddition reactions.
64
 Synthesis of DAC’s typically proceeds via 
catalytic cycloropanation of enol ethers with carbenoids generated from diazoacetates
65
 or 
through reacting Fisher carbenes with electron-deficient olefins.
66
 In contrast, our approach 
23 
 
enables the direct functionalization of cyclopropene with a variety of donor groups, or 
nucleophiles.   
Direct functionalization of α,β-unsaturated cyclopropenyl carboxamides involves several 
unique challenges that had to be addressed in order to make this methodology viable.  The first 
and perhaps, biggest challenge, stems from the instability of these highly reactive molecules, 
which readily decompose via polymerization and ene-reactions.
67
 To circumvent the inherent 
lack of shelf-life, monosubstituted carbonyl-conjugated cyclopropenes have to be generated and 
used in situ.
68
 Precedence for this pattern of reactivity has been sporadically observed in the 
literature, however elaboration of a general methodology has only recently seen development 
within the past five years by this research group.
67,69
 
2.2. In situ generation and trapping of cyclopropene with alkoxide nucleophiles 
 
Rubin and coworkers has demonstrated that while cyclopropene 65 can be synthesized, 
isolated and stored under nitrogen at low temperatures for several months
70a
 to even several 
years; 65 can be used as an electrophile in the addition of oxygen-based nucleophiles, forgoing 
the isolation step.
70b
 This was accomplished via bromocyclopropane 64, which can undergo 
dehydrohalogenation in the presence of t-BuOK and catalytic 18-crown-6 to form 65 followed 
by subsequent trapping by base, or by a competing pronucleophile, to form cyclopropanol 
derivatives 66 (Scheme 27).   
24 
 
Scheme 27 
 
 
Table 3: Addition of alkoxides to steric controlled system 
Entry No. R Yield (%) dr 
1 66a t-BuO 93 >25:1 
2 66b i-PrO 96 18:1 
3 66c n-PrO 99 16:1 
4 66d PhCH2O 75 >25:1 
5 66e Me2NCH2CH2O 83 11:1 
 
The diastereoselectivity for this particular system is governed by steric factors, allowing 
nucleophiles to react at the least hindered face of the cyclopropene.  It was demonstrated that a 
variety of functionally diverse (Table 3, entries 4, 5) and sterically demanding (entries 1 and 2) 
cyclopropanol-derivatives can be synthesized in this fashion, all giving good yields and a high 
diastereoselectivity. 
Similarly, bromocyclopropanes 67 bearing a carboxamide or carboxylate moiety 
underwent dehydrohalogenation, followed by nucleophilic addition to form cyclopropanol 
derivatives 69 in good to excellent isolated yields (Scheme 28).
70b
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Scheme 28 
 
Table 4: Addition of alkoxides to cyclopropenes bearing directing groups 
Entry SM R
1
 R
2
 No. Yield (%) dr 
1 67a NEt2 t-BuO 69a 87 20:1 
2 67d NHBu-t t-BuO 69g 92 >25:1 
3 67a NEt2 n-PrO 69b 94 14:1 
4 67b N(CH2CH2)2 CH2=CH(CH2)3O 69c 92 20:1 
5 67c OK t-BuO
a 
69d 79 >25:1 
6 67c OK t-BuO
b 
69e 81 >25:1 
7 67c OK n-PrO
a 
69f 83 >25:1 
a 
Quenched with MeI prior to isolation.  
b
 Quenched with allyl bromide prior to isolation. 
 
In this system, diastereoselectivity is controlled by the carbonyl group which coordinates 
to a potassium ion, thereby directing the negatively charged nucleophile to the carbonyl face of 
the cyclopropene.  It was demonstrated that secondary (Table 4, entry 2) and tertiary amides 
(entries 1, 3, 5), as well as carboxylate moieties (entries 5-7) are effective directing groups.   
 Having met success with in situ trapping of relatively stable cyclopropene intermediates  
65 and 68,  we then set out to apply our methodology to the unstable conjugated cyclopropene 
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intermediate 71 (Scheme 29).
70,71,72
  Lacking any reasonable shelf life, in situ generation and 
trapping of intermediate 71 is not a synthetic shortcut, but is in fact a necessity.
68,69
  
Scheme 29 
 
 
Initial experiments demonstrate that bromocyclopropane 70 undergoes 1,2-dehydrobromination 
in the presence of t-BuOK and catalytic 18-crown-6 to form 71, which is subsequently trapped 
by base to form tert-butyl ether adduct 72 in good yield.  Unlike cyclopropene intermediates 68 
bearing an amide function and yielding diastereomeric ratios indicitave of directing control, the 
adduct of cyclopropene 71 yields predominately a trans-diastereomer.  Given the fact that 71 is 
flat, achiral and has no possibility for a facially selective nucleophilic attack; the selectivity is 
thought to arise from a thermodynamically-driven epimerization of the C-H bond in the α-
position to the carbonyl group after the addition step has occurred.  This was an especially 
exciting result for several reasons.  Not only did it provide a proof of concept that strain release 
energy could be used to drive nucleophilic addition to an α,β-unsaturated amide,
 73
 but it also 
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opened up the possibility for exploiting a new mode of selectivity control in our evolving 
methodology.   
 However, the next step involving the implementation of competing pronucleophiles 
revealed yet another challenge.  It was observed that cyclopropene intermediate 71 is so reactive, 
that 
t
BuOK can compete with isopropoxide, and even to some extent n-propoxide, for the 
electrophilic β-carbon (Scheme 29).  To remedy this, we first had to take into account two 
observations.  First, the fact that the carbonyl group on bromocyclopropane 70 renders the α-CH 
bond relatively acidic suggests that a potentially weaker base could be utilized for 
dehydrobromination.  Secondly, during optimization of a preparative synthesis of cyclopropene 
intermediates 68, it was found that KOH can affect 1,2-elimination and even after prolonged 
heating at 110
 o
C
 
, cyclopropene 68b
70,72
 generated from bromocyclopropane 67b in the presence 
of KOH and 18-crown-6, did not show any traces of addition or decomposition (Scheme 30). 
 
Scheme 30 
 
 
Fortunately, utilization of KOH was indeed a solution which allowed for combining the 
1,2-elimination reaction with the addition of an alkoxide, generated in situ from an appropriate 
alcohol pronucleophile, in a sequential chemoselective transformation (Table 5, eq. 2). 
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Table 5: Addition of alkoxides to conjugated cyclopropenyl carboxamides 
 
no. R
1
, R
2
 RO product yield, %
b
 dr
c
 dr upgraded
d
 
1 t-Bu, H (70a) n-PrO 72b 71 9:1 39:1 (100) 
2 t-Bu, H (70a) MeOCH2CH2O 72c 97 8:1 19:1 (97) 
3 Et, Et (70b) MeOCH2CH2O 72d 87 16:1  
4 t-Bu, H (70a) CH2=CH(CH2)3O 72e 85 7:1 19:1 (95) 
5 morph
e
 (70c) CH2=CH(CH2)3O 72f 84 12:1  
6 t-Bu, H (70a) m-NO2C6H4CH2O 72g 81 8:1 24:1 (98) 
7 Et, Et (70b) m-NO2C6H4CH2O 72h 93 7:1 22:1 (97) 
8 Et, Et (70b) PhCH2O 72i 87
f
 6:1 >50:1 (100) 
9 t-Bu, H (70a) c-HexNH(CH2)3O 72j 78 14:1  
10 piper
g
 (70d) CH2=CHCH2O 72k 95
h
 15:1  
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Table 5 (continued) 
no. R
1
, R
2
 RO product yield, %
b
 dr
c
 dr upgraded
d
 
11 piper
g
 (70d) PhCH=CHCH2O 72l 81 19:1  
12 t-Bu, H (70a) HCC-CH2O 72m 78
h
 10:1  
13 t-Bu, H (70a) i-PrO 72n 71 8:1 16:1 (96) 
14 t-Bu, H (70a) HCC-CMe2O 72o 59 10:1  
15 t-Bu, H (70a) Ph3CO 72p 50 25:1  
16 Me, MeO PhCH2O 72q 44
j
 >25:1  
a
 Reactions performed in 0.3-0.5 mmol scale unless specified otherwise.   
b
 Isolated yields of diastereomeric 
mixtures.  
c
 dr (trans:cis) determined by GC or 
1
H NMR analysis of crude reaction mixtures prior to the 
diastereoselectivity upgrade.   
d
 dr (trans:cis) determined by GC or 
1
H NMR analysis of crude reaction mixtures 
after the diastereoselectivity upgrade, material balance (%) is given in parentheses.   
e
 morph = morpholine 
derivative, R
1
R
2
 = (CH2CH2)2O.   
f
 Reaction performed in 8 mmol scale.  
 g
 piper = piperidine derivative, R
1
R
2
 = 
(CH2)5.   
h
 Reaction carried out at 50 
  C 
.   
i
 Reaction mixture was stirred for 3 hrs at 60 
  C 
.  
j
 t-BuOK (2.5 equiv) was 
employed as base, the reaction was performed at r.  t.   
 
Having a chemoselective method for the addition of pronucleophiles, the scope of this 
transformation was investigated with respect to the N-substituents on cyclopropanes 70 as well 
as the compatibility of functional groups and steric factors associated with the nucleophile.  
Thus, the reaction of bromocyclopropane 70a with KOH in the presence of n-propanol and 
catalytic amounts of 18-crown-6 proceeded smoothly affording trans-n-propoxide adduct 72b in 
good yield and high diastereoselectivity.  Functional group compatibility was demonstrated 
through addition of other primary alkoxides possessing functional groups, such as a methyl ether 
or an isolated C=C double bond which added very efficiently without subsequent olefin 
isomerization or other chemoselectivity issues; providing cyclopropanol ethers 72c, 72d, 72e, 
and 72f in high yields (entries 2-5).  Formal substitution with alkoxides generated from allyl and 
cinnamyl alcohols
72
 also proceeded smoothly, affording the corresponding ethers 72k and 72l 
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(entries 10 and 11).  Similarly, a reaction carried out in the presence of propargyl alcohol readily 
afforded propargyl ether 72m (entry 12).  It should be mentioned that the latter reaction must be 
performed at temperatures <60 
 o
C
 
 and monitored closely to prevent a base-assisted 1,3-
prototropic rearrangement of allyl and propargyl ether moieties into enol and allenyl ether 
functions, respectively.   
 After demonstrating that m-nitrobenzyl and benzyl-protected alcohols could be added 
(entries 6-7 and 16) we set out to investigate scalability.  Utilizing benzyl alcohol as a 
nucleophile, we were able to isolate benzyl-protected cyclopropanol 72i (entry 8) on 8 mmole 
scale via vacuum distillation in 87% yield.  It is also noteworthy that cyclopropanes bearing both 
secondary and tertiary amides readily undergo nucleophilic addition.  In the case of secondary 
amides, the relatively acidic N-H bond can undergo deprotonation by KOH to form equilibrium 
species 71aii (Figure 2).  As a consequence of charge delocalization, the electrophilicity of 71aii 
should be much less than electronically neutral 71ai.  That being said, cyclopropanes bearing 
secondary amides readily undergo nucleophilic addition (Table 5, entries 1-2, 4, 6, 9, 12-15), 
indicating that either 71aii is not present in significant quantities, or that 71aii is still sufficiently 
reactive despite being highly deactivated.  In the case of tertiary amides such as 71b, potentially 
negative steric interactions did not seem to effect reaction efficacy (Table 5, entries 3, 5, 7-8, 10-
11), yielding cyclopropanol derivatives bearing a tertiary carboxamide in good to excellent 
yields. 
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Figure 2: Potential electronic and steric challenges to nucleophilic addition. 
 
When bifunctional 3-cyclohexylaminopropanol pronucleophile bearing an N- and O- 
terminus was reacted with bromocyclopropane 71a, the reaction was chemoselective for the O-
terminus yielding exclusively cyclopropyl ether 72j in good yield (entry 9).  Initially, it was 
rationalized that chemoselectivity was a result of selective deprotonation of more acidic O-H 
bond, however further investigations that will be discussed in following sections revealed that 
nitrogen nucleophiles require an activating group in order to add to conjugated cyclopropene 
intermediates.   
Finally the impact of the steric environment about the alkoxide nucleophile was 
investigated.  While primary alkyl and benzyl as well as secondary alkoxide nucleophiles add 
with good to excellent yield
74
 (71-97% yield; Table 5, representative entries 1, 3, 7 and 13); it 
was found that tertiary alcohols were viable, but suffered from diminished yields as steric bulk 
increased.  For example, tertiary propargyl alcohol added to form propargyl ether 72o in 59% 
yield (entry 14).  When extremely bulky trityl alcohol was used, only 50% of the corresponding 
ether 72p was isolated.   
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Regardless of the nucleophile source, all of these additions provided trans-
cyclopropylethers as major products.  However, in some cases, the relatively low basicity of 
hydroxide led to incomplete epimerization and less than ideal diastereoselectivity was achieved 
(Table 5, entries 1-2, 4, 6-8, 13).  Initial attempts at improving selectivity via increasing base 
loading, reaction temperature or reaction time had no effect.  However it was found that after 
removing solvent, crude mixtures could be treated with fresh THF and t-BuOK, which 
significantly improved diastereomeric ratios without notable decomposition (Table 6).   
Table 6: Epimerization protocol  
 
  
dr before 
treatment 
dr after 
treatment 
material 
balance, % 
72b 9:1 39:1 100 
72c 8:1 19:1 97 
72e 7:1 19:1 95 
72i 6:1 >50:1 100 
72n 8:1 16:1 96 
 
We also questioned whether the thermodynamic control of the diastereoselectivity is 
realized via an epimerization of the tertiary carbon atom adjacent to the amide functionality, or 
via a reversible addition of a nucleophilic species.  To clarify the mechanism, we performed a 
crossover experiment employing a pair of 2-alkoxycyclopropane carboxamides 72c and 72h, 
bearing different alkoxide and amide groups.   A mixture of 72c and 72h was subjected to the 
typical reaction conditions in the presence of either KOH or t-BuOK as a base.  In both cases no 
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formation of crossover products 72g and 72d was detected by GC analysis of the crude reaction 
mixtures (Scheme 31).   These results strongly support irreversibility of the nucleophilic addition 
which, in turn, suggests that thermodynamic control of the diastereoselectivity in this reaction is 
realized solely via a base-assisted epimerization of the α-CH group. 
Scheme 31.  Test on Reversibility of the Nucleophilic Addition of Alkoxide Species 
 
 
Conditions i: 72c (50 μmol), 72h (50 μmol), 18-crown-6 ((5 μmol), KOH (175 μmol), THF (500 
μL), 85 
  
 C
 
, 48 h.  Conditions ii: Same as above, but using  t-BuOK (175 μmol) in place of KOH. 
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2.3. Phenoxide addition 
 
While there has been interest in β-phenoxy substituted amides as antitumor agents,
75
 
protein modulators
75b
 and Alzheimer’s therapeutics,
76
 these compounds are accessed via addition 
to epoxide-substituted amides or through substitution of a β-bromomethylene group; resulting in 
a non-stereogenic center.  Reports of efficient, diastereoselective methods to add aryloxy 
moieties to the β-carbon of amides are non-existent in literature.  Conjugate addition to an 
unsaturated amide would be an attractive method to achieve this goal.
77
 With an established 
protocol for the addition of alkoxides to unsaturated cyclopropenyl amides, we ventured to 
extend this methodology to the addition of aryloxide species.
78
 To our delight, reactions between 
cyclopropyl bromide and phenol provided phenyl ether in good isolated yield and high 
diastereoselectivity (Table 7, eq.  7).
72  
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Table 7: Phenoxide addition 
 
no. R
1
, R
2
 ArO product yield, %
b
 dr
c
 dr upgraded
d
 
1 t-Bu, H (70a) PhO 73a 79 6:1 >50:1 (96) 
2 t-Bu, H (70a) p-MeOC6H4O 73b 75 7:1 >50:1 (97) 
3 t-Bu, H (70a) p-BrC6H4O 73c 86 8:1 46:1 (100) 
4 t-Bu, H (70a) p-IC6H4O 73d 80 10:1  
5 t-Bu, H (70a) p-PhCOC6H4O 73e 90 10:1  
6 t-Bu, H (70a) p-NCC6H4O 73f 74 10:1 42:1 (96) 
7 t-Bu, H (70a) o-FC6H4O 73g 89 12:1  
8 t-Bu, H (70a) o-CF3OC6H4O 73h 84 15:1  
9 Et, Et (70b) o-FC6H4O 73i 82 12:1  
10 t-Bu, H (70a) 3,5-(CH3)2C6H3O 73j 95 13:1  
11 morph
e
 (70c) 3,5-(CH3)2C6H3O 73k 87 20:1  
12 t-Bu, H (70a) 3,5-(CF3)2C6H3O 73l 85 17:1  
13 t-Bu, H (70a) 2,4-(t-Bu)2C6H3O 73m 95 15:1  
14 morph
e
 (70c) 2,6-(CH3)2C6H3O 73n 83 25:1  
15 piper
f
 (70d) quinolin-8-olate 73o 97 single  
a
 Reactions performed in 0.3-0.5 mmol scale unless specified otherwise.   
b
 Isolated yields of diastereomeric 
mixtures.   
c
 dr (trans:cis) determined by GC or 
1
H NMR analysis of crude reaction mixtures.   
d
 dr (trans:cis) 
determined by GC or 
1
H NMR analysis of crude reaction mixtures after diastereoselectivity upgrade, material 
balance (%) is given in parentheses.   
e
 morph = morpholine derivative, R
1
R
2
 = (CH2CH2)2O.   
f
 piper = piperidine 
derivative, R
1
R
2
 = (CH2)5.    
36 
 
 
Electronically diverse para-substituted aryloxides also reacted smoothly producing the 
corresponding aryl cyclopropyl ethers 73b, 73c, 73d, 73e, 73f in high yields (entries 2-6).  
Similarly, excellent reactivity was demonstrated in the addition of ortho-substituted phenoxides 
(entries 7-9).  Both electron-rich and electron-poor 3,5-disubstituted phenoxides reacted 
smoothly to produce aryloxycyclopropanes 73j, 73k, and 73l (entries 10-12).  Remarkably, 
highly sterically encumbered phenoxides derived from 2,4-di-tertbutylphenol, 2,6-
dimethylphenol, and 8-hydroxyquinoline provided the corresponding adducts 73m, 73n, and 73o 
in high yields and excellent diastereoselectivities (entries 13-15).   
It also deserves noting that formal substitution with phenoxides proceeded much slower 
and required higher temperatures to achieve complete conversion, as compared to analogous 
reactions with alkoxides.  This difference can be explained in terms of increased acidity of 
phenols, which readily produce phenoxides and water by a stoichiometric reaction with KOH.  
Although small amounts of moisture do not adversely affect this transformation, formation of the 
hydroxide-phenoxide “buffer” lowers the effective basicity of the system.  This, in turn, results 
in significant inhibition of the dehydrobromination step.  The latter process is a rate-determining 
step in this reaction, which was confirmed by the fact that the overall kinetic rate of the 
transformation did not depend on electronic properties of the phenoxide species.  The Swain-
Lupton LFER parameters obtained from a series of competing parallel reactions reveal a 
profound negative F-value, indicating the diminution of the negative charge in the anionic 
phenoxide reagent as a result of addition to an electrophilic double bond (Figure 3). 
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Figure 3.  Swain-Lupton LFER studies of the formal nucleophilic substitution of 
bromocyclopropane 70a with aryloxides.
79
 
 
With a well-elaborated protocol for intermolecular addition of oxygen–based 
nucleophiles in hand, we began investigating intramolecular cyclization reactions.  Initial 
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attempts involved 7-endo-trig cyclization of bromocyclopropane 74 which did not yield any 
observable quantity of 76.  It is thought that intermediate 75 is too strained for intramolecular 
addition and instead prefers intermolecular addition to another equivalent of 75, resulting in 
polymeric products.  8-endo-trig cyclization of alkoxy-tethered cyclopropane 77 on the other 
hand, proceeds smoothly yielding 8-membered heterocyclic adducts 79a-c in excellent yield 
(Scheme 32).   
Scheme 32 
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When attempting 8-endo-trig cyclization of phenoxide-tethered cyclopropane 80, it was found 
that increasing steric bulk of the amide substituent has a positive effect on the efficacy of the 
reaction (Scheme 33). 
Experimentally, it was observed that cyclizations of N-hexyl (80a) and N-cyclohexyl 
(80b) derivatives proceeded sluggishly to give 40-50% conversion, and after a laborious 
purification benzoxacinones 81a and 81b were isolated in ~30% yield only.  In contrast, N-tert-
butyl amide 80c reacted cleanly affording cyclization product 81c in high yield (Scheme 33).  To 
explzin this observation, we rationalized that upon forming cyclopropene intermediate 80i, the 
phenoxide anion is coordinated with potassium, which in turn is also coordinated with the 
carbonyl oxygen.  This coordination would cause the phenoxide anion to rotate away from the 
electrophilic β-carbon leaving the molecule in a non-reactive conformation.  If the amide 
substituent is sufficiently bulky, de-coordination is favored allowing the phenoxide anion to 
rotate into reactive conformation 80ii for nucleophilic attack on the olefin.   
Scheme 33 
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2.4. Thiolate addition 
 
 Given our success with the addition of relatively soft phenoxide nucleophiles, we began 
exploring the addition of thiolates to bromocyclopropanes 70 (Table 8, eq 8).  These reactions 
were carried out under conditions identical to those used for phenoxide addition, in the presence 
of alkylthiol pronucleophiles to afford the corresponding cyclopropylsulfides 82a, 82b, 82c in 
high yields but with only marginal diastereoselectivity.  The selectivity was substantially 
improved, however, upon treatment of the crude products with a stronger base (entries 1-3).   
The chemoselectivity in the reaction with bifunctional nucleophiles 2-mercaptoethanol and 2-
(benzylamino)ethanethiol was investigated (entries 4-6).   Expectedly, the less reactive alkoxide 
and the 2
o
 amine moieties were completely outcompeted by the much more nucleophilic thiolate 
species, leading to the exclusive formation of cyclopropyl sulfides 82d, 82d, and 82e (entries 4-
6).   Interestingly, the reactions with 2-mercaptoethanol were sufficiently stereoselective for 
preparative purpose, therefore no further diastereoselectivity upgrade was necessary (entries 4-
5).   Finally, the reaction with thiophenol provided the corresponding adduct 82f in high yield 
and poor diastereoselectivity, which was routinely upgraded after treatment of the crude reaction 
mixture with potassium tert-butoxide (Table 8, entry 7).     
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Table 8.  Formal nucleophilic substitution of bromocyclopropanes with thiolates and 
thiophenols
a 
 
no. R
1
, R
2
 RS product yield, %
b
 dr
c
 dr upgraded
d
 
1 Bu, H (70f) n-C12H25S 82a 95 1:1 16:1 
2 morph
e
 (70c) PhCH2S 82b 92 2:1 >30:1 
3 PhCH2, H (70g) PhCH2S(CH2)3S 82c 87 2:1 >30:1 
4 t-Bu, H (70a) HOCH2CH2S 82d 97 10:1  
5 Ph, H (70h) HOCH2CH2S 82d 85 >30:1  
6 Bu, H (70f) PhNHCH2CH2S 82e 94 2:1 >30:1 
7 Bu, H (70f) PhS 82f 98 2:1 >30:1 
a
 Reactions performed in 0.5 mmol scale unless specified otherwise.   
b
 Isolated yields of diastereomeric mixtures 
after the diastereoselectivity upgrade.   
c
 dr (trans:cis) determined by GC or 
1
H NMR analysis of crude reaction 
mixtures prior to the upgrade.   
d
 dr (trans:cis) determined by GC or 
1
H NMR analysis of crude reaction mixtures 
after the diastereoselectivity upgrade.   
e 
morph = morpholine derivative, R
1
R
2
 = (CH2CH2)2O. 
 
2.5. Conclusions 
 
In situ generation and trapping of cyclopropene has been demonstrated as a viable 
approach to accessing a variety of sterically and functionally diverse cyclopropanol and 
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cyclopropyl thiol derivatives, even when the generated cyclopropene has no shelf life.  We 
demonstrated that diastereoselectivity can be controlled by steric factors, directing groups or 
thermodynamic epimerization of the nucleophilic adduct, granting access to stereodefined 
DAC’s from diastereomeric mixtures of starting material.  Through this methodology, we have 
demonstrated a new activation pathway for oxa- and thio- Michael additions, showing 
unprecedented reactivity towards alkoxide and aryloxide nucleophiles.   
2.6. Experimental 
2.6.1. General Information 
 
NMR spectra were recorded on a Bruker Avance DPX-400 instrument, equipped with a 
quadruple-band gradient probe (H/C/P/F QNP) or a Bruker Avance DRX-500 with a dual 
carbon/proton cryoprobe (CPDUL).  
13
C NMR spectra were registered with broad-band 
decoupling.  The (+) and (-) designations represent positive and negative intensities of signals in 
13
C DEPT-135 experiments.  Column chromatography was carried out employing silica gel 
(Selecto Scientific, 63-200 μm).  Pre-coated silica gel plates (Merck Kieselgel 60 F-254) were 
used for thin-layer chromatography.  GC/MS analyses were performed on a Shimadzu GC-2010 
gas chromatograph interfaced to a Shimadzu GCMS 2010S mass selective detector, and 
equipped with an AOC-20i auto-injector and an AOC-20S auto-sampler tray (150 vials).   30 m 
 0.25 mm  
employed.  Helium (99.96%), additionally purified by passing consecutively through a CRS 
oxygen/ moisture/hydrocarbon trap (#202839) and VICI oxygen/moisture trap (P100-1), was 
used as a carrier gas.  High resolution mass-spectra were obtained using a LCT Premier 
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(Micromass Technologies) instrument using electrospray ionization and time of flight detection 
techniques.   IR spectra were recorded on a Shimadzu FT-IR 8400S instrument.   
Glassware employed in moisture-free syntheses was flame-dried in vacuum prior to use.  
Water was purified by dual stage deionization, followed by dual stage reverse osmosis.   
Anhydrous THF was obtained by passing degassed commercially available HPLC-grade 
inhibitor-free solvent consecutively through two columns filled with activated alumina 
(Innovative Technology).   Anhydrous Et3N was obtained by distillation of ACS-grade 
commercially available materials over calcium hydride in a nitrogen atmosphere.  3-
Benzylamino-1-propanol was purchased from TCI America and used as received.  All other 
commercially available reagents were purchased from Sigma-Aldrich or Acros Organics.  
Synthesis, physical properties and spectral data of all new compounds obtained in a frame of 
these studies are described below.  All manipulations with t-BuOK and 18-crown-6 ether were 
conducted under inert atmosphere (<8 ppm residual oxygen and moisture) using a combination 
of glovebox and standard Schlenk techniques.  After quench the reaction mixtures and 
compounds were treated on air.  All the obtained materials were moisture and oxygen stable at 
ambient temperatures. 
 
2.6.2. Synthesis of 2,2-Dibromocyclopropanecarboxylic acid derivatives 
 
2,2-Dibromocyclopropanecarboxylic acid (83): A three neck round-bottom 
2000 mL flask was equipped with an overhead mechanical stirrer, dropping 
funnel and Dewar condenser (filled with a dry ice-acetone mixture) connected to a cylinder with 
1,3-butadiene.  The flask was filled with dry nitrogen and charged with t-BuOK (123 g, 1.10 
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mol) and 450 mL of anhydrous hexane, then cooled down to -50  
o
C, and 1,3-butadiene (76 g, 
117 mL, 1.40 mol) was condensed.  The formed suspension was vigorously stirred at -50 
o
C , 
while a solution of bromoform (270 g, 95 mL, 1.07 mmol) in dry hexane (200 mL) was added 
dropwise over 2 hrs.  After the addition was complete the reaction mixture was stirred for 1 hr at 
-50 
o
C, and then warmed up to room temperature.  To destroy unreacted bromoform an 
additional portion of t-BuOK was added (11 g, 0.10 mol), the mixture was stirred for 2 hrs, and 
then quenched with water (500 mL).  The organic layer was separated; the aqueous phase was 
extracted with hexane (3 x 100 mL).  Combined organic phases were dried with MgSO4, filtered 
and concentrated in vacuum.  The oily residue was distilled in vacuum to afford 2,2-dibromo-1-
vinylcyclopropane as a colorless oil.  Yield 162 g (716 mmol, 67%).  This material was oxidized 
to the corresponding carboxylic acid by KMnO4 under PTC-conditions.  A 4000 mL Erlenmeier 
flask equipped with overhead stirrer, and thermometer was charged with water (1200 mL), 
glacial acetic acid (25 mL), a solution of H2SO4 (75 mL) in water (100 mL), a solution of 2,2-
dibromo-1-vinylcyclopropane (90.4 g, 0.40 mmol) in CH2Cl2 (1200 mL), and cetrimide (2.9 g, 8 
mmol).  The mixture was vigorously stirred at 5 
o
C  (cooled in rock salt-ice bath), and KMnO4 
(213 g, 1.35 mmol) was added by portions over 2 hrs.  The mixture was warmed to room 
temperature, and stirred for additional 2 hrs.  Then a solution of H2SO4 (54 mL) in water (500 
mL) was added, followed by powdered Na2SO3 (179 g, 1.42 mol), which was put in by small 
portions maintaining the temperature in the interval of 15-20 
o
C until the brown precipitate of 
MnO2 dissolved completely.  The organic layer was separated, and the aqueous phase was 
extracted with CH2Cl2 (2 x 500 mL).  Combined organic solutions were concentrated to the total 
volume of 500 mL and extracted with 1M aqueous NaOH (400 mL, 100 mL).  Combined 
aqueous extracts were acidified with 5M aqueous H2SO4 (60 mL) and extracted with CHCl3 (300 
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mL, 3 x 200 mL).  The combined organic extracts were dried with MgSO4, filtered and 
concentrated in vacuum.  A similar reaction was performed with a second batch of 
vinylcyclopropane  (71.6 g, 31.7 mmol).  Combined crude acid from both batches was purified 
by recrystallization from hexane-benzene (3:2) to obtain pure 83 as colorless crystals, identical to 
the material previously described in literature.2 Yield 85.37 g (0.35 mmol, 49%). 
 
2,2-Dibromocyclopropanecarbonyl chloride (84): A mixture of carboxylic 
acid 83 (26.9 g, 110 mmol) and thionyl chloride (20.0 mL, 276 mmol) was 
stirred overnight at room temperature under an atmosphere of dry nitrogen.  The excess thionyl 
chloride was distilled out at ambient pressure, and the residue was distilled in vacuum (bp 82-84 
o
C /4 torr) to afford acyl chloride 84 as colorless oil, identical to the material previously 
described in literature.3 Yield 26.3 g (100 mmol, 91%). 
 
2,2-Dibromo-N-tert-butylcyclopropanecarboxamide (85a): 
Typical procedure.  To a stirred solution of acyl chloride 84 (6.00 g, 22.9 
mmol) in dry THF (40 mL) was added tert-butylamine (3.90 mL, 2.74 g, 45.8 mmol).  The 
mixture was stirred at room temperature overnight, then partitioned between water (100 mL) and 
EtOAc (50 mL).  The organic layer was separated; the aqueous phase was extracted with EtOAc 
(2 x 50 mL).  Combined organic extracts were washed with brine (50 mL), dried with MgSO4, 
filtered, and concentrated.  The residue was purified by vacuum distillation on Kugelröhr (oven 
temp.  120 
o
C  at 0.4 torr) to afford a colorless crystalline material, mp 107-109 
o
C  (from 
hexane).  Yield 6.60 g (22.2 mmol, 97%).  
1
H NMR (500.19 MHz, CDCl3) δ 5.76 (br.s, 1H), 
2.36 (dd, J = 9.7 Hz, 7.5 Hz, 1H), 2.18 (t, J = 7.5 Hz, 1H), 1.91 (dd, J = 9.7 Hz, 7.5 Hz, 1H), 
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1.42 (s, 9H); 
13
C NMR (125.76 MHz, CDCl3) δ 164.2, 52.3, 35.6, 28.8 (3C), 26.1, 21.3; IR (film, 
cm
-1
): 3308, 3078, 2968, 2967, 1657, 1551, 1454, 1414, 1366, 1271, 1225, 1205, 1103; HRMS 
(TOF ES): found 297.9443, calculated for C8H14Br2NO (M+H) 297.9442 (0.3 ppm). 
 
2,2-Dibromo-N,N-diethylcyclopropanecarboxamide (85b):  
Was obtained according to the typical procedure from acyl chloride 84 (3.00 
g, 11.4 mmol) and diethylamine (2.38 mL, 1.67 g, 22.9 mmol).  Kugelrohr distillation (oven 
temperature 115 
o
C  at 0.4 torr) afforded a title compound as a colorless oil.  Yield 3.286 g 
(10.99 mmol, 96%).  
1
H NMR (500.19 MHz, CDCl3) δ 3.70 (dq, J = 14.3 Hz, 7.3 Hz, 1H), 3.62 
(dq, J = 14.3 Hz, 7.3 Hz, 1H), 3.49 (dq, J = 14.3 Hz, 7.3 Hz, 1H), 3.28 (dq, J = 14.3 Hz, 7.3 Hz, 
1H), 2.57 (dd, J = 9.7 Hz, 7.7 Hz, 1H), 2.28 (t, J = 7.7 Hz, 1H), 1.95 (dd, J = 9.7 Hz, 7.7 Hz, 
1H), 1.34 (t, J = 7.3 Hz, 3H), 1.16 (t, J = 7.3 Hz, 3H); 
13
C NMR (125.76 MHz, CDCl3) δ 164.8, 
42.0 (-), 40.6 (-), 34.0 (+), 26.2 (-), 21.8, 14.1 (+), 12.9 (+); IR (film, cm
-1
): 2974, 2934, 2874, 
1651, 1477, 1447, 1381, 1346, 1263, 1221, 1144, 1107; HRMS (TOF ES):found 224.0657, 
calculated for C8H19BrNO (M-Br) 224.0650 (3.1 ppm). 
 
(2,2-Dibromocyclopropyl)(morpholin-4-yl)methanone (85c): Was 
obtained according to the typical procedure from acyl chloride 84 (3.71 g, 
14.1 mmol) and morpholine (4.0 mL, 3.7 g, 424 mmol).  After aqueous work up and extraction, 
crude crystalline solid was re-crystallized from hexane-dichloromethane mixture to colorless 
glassy solid.  Yield 2.06 g (6.65 mmol, 47%).  
1
H NMR (400.13 MHz, CDCl3) δ 3.96-3.66 (m, 
7H), 3.50 (ddd, J = 13.4 Hz, 7.7 Hz, 3.4 Hz, 1H), 2.56 (dd, J = 10.0 Hz, 7.7 Hz, 1H), 2.29 (t, J = 
7.7 Hz, 1H), 2.02 (dd, J = 10.0 Hz, 7.7 Hz, 1H); 
13
C NMR (125.76 MHz, CDCl3) δ 163.8, 66.20 
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(-), 66.17 (-), 45.5 (-), 42.2 (-), 33.7 (+), 25.7 (-), 20.8; IR (film, cm
-1
): 2974, 2934, 1653, 1483, 
1460, 1448, 1435, 1381, 1362, 1265, 1221, 1142; HRMS (TOF ES): found 234.0127, calculated 
for C8H13BrNO2 (M-Br+H) 234.0130 (1.3 ppm). 
 
2.6.3. Synthesis of 2-bromocyclopropanecarboxamide derivatives 
Nonselective Grignard reduction: 
 
2-Bromo-N-tert-butylcyclopropanecarboxamide (70a): Typical 
procedure.  To a stirred at -50 
o
C  solution of dibromocyclopropane 85a 
(3.20 g, 10.7 mmol) in anhydrous CH2Cl2 (20 mL) was added dropwise a solution of i-PrMgBr 
(2.0M in Et2O, 8.0 mL, 16 mmol).  The mixture was stirred at -50 
o
C  for 15 min, then quenched 
with saturated aqueous NH4Cl (10 mL), followed by 5% aqueous HCl (20 mL) to dissolve 
inorganic precipitate.  Organic layer was separated; aqueous phase was extracted with EtOAc (3 
x 20 mL).  Combined organic solutions were washed with brine, dried with MgSO4, filtered, and 
concentrated.  The residue was purified by Kugelrohr distillation (oven temp.  100 
o
C  at 0.4 torr) 
to afford a mixture of diastereomeric bromocyclopropanes 70a (2.13:1) as colorless solid, mp 
87-89 
o
C .  Yield 1.72 g (7.85 mmol, 73%).  
1
H NMR (500.19 MHz, CDCl3) δ [5.82 (br.s) & 
5.87 (br.s), Σ1H], [3.17 (ddd, J = 7.7 Hz, 4.0 Hz, 3.2 Hz) & 3.08 (td, J = 7.7 Hz, 5.5 Hz), Σ1H], 
1.81-1.72 (m, 1H), 1.58-1.51 (m, 1H), [1.38 (s) & 1.35 (s), Σ9H], [1.34-1.29 (m) & 1.24-1.20 
(m), Σ1H]; 
13
C NMR (125.76 MHz, CDCl3) δ major: 169.1, 51.6, 28.8 (+, 3C), 26.2 (+), 18.9 
(+), 17.2 (-); minor: 169.4, 51.8, 28.9 (+, 3C), 22.5 (+), 19.2 (+), 13.1 (-); IR (film, cm
-1
): 3315, 
3080, 2966,2932, 1641, 1555, 1454, 1391, 1364, 1277, 1225; HRMS (TOF ES): found 220.0340, 
calculated for C8H15BrNO (M+H) 220.0337 (1.4 ppm). 
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2-Bromo-N,N-diethylcyclopropanecarboxamide (75b): Was obtained 
according to a typical procedure from dibromocyclopropane 85b (3.24 g, 
10.82 mmol).  Kugelrohr distillation (oven temp.  70 
o
C  at 0.3 torr) afforded 
a title compound (mixture of diastereomers 7:1) as a colorless oil.  Yield 
2.09 g (9.50 mmol, 88%).  
1
H NMR (400.13 MHz, CDCl3) δ major: 3.49 (q, J = 7.1 Hz, 2H), 
3.39 (q, J = 7.1 Hz, 2H), 3.23 (ddd, J = 7.6 Hz, 4.6 Hz, 3.2 Hz, 1H), 2.12 (ddd, J = 9.2 Hz, 5.9 
Hz, 3.0 Hz, 1H), 1.67 (dt, J = 7.5 Hz, 5.8 Hz, 1H), 1.31 (ddd, J = 9.4 Hz, 5.8 Hz, 4.6 Hz, 1H), 
1.28 (t, J = 7.2 Hz, 3H), 1.12 (t, J = 7.2 Hz, 3H); 
13
C NMR (125.76 MHz, CDCl3) δ major: 
169.0, 42.2 (-), 40.9 (-), 22.6 (+), 19.9 (+), 17.7 (-), 14.9 (+), 13.1 (+); IR (film, cm
-1
): 2964, 
2918, 2856, 1653, 1460, 1437, 1362, 1273, 1234, 1115; GC 8.28 min (minor), 8.42 min (major); 
HRMS (TOF ES): found 220.0333, calculated for C8H15BrNO (M+H) 220.0337 (1.8 ppm). 
 
(2-Bromocyclopropyl)(morpholin-4-yl)methanone (70c): Was obtained 
according to a typical procedure from dibromocyclopropane 85c (2.06 g, 
6.65 mmol).  Flash column chromatography on silica gel (eluent hexane-
EtOAc 3:1) afforded a title compound (single diastereomer) as colorless crystalline solid, mp.  
74-77 
o
C .  Yield 1.34 g (5.74 mmol, 86%).  
1
H NMR (400.13 MHz, CDCl3) δ 3.74-3.50 (m, 
8H), 3.25 (ddd, J = 7.6 Hz, 4.7 Hz, 3.2 Hz, 1H), 2.13 (ddd, J = 9.2 Hz, 6.0 Hz, 3.3 Hz, 1H), 1.77-
1.59 (m, 1H), 1.36 (ddd, J = 9.2 Hz, 5.8 Hz, 4.7 Hz, 1H); 
13
C NMR (125.76 MHz, CDCl3) δ 
168.5, 66.5 (-, 2C), 45.8 (-), 42.4 (-), 22.1 (+), 19.3 (+), 17.7 (-); IR (film, cm
-1
): 2968, 2920, 
2999, 2856, 1632, 1441,1364, 1274, 1242, 1115, 1043; HRMS (TOF ES): found 177.0771, 
calculated for C8H12NO2Na (M-Br+Na) 177.0766 (2.8 ppm). 
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Alternative selective reduction: 
 
 
 
(1S*,2R*)-2-Bromocyclopropanecarbonyl chloride (87): Flame-dried 3000 mL three neck 
round bottom flask was charged with solution of 2,2-dibromocyclopropanecarboxylic acid (83) 
(27.0 g, 111 mmol) in anhydrous ether (1300 mL) under nitrogen atmosphere.  The mixture was 
vigorously stirred (500-650 rpm) at -20 
o
C, and methyl lithium solution (1.6M in ether, 95 mL, 
152 mmol, 1.37 equiv) was added dropwise.  For safety reasons it is essential to add methyl 
lithium directly to a solution rather than draining along the flask wall to minimize the amount of 
solid precipitate, which might ignite during the following work up.  An aliquot of solution (1 
mL) was withdrawn from the flask with a syringe, quenched consecutively with brine (2-3 drops) 
and 5% aqueous HCl (2-3 drops) in 10 mL test tube.  The aqueous layer was saturated with 
NaCl, and extracted with EtOAc (3 x 0.5 mL).  The combined organic phases collected with 
Pasteur pipet were dried with MgSO4 and concentrated.  The conversion was measured based on 
1
H NMR analysis of this probe, and additional amount of MeLi necessary to complete the 
transformation was assessed (35 mL, 56 mmol).  The mixture was quenched at -20 
o
C by adding 
brine (100 mL) and 5% aqueous HCl (100 mL).  (It is essential to perform the quenching at low 
temperature and to maintain inert atmosphere to avoid ignition of the mixture).  The mixture was 
allowed to warm up to rt, then aqueous layer was saturated with NaCl.  Ethereal layer was 
separated, and then aqueous phase was extracted with EtOAc (6 x 100 mL).  Combined organic 
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phases were dried with MgSO4, filtered and concentrated.  The oily residue was distilled in 
vacuum (bp 71 
o
C at 3 torr) to provide (1S*,2R*)-2-bromocyclopropanecarboxylic acid (86) as a 
colorless oil, which solidified upon standing.  Yield 8.79 g (53.3 mmol, 48%).  This material was 
charged into a 25 mL round bottomed flask equipped and thionyl chloride (11.5 g, 110 mmol) 
was added.  The mixture was stirred at room temperature overnight, then an excess of thionyl 
chloride was distilled off, and the residue was fractionated in vacuum to obtain the title 
compound as clear oil, bp 56 
o
C at 15 torr.  Yield 9.19 g (50.1 mmol, 94%). 
 
 
 
(1S*,2R*)-2-bromo-N-cyclohexylcyclopropanecarboxamide (70d) 
(typical procedure): To a stirred solution of cyclohexylamine (1.87 mL, 
1.62 g, 16.4 mmol, 3 equiv.) in dry THF (30 mL) was added trans-2-
bromocyclopropanecarbonyl chloride 87 (1.0 g, 5.5 mmol).  The mixture was stirred for 1 hr at 
room temperature, and then the solvent was removed in vacuum.  The residue was partitioned 
between 10% aqueous HCl (20 mL) and EtOAc (20 mL).  The organic layer was separated and 
washed consecutively with 10% aqueous HCl (3 x 20 mL) and 4N aqueous NaOH (5 mL), dried 
with MgSO4, filtered and concentrated.  The obtained colorless crystalline material (mp 102-105 
o
C) was pure enough to be used for the following transformations without additional purification.  
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Yield 1.26 g (5.12 mmol, 94%).  
1
H NMR (500.13 MHz, CD3OD) δ ppm 3.62 (tt, J = 10.7 Hz, 
3.7 Hz, 1H), 3.14 (ddd, J = 7.9 Hz, 4.7 Hz, 3.2 Hz, 1H), 1.99 (ddd, J = 9.1 Hz, 6.0 Hz, 3.2 Hz, 
1H), 1.90-1.80 (m, 2H), 1.79-1.72 (m, 2H), 1.67-1.61 (m, 1H), 1.49 (dt, J = 7.6 Hz, 6.0 Hz, 1H), 
1.40-1.30 (m, 2H), 1.28-1.16 (m, 4H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 171.7, 50.2 (+), 
34.0 (-), 33.9 (-), 26.8 (-), 26.24 (-, 2C), 26.18 (+), 19.3 (+), 17.8 (-); FTIR (NaCl, film, cm
-1
): 
3292, 2932, 2854, 1634, 1553, 1450, 1393, 1211, 1024, 945, 981, 843; HRMS (TOF ES): found 
246.0483, calculated for C10H17BrNO (M+H) 246.0494 (4.5 ppm). 
 
(1S*,2R*)-2-Bromo-N-tert-butylcyclopropanecarboxamide (70a): The 
reaction was performed according to the typical procedure, employing acyl 
chloride 87 (1.0 g, 5.5 mmol) and tert-butylamine (1.72 mL, 1.20 g, 16.4 mmol) to produce the 
title compound as a colorless solid, yield 1.13 g (5.12 mmol, 93%).  The physical and spectral 
properties of this material were identical to those reported above. 
 
((1S*,2R*)-2-Bromocyclopropyl)(morpholino)methanone (70b): The 
reaction was performed according to the typical procedure, employing acyl 
chloride 87 (1.0 g, 5.5 mmol) and morpholine (1.42 mL, 1.43 g, 16.4 mmol) 
to produce the title compound as a colorless solid, yield 1.16 g (4.95 mmol, 90%).  The physical 
and spectral properties of this material were identical to those reported above.   
 
((1S*,2R*)-2-Bromocyclopropyl)(piperidin-1-yl)methanone (70c): The 
reaction was performed according to the typical procedure, employing acyl 
chloride 87 (1.0 g, 5.5 mmol) and piperdine (1.64 mL, 1.40 g , 16.4 mmol) to produce the title 
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compound as a colorless oil, yield 1.20 g (5.18 mmol, 95%).  
1
H NMR (500.13 MHz, CDCl3) δ 
ppm 3.63-3.59 (m, 2H), 3.57-3.53 (m, 2H), 3.22 (ddd, J = 9.5 Hz, 6.0 Hz, 3.2 Hz, 1H), 1.70-1.61 
(m, 5H), 1.57-1.52 (m, 2H), 2.18 (ddd, J = 7.6 Hz, 4.7 Hz, 3.2 Hz, 1H), 1.31 (ddd, J = 9.5 Hz, 
6.0 Hz, 4.7 Hz, 1H); 
13
C NMR (125.76 MHz, CDCl3) δ ppm 168.1, 46.8 (-), 43.4 (-), 26.6 (-), 
25.4 (-), 24.5 (-), 22.6 (+), 19.6 (+), 17.5 (-); FTIR (NaCl, film, cm
-1
): 2935, 2854, 1634, 1445, 
1367, 1354, 1254, 1223, 1138, 1024, 955, 926, 852; HRMS (TOF ES): found 232.0327, 
calculated for C9H15BrNO (M+H) 232.0337 (4.3 ppm). 
 
2-Bromo-N-phenylcyclopropanecarboxamide (70h):  The reaction was 
performed according to the typical procedure, employing aniline (930 mg, 
10 mmol, 2.5 equiv.) and 2-bromocyclopropanecarbonyl chloride (730 mg, 4.0 mmol).   Yield 
874 mg (3.64 mmol, 91%).   
1
H NMR (500.13 MHz, CDCl3) δ 7.66 (br.  s., 1H), 7.50 (d, J = 7.9 
Hz, 2H), 7.34 (t, J = 7.7 Hz, 2H), 7.14 (t, J = 7.4 Hz, 1H), 3.34 (ddd, J = 7.7 Hz, 4.9 Hz, 3.2 Hz, 
1H), 1.98 (ddd, J = 8.9 Hz, 5.8 Hz, 3.0 Hz, 1H), 1.77 (dt, J = 7.6 Hz, 6.0 Hz, 1H), 1.43 (dt, J = 
9.0 Hz, 5.4 Hz, 1H); 
13
C NMR (125.76 MHz, CDCl3) δ 168.4, 137.6, 129.1 (+, 2C), 124.6 (+), 
119.9 (+, 2C), 26.6 (+), 19.3 (+), 18.2 (-);  FT IR (NaCl, film, cm
-1
): 3300, 3063, 2932, 1657, 
1547, 1447, 1385, 1186, 1024, 756;  HRMS (TOF ES): found 261.9844, calculated for 
C10H10BrNONa (M+Na) 261.9843 (0.4 ppm).   
N-Benzyl-2-bromocyclopropanecarboxamide (70g): The reaction was 
performed according to the typical procedure, employing benzylamine 
(1.10 g, 10.0 mmol, 2.50 equiv.) and 2-bromocyclopropanecarbonyl chloride (730 mg, 4.0 
mmol).   Yield 910 mg (3.57 mmol, 89%).   
1
H NMR (400.13 MHz, CDCl3) δ ppm 7.37-7.23 (m, 
5H), 6.89 (br.  s., 1H), 4.42-4.31 (m, 2H), 3.18 (ddd, J = 7.6 Hz, 4.7 Hz, 3.0 Hz, 1H), 1.91 (ddd, 
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J = 9.2 Hz, 5.9 Hz, 3.0 Hz, 1H), 1.58 (dt, J = 7.6 Hz, 5.9 Hz, 1H), 1.27 (dt, J = 9.2 Hz, 5.4 Hz, 
1H);  
13
C NMR (100.67 MHz, CDCl3) δ 170.2, 137.7, 128.6 (+, 2C), 127.6 (+, 2C), 127.5 (+), 
43.8 (-), 25.3 (+), 19.0 (+), 17.5 (-);  FT IR (NaCl, film, cm
-1
): 3296, 3088, 3063, 2930, 1634, 
1553, 1454, 1213, 1034, 746, 696, 515;  HRMS (TOF ES): found 254.0176, calculated for 
C11H13BrNO (M+H) 254.0181 (2.0 ppm). 
2-Bromo-N-butylcyclopropanecarboxamide (70f): The reaction was 
performed according to the typical procedure, employing butylamine 
(0.73 g, 10.0 mmol, 2.50 equiv.) and 2-bromocyclopropanecarbonyl chloride (730 mg, 4.0 
mmol).  Yield 809 mg (3.68 mmol, 92%).  
1
H NMR (500.13 MHz, CD3OD) δ 3.19 (t, J = 6.9 Hz, 
2H), 3.16 (td, J = 7.6 Hz, 4.7 Hz, 3.2 Hz, 1H), 2.01 (ddd, J = 9.2 Hz, 5.9 Hz, 3.2 Hz, 1H), 1.55-
1.46 (m, 3H), 1.38 (sxt, J = 7.4 Hz, 2H), 1.32-1.25 (m, 1H), 0.95 (t, J = 7.3 Hz, 3H);  
13
C NMR 
(125.76 MHz, CD3OD) δ 172.7, 40.6 (-), 32.7 (-), 26.1 (+), 21.2 (-), 19.2 (+), 17.8 (-), 14.2 (+);  
FT IR (NaCl, film, cm
-1
): 3302, 3092, 3065, 2959, 2932, 2872, 2419, 1634, 1462, 1223, 1020, 
953, 800, 696;  HRMS (TOF ES): found 220.0337, calculated for C8H15BrNO (M+H) 220.0337 
(0.0 ppm). 
 
(1S*,2R*)-2-Bromo-N-methoxy-N-methylcyclopropanecarboxamide 
(70e): To a solution of carboxylic acid 86 (3.27 g, 19.82 mmol) in dry 
CH2Cl2 (60 mL) was added 1,1-carbonyldiimidazole (3.86 g, 23.8 mmol, 1.20 equiv) at 0 
o
C, and 
the resulting mixture was stirred for 30 min.  Then N,O-dimethylhydroxylamine hydrochloride 
(4.50 g, 46.5 mmol, 2.35 equiv) was added; the resulting suspension was stirred for 24 hrs at 
room temperature, then filtered.  The filter cake was washed with DCM.  The filtrate was washed 
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with water, brine, dried with MgSO4, filtered, and concentrated in vacuum to give 3.41 g (16.4 
mmol, 83%) of Weinreb amide 70e as an yellow oil.  
1
H NMR (500.13 MHz, CDCl3) δ ppm 3.80 
(s, 3H), 3.24 (ddd, J = 7.6 Hz, 4.7 Hz, 3.2 Hz, 1H), 3.22 (s, 3H), 2.59 (br.  s, 1H), 1.65 (dt, J = 
7.6 Hz, 6.0 Hz, 1H), 1.39 (ddd, J = 9.5 Hz, 5.7 Hz, 4.7 Hz, 1H); 
13
C NMR (125.76 MHz, CDCl3) 
δ ppm 171.1, 61.9 (+), 32.5 (+), 21.2 (+), 19.9 (+), 18.0 (-); FTIR (teflon, film, cm
-1
): 3501, 
3082, 3069, 3003, 2966, 2937, 2901, 1655, 1475, 1462, 1421, 1391, 1327, 1207, 1177, 1153, 
1105, 1016, 997, 943, 760, 727, 609, 582, 507, 440; HRMS (TOF ES): found 207.9974, 
calculated for C6H11BrNO2 (M+H) 207.9973 (0.5 ppm). 
 
2.6.4. Preparation of Nucleophiles 
Thiols 
 
2-(Phenylamino)ethanethiol:
80
 An oven dried 250 mL round bottom flask 
equipped with a reflux condenser was charged with 2-(phenylamino)ethanol 
(686 mg, 5.00 mmol), 2,4-bis(4-methoxyphenyl)-1,3,2,4-dithiadiphosphetane-2,4-disulfide 
(Lawesson’s reagent, 1.01 g, 2.50 mmol) and dry toluene (150 mL).  The mixture was stirred at 
reflux for 1 hr, and then filtered through a frit funnel.   The filtrate was concentrated, and the 
crude residual oil was distilled in vacuum.   (Kugelrohr oven temperature 250 
o
C, at 2.5 torr) to 
yield colorless oil (475 mg, 3.10 mmol, 62% yield).   
1
H NMR (500.13 MHz, CDCl3) δ 7.22 
(app.  t, J = 8.2 Hz, 7.3 Hz, 2H), 6.77 (t, J = 7.3 Hz, 1H), 6.87 (d, J = 8.2 Hz, 2H), 3.39 (t, J = 6.3 
Hz, 2H), 2.81 (q, J = 6.6 Hz, 2H), 1.44 (t, J = 6.9 Hz, 1H, 1H, suppressed after treatment with 
D2O);  
13
C NMR (125.76 MHz, CDCl3) δ 147.7, 129.4 (+, 2C), 117.9 (+), 113.2 (+, 2C), 42.4 (-), 
32.8 (-).  
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3-(Benzylthio)propane-1-thiol:
81
 An oven dried 250 mL round bottom 
flask was charged with 1,3-propanedithiol (2.16 g, 20 mmol, 1.1 
equiv) and tetrabutylammonium iodide (150 mg, 0.40 mmol, 2.2 mol%) in dry THF (100 mL).   
The mixture was stirred at room temperature and sodium hydride (60% suspension in mineral 
oil, 0.80 g, 20 mmol, 1.1 equiv.) was added by portions.   The resulting mixture was stirred for 
30 minutes, then benzyl bromide (2.1 mL, 3.1 g, 18 mmol) was added dropwise.  The solution 
was stirred for 1 hr at room temperature, then filtered on a frit funnel and concentrated in 
vacuum.  The resulting crude oil was distilled in vacuum to afford the title compound as 
colorless oil, bp 135-136 
o
C
 
 (1.0 torr).   Yield 1.82 g (9.19 mmol, 51%).   
1
H NMR (500.13 
MHz, CDCl3) δ 7.37-7.33 (m, 4H), 7.30-7.25 (m, 1H), 3.74 (s, 2H), 2.62 (dt, J = 7.9 Hz, 6.9 Hz, 
2H), 2.56 (t, J = 7.1 Hz, 2H), 1.87 (quin, J = 7.1 Hz, 2H), 1.34 (t, J = 8.0 Hz, 1H, suppressed 
after treatment with D2O);  
13
C NMR (125.76 MHz, CDCl3) δ 138.3, 128.8 (+, 2C), 128.4 (+, 
2C), 126.9 (+), 36.2 (-), 32.9 (-), 29.5 (-), 23.3 (-);  HRMS (TOF ES): found 199.0613, calculated 
for C10H15S2 (M+H) 199.0615 (1.0 ppm); 
 
2.6.5. Alkoxide adducts 
 
(1R*,2R*)-2-tert-butoxy-N-(tert-butyl)cyclopropanecarboxamide 
(72a): An oven-dried 10 mL Weaton vial was charged with 
bromocyclopropane 70a (219 mg, 1.00 mmol), 18-crown-6 (26.4 mg, 
0.10 mmol, 10 mol%), t-BuOK (281 mg, 2.50 mmol, 2.5 equiv.), and anhydrous THF (5 mL).  
The mixture was stirred at 20 
o
C  for 1 hr, when GC analysis showed full consumption of starting 
material and formation of two diastereomeric adducts in a ratio ~1:1.  Further stirring at 80 
o
C  
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for 12 hrs caused cis- to trans-isomerization, achieving the final diastereomeric ratio ~10:1.  The 
mixture was partitioned between water (50 mL) and EtOAc (15 mL).  Organic layer was 
separated; aqueous phase was extracted with EtOAc (2 x 15 mL).  Combined organic phases 
were washed with brine (20 mL), dried with MgSO4, filtered and concentrated.  The residue was 
purified by flash column chromatography on silica gel (eluent hexane/EtOAc 3:1, Rf 0.45) to 
afford the title compound as crystalline white solid, mp.  98-99 
o
C  Yield 148 mg (0.69 mmol, 
69%) 
1
H NMR (500.19 MHz, CDCl3) δ 5.46 (br.s, 1H), 3.48 (ddd, J = 6.6 Hz, 4.4 Hz, 2.2 Hz, 
1H), 1.37-1.33 (m, 1H), 1.35 (s, 9H), 1.25 (s, 9H), 1.22 (ddd, J = 6.6 Hz, 5.7 Hz, 5.4 Hz, 1H), 
0.97 (ddd, J = 9.5 Hz, 5.4 Hz, 4.4 Hz, 1H); 
13
C NMR (125.76 MHz, CDCl3) δ 170.8, 75.4, 53.1 
(+), 51.2, 28.9 (+, 3C), 28.1 (+, 3C), 24.1 (+), 14.3 (-); IR (film, cm
-1
): 3317, 2974, 2934, 1643, 
1549, 1456, 1435, 1393, 1366, 1258, 1227, 1196, 1099, 945, 930, 908, 866; HRMS (TOF ES): 
found 236.1627, calculated for C12H23NO2Na (M+Na) 236.1626 (0.4 ppm). 
 
 
(1R*,2R*)-N-(tert-butyl)-2-propoxycyclopropanecarboxamide 
(72b): An oven-dried 10 mL Weaton vial was charged with 
bromocyclopropane 70a (220 mg, 1.00 mmol), 18-crown- 6 (16.4 mg, 0.10 mmol, 10 mol%), 
powdered KOH (112 mg, 2.00 mmol, 2.00 equiv.), 1- propanol (180 mg, 3.00 mmol, 3.00 
equiv.), and anhydrous THF (10 mL).  The mixture was stirred at 85 
o
C for 12 hrs, then filtered 
through a fritted funnel and concentrated in vacuum.  The residue was purified by flash 
chromatography on silica gel (eluent hexane:EtOAc 4:1; Rf 0.30) to afford the title compound as 
colorless solid, mp 61-63 
o
C .  Yield 143 mg (0.72 mmol, 72%), d.r.  9:1 (GC).  
1
H NMR 
(500.19 MHz, CDCl3) δ 5.49 (br.s, 1H), 3.55 (ddd, J = 6.3 Hz, 4.1 Hz, 2.2 Hz, 1H), 3.51-3.44 
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(m, 2H), 1.59 (sextet, J = 7.3 Hz, 2H), 1.44 (ddd, J = 9.5 Hz, 5.7 Hz, 2.2 Hz, 1H), 1.35 (s, 9H), 
1.20 (ddd, J = Hz, 1H), 1.03 (ddd, J = 9.5 Hz, 5.4 Hz, 4.1 Hz, 1H), 0.92 (t, J = 7.3 Hz, 3H); 
13
C 
NMR (125.76 MHz, CDCl3) δ 170.5, 72.6 (-), 59.3 (+), 51.2, 28.9 (+, 3C), 23.6 (+), 22.7 (-), 14.1 
(-), 10.5 (+); IR (film, cm
-1
): 3315, 2966, 2934, 1641, 1549, 1456, 1443, 1391, 1364, 1255, 1224, 
1200, 1177, 1099, 974; HRMS (TOF ES): found 222.1479, calculated for C11H21NO2Na (M+Na) 
222.1470 (4.1 ppm). 
 
(1R*,2R*)-N-tert-Butyl-2-(2-
methoxyethoxy)cyclopropanecarboxamide (72c): An oven-dried 
5 mL Weaton vial was charged with bromocyclopropane 70a (110 mg, 0.5 mmol), 18-crown-6 
(13.2 mg, 0.05 mmol, 10 mol%), powdered KOH (98 mg, 1.75 mmol, 3.5 equiv.), 2-
methoxyethanol (79 μL, 76.1 mg, 1.00 mmol, 2 equiv.), and anhydrous THF (5 mL).  The 
mixture was stirred at 85 
o
C for 12 hrs, then filtered through a fritted funnel and concentrated.  
The residue was purified by flash chromatography on silica gel (eluent hexane/EtOAc 2:1) to 
afford the title compound as a colorless oil.  Yield 104 mg (0.49 mmol, 97%).  
1
H NMR (500.13 
MHz, CDCl3) δ 5.47 (br.s., 1H), 3.62-3.73 (m, 2H), 3.58 (ddd, J = 5.3 Hz, 3.5 Hz, 2.2 Hz, 1H), 
3.52 (t, J = 4.4 Hz, 2H), 3.37 (s, 3H), 1.49 (ddd, J = 9.5 Hz, 6.0 Hz, 2.2 Hz, 1H), 1.33 (s, 9H), 
1.20 (ddd, J = 6.3 Hz, 6.0 Hz, 5.3 Hz, 1H), 1.07 (ddd, J = 9.5 Hz, 6.3 Hz, 3.5 Hz, 1H); 
13
C NMR 
(125.76 MHz, CDCl3) δ 170.3, 71.4 (-), 69.9 (-), 59.7 (+), 58.9 (+), 51.2, 28.8 (+, 3C), 23.5 (+), 
14.0 (-); IR (KBr, cm
-1
): 3321, 2966, 2928, 2881, 1645, 1549, 1456, 1393, 1366, 1331, 1256, 
1227, 1202, 1173, 1128, 1099, 1030, 962, 928, 908, 878, 865; HRMS (TOF ES): found 
216.1599, calculated for C11H22NO3 (M+H) 216.1600 (0.5 ppm). 
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(1R*,2R*)-N-tert-Butyl-2-(pent-4-en-1-
yloxy)cyclopropanecarboxamide (72e): An oven-dried 5 mL 
Weaton vial was charged with bromocyclopropane 70a (110 mg, 0.5 mmol), 18-crown-6 (13.2 
mg, 0.05 mmol, 10 mol%), powdered KOH (98 mg, 1.75 mmol, 3.5 equiv.), 4- penten-1-ol (103 
μL, 86.1 mg, 1.00 mmol, 2.0 equiv.), and anhydrous THF (5 mL).  The mixture was stirred at 85 
o
C for 12 hrs, then filtered through a fritted funnel and concentrated.  The residue was purified 
by flash chromatography on silica gel (eluent hexane/EtOAc 10:1) to afford the title compound 
as a colorless oil.  Yield 96 mg (0.43 mmol, 85%).  
1
H NMR (400.13 MHz, CDCl3) δ 5.82 (ddt, J 
= 17.0 Hz, 10.3 Hz, 6.6 Hz, 1H), 5.46 (br.  s., 1H), 5.04 (ddt, J = 17.0 Hz, 1.8 Hz, 1.5 Hz, 1H), 
4.99 (ddt, J = 10.4 Hz, 2.0 Hz, 1.0 Hz, 1H), 3.60-3.47 (m, 3H), 2.17-2.05 (m, 2H), 1.79-1.55 (m, 
4H), 1.44 (ddd, J = 9.3 Hz, 5.8 Hz, 2.0 Hz, 1H), 1.36 (s, 9H), 1.20 (q, J = 6.1 Hz, 1H), 1.04 (ddd, 
J = 9.4 Hz, 5.3 Hz, 4.0 Hz, 1H); 
13
C NMR (125.76 MHz, CDCl3) δ 170.5, 138.0 (+), 114.9 (-), 
70.2 (-), 59.4 (+), 51.3, 30.2 (-), 28.9 (+, 3C), 28.6 (-), 23.6 (+), 14.1 (-); IR (KBr, cm
-1
): 3317, 
3078, 2964, 2928, 2868, 1643, 1549, 1456, 1441, 1391, 1381, 1364, 1256, 1225, 1200, 1169, 
1101, 1076, 1043, 995, 962, 910, 881; HRMS (TOF ES): found 226.1811, calculated for 
C13H24NO2 (M+H) 226.1807 (1.8 ppm). 
 
(1R*,2R*)-N-tert-Butyl-2-(3-
nitrobenzyloxy)cyclopropanecarboxamide (72g): An oven-
dried 5 mL Weaton vial was charged with bromocyclopropane 70a (110 mg, 0.5 mmol), 18-
crown-6 (13.2 mg, 0.05 mmol, 10 mol%), powdered KOH (98 mg, 1.75 mmol, 3.5 equiv.), 3-
nitrobenzyl alcohol (153 mg, 1.00 mmol, 2 equiv.), and anhydrous THF (5 mL).  The mixture 
was stirred at 85 
o
C for 12 hrs, then filtered through a fritted funnel and concentrated.  The 
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residue was purified by flash chromatography on silica gel (eluent hexane/EtOAc 10:1) to afford 
the title compound as a colorless oil.  Yield 96 mg (0.41 mmol, 81%).  
1
H NMR (500.13 MHz, 
CDCl3) δ 8.20 (t, J = 2.2 Hz, 1H), 8.16 (dd, J = 8.2 Hz, 2.2 Hz, 1H), 7.65 (d, J = 7.6 Hz, 1H), 
7.53 (t, J = 7.9 Hz, 1H), 5.45 (br.  s., 1H), 4.69 (d, J = 12.3 Hz, 1H), 4.63 (d, J = 12.3 Hz, 1H), 
3.67 (ddd, J = 6.4 Hz, 4.0 Hz, 1.9 Hz, 1H), 1.52 (ddd, J = 9.7 Hz, 5.9 Hz, 2.0 Hz, 1H), 1.34 (s, 9 
H), 1.25 (ddd, J = 6.4 Hz, 5.9 Hz, 5.6 Hz, 1H), 1.12 (ddd, J = 9.5 Hz, 5.6 Hz, 4.1 Hz, 1H); 
13
C 
NMR (125.76 MHz, CDCl3) δ 170.0, 148.3, 139.8, 133.5 (+), 129.3 (+), 122.7 (+), 122.4 (+), 
71.6 (-), 59.6 (+), 51.3, 28.8 (+, 3C), 23.6 (+), 14.1 (-); IR (KBr, cm
-1
): 3304, 2968, 2928, 1639, 
1531, 1456, 1350, 1254, 1225, 1202, 1165, 1099, 810, 731, 671; HRMS (TOF ES): found 
293.1506, calculated for C15H21N2O4 (M-H) 293.1501 (1.7 ppm). 
 
(1R*,2R*)-N-(tert-butyl)-2-isopropoxycyclopropanecarboxamide 
(72n): An oven-dried 10 mL Weaton vial was charged with 
bromocyclopropane 70a (220 mg, 1.00 mmol), 18-crown-6 (16.4 mg, 0.10 mmol, 10%), 
powdered KOH (112 mg, 2.00 mmol, 2.00 equiv.), 2- propanol (180 mg, 3.00 mmol, 3.00 
equiv.), and anhydrous THF (10 mL).  The mixture was stirred at 85 
o
C for 12 hrs, then filtered 
through a fritted funnel and concentrated.  The residue was purified by flash chromatography on 
silica gel (eluent hexane:EtOAc 4:1; Rf 0.29) to afford the title compound as a white needles, 
mp.  84-86 
o
C .  Yield 141 mg (0.71 mmol, 71%), d.r.  9:1 (GC).  
1
H NMR (400.13 MHz, 
CDCl3) δ 5.49 (br.s, 1H), 3.75 (septet, J = 6.1 Hz, 1H), 3.54 (ddd, J = 6.3 Hz, 4.0 Hz, 2.0 Hz, 
1H), 1.43 (ddd, J = 9.3 Hz, 5.8 Hz, 2.0 Hz, 1H), 1.34 (s, 9H), 1.19 (d, J = 6.1 Hz, 3H), 1.21 (m, 
1H), 1.18 (d, J = 6.1 Hz, 3H), 1.01 (ddd, J = 9.3 Hz, 5.3 Hz, 4.0 Hz, 1H); 
13
C NMR (100.61 
MHz, CDCl3) δ 170.6, 72.3 (+), 57.3 (+), 51.2, 28.9 (+, 3C), 23.8 (+), 22.3 (+), 22.1 (+), 14.1 (-); 
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IR (film, cm
-1
): 3315, 2972, 2931, 1641, 1549, 1456, 1436, 1394, 1364, 1258, 1225, 1200, 1182, 
1097, 957, 889; HRMS (TOF ES): found 200.1644, calculated for C11H22NO2 (M+H) 200.1651 
(3.5 ppm). 
 
(1R*,2R*)-N-tert-Butyl-2-(2-methylbut-3-yn-2-
yloxy)cyclopropanecarboxamide (72o): An oven-dried 5 mL 
Weaton vial was charged with bromocyclopropane 70a (110 mg, 0.5 mmol), 18-crown-6 (13.2 
mg, 0.05 mmol, 10%), powdered KOH (98 mg, 1.75 mmol, 3.5 equiv.), 2-methyl-3-butyn-2-ol 
(97 μL, 84.1 mg, 1.00 mmol, 2 equiv.), and anhydrous THF (5 mL).  The mixture was stirred at 
85 
o
C for 12 hrs, then filtered through a fritted funnel and concentrated.  The residue was 
purified by flash chromatography on silica gel (eluent hexane/EtOAc 10:1) to afford the title 
compound as a white needle-like solid, mp.  56-58 
o
C .  Yield 66 mg (0.30 mmol, 59%).  
1
H 
NMR (500.13 MHz, CDCl3) δ 5.48 (br.  s, 1H), 3.74 (ddd, J = 6.9 Hz, 4.1 Hz, 2.2 Hz, 1H), 2.49 
(s, 1H), 1.53 (s, 3H), 1.52 (m, 1H), 1.51 (s, 3H), 1.36 (s, 9H), 1.27 (m, 1H), 1.08 (ddd, J = 9.5 
Hz, 5.7 Hz, 4.1 Hz, 1H); 
13
C NMR (125.76 MHz, CDCl3) δ 170.5, 86.2, 72.6 (+), 71.3, 54.9 (+), 
51.2, 29.3 (+), 28.9 (+, 3C), 28.7 (+), 23.9 (+), 13.4 (-); IR (KBr, cm
-1
): 3310, 2970, 2934, 1643, 
1549, 1456, 1435, 1394, 1381, 1364, 1258, 1227, 1194, 1148, 1097, 955, 908, 864, 654, 632, 
444, 432; HRMS (TOF ES): found 246.1481, calculated for C13H21NO2Na (M+Na) 246.1470 
(4.5 ppm). 
 
(1R*,2R*)-N-tert-Butyl-2-(trityloxy)cyclopropanecarboxamide 
(72p): An oven-dried 5 mL Weaton vial was charged with 
bromocyclopropane 70a (110 mg, 0.5 mmol), 18-crown-6 (13.2 mg, 0.05 mmol, 10 mol%), 
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powdered KOH (98 mg, 1.75 mmol, 3.5 equiv.), triphenylmethanol (260 mg, 1.00 mmol, 2 
equiv.), and anhydrous THF (5 mL).  The mixture was stirred at 85 
o
C for 12 hrs.  then filtered 
through a fritted funnel and concentrated.  The residue was purified by flash chromatography on 
silica gel (eluent hexane/EtOAc 10:1) to afford the title compound as a white solid, mp.  176-184 
o
C  (dec).  Yield 90 mg (0.23 mmol, 45%).  
1
H NMR (500.13 MHz, CDCl3) δ 7.43-7.51 (m, 6H), 
7.30-7.36 (m, 6H), 7.24-7.30 (m, 3H), 4.52 (br.s, 1H), 3.53 (ddd, J = 7.1 Hz, 3.9 Hz, 1.9 Hz, 
1H), 1.23 (s, 9H), 1.18 (ddd, J = 7.1 Hz, 5.9 Hz, 5.3 Hz, 1H), 1.04 (ddd, J = 9.2 Hz, 5.3 Hz, 4.1 
Hz, 1H), 0.75 (ddd, J = 9.1 Hz, 5.9 Hz, 2.0 Hz, 1H); 
13
C NMR (125.76 MHz, CDCl3) δ 170.0, 
144.1 (3C), 128.7 (+, 6C), 127.9 (+, 6C), 127.0 (+, 3C), 87.6, 54.9 (+), 50.9, 28.8 (+, 3C), 25.0 
(+), 12.3 (-); IR (film, cm
-1
): 3085, 3057, 2996, 2358, 1660, 1643, 1590, 1448, 1391, 1151; 
HRMS (TOF ES): found 422.2092, calculated for C27H29NO2Na (M+Na) 222.2096 (0.9 ppm). 
 
(1R*,2R*)-N,N-Diethyl-2-(2-
methoxyethoxy)cyclopropanecarboxamide (72d): An oven-dried 
5 mL Weaton vial was charged with bromocyclopropane 70b (110 mg, 0.50 mmol), 18-crown-6 
(13.2 mg, 0.05 mmol, 10 mol%), powdered KOH (98 mg, 1.75 mmol, 3.50 equiv.), 2-
methoxyethanol (76 mg, 1.00 mmol, 2.00 equiv.), and anhydrous THF (5 mL).  The mixture was 
stirred at 80 
o
C for 12 hrs, then filtered through a fritted funnel and concentrated.  The residue 
was purified by flash chromatography on silica gel (eluent hexane/EtOAc 2:1, Rf 0.13) to afford 
the title compound as a colorless oil.  Yield 93 mg (0.43 mmol, 87%), dr 6:1 (GC).  
1
H NMR 
(400.13 MHz, CDCl3) δ 3.76-3.63 (m, 3H), 3.53 (t, J = 4.6 Hz, 2H), 3.47 (dq, J = 11.7 Hz, 7.4 
Hz, 2H), 3.41-3.33 (m, 2H), 3.38 (s, 3H), 1.94 (ddd, J = 9.5 Hz, 5.9 Hz, 2.3 Hz, 1H), 1.31-1.22 
(m, 4H), 1.17 (ddd, J = 9.4 Hz, 5.2 Hz, 3.8 Hz, 1H), 1.10 (t, J = 7.1 Hz, 3H); 
13
C NMR (125.76 
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MHz, CDCl3) δ ppm 170.4, 71.4 (-), 70.0 (-), 60.8 (+), 59.0 (+), 42.1 (-), 40.6 (-), 19.5 (+), 15.3 
(+), 14.8 (-), 13.1 (+); IR (film, cm
-1
): 2976, 2932, 2876, 1632, 1483, 1462, 1452, 1379, 1360, 
1256, 1208, 1130, 1097, 1032, 957; GC: 9.71 min (major); 9.75 min (minor).  HRMS (TOF ES): 
found 222.1682 calculated for C11H21NO3Li (M+Li) 222.1681 (0.5 ppm) 
 
(1R*,2R*)-N,N-Diethyl-2-[(3-
nitrobenzyl)oxy]cyclopropanecarboxamide (72h): An 
oven-dried 5 mL Weaton vial was charged with bromocyclopropane 70b (110 mg, 0.50 mmol), 
18-crown-6 (13.2 mg, 0.05 mmol, 10 mol%), powdered KOH (98 mg, 1.75 mmol, 3.50 equiv.), 
3-nitrobenzyl alcohol (153 mg, 1.00 mmol, 2.00 equiv.), and anhydrous THF (5 mL).  The 
mixture was stirred at 80 
o
C for 12 hrs, then filtered through a fritted funnel and concentrated.  
The residue was purified by flash chromatography on silica gel (eluent hexane/EtOAc 3:1, Rf 
0.19) to afford the title compound as a white solid, mp.  83-85 
o
C .  Yield 136 mg (0.46 mmol, 
92%) dr 7:1 (GC).  
1
H NMR (500.13 MHz, CDCl3) δ 8.20 (s, 1H), 8.16 (d, J = 8.2 Hz, 1H), 7.66 
(d, J = 7.6 Hz, 1H), 7.53 (t, J = 7.9 Hz, 1H), 4.70 (d, J = 12.3 Hz, 1H), 4.65 (d, J = 12.3 Hz, 1H), 
3.76 (ddd, J = 6.3 Hz, 4.1 Hz, 2.2 Hz, 1H), 3.46 (q, J = 7.3 Hz, 2H), 3.38 (q, J = 7.0 Hz, 2H), 
1.97 (ddd, J = 9.8 Hz, 6.0 Hz, 2.2 Hz, 1H), 1.32 (ddd, J = 6.3 Hz, 6.0 Hz, 5.3 Hz, 1H), 1.26 (t, J 
= 7.3 Hz, 3H), 1.21 (ddd, J = 9.5 Hz, 5.3 Hz, 3.8 Hz, 1H), 1.11 (t, J = 7.3 Hz, 3H); 
13
C NMR 
(125.76 MHz, CDCl3) δ 170.1, 148.4, 139.8, 133.5 (+), 129.4 (+), 122.8 (+), 122.4 (+), 71.7 (-), 
60.6 (+), 42.2 (-), 40.7 (-), 19.7 (+), 15.3 (+), 14.9 (-), 13.2 (+); IR (KBr, cm
-1
): 3450, 2976, 
2932, 1632, 1585, 1529, 1483, 1462, 1427, 1379, 1350, 1321, 1256, 1209, 1171, 1138, 1095, 
10559, 1022, 960, 891, 808, 733, 689, 673, 420, 411; GC: 13.86 min (major); 13.99 min (minor).  
HRMS (TOF ES): found 293.1500, calculated for C15H21N2O4 (M+H) 293.1501 (0.3 ppm). 
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(1R*,2R*)-2-(benzyloxy)-N,N-diethylcyclopropanecarboxamide 
(72i): An oven-dried 100 mL pressure tube was charged with 
bromocyclopropane 70b (1.80 g, 8.18 mmol), 18-crown-6 (216 mg, 0.82 mmol, 10 mol%), 
powdered KOH (1.60 g, 28.6 mmol, 3.50 equiv.), benzyl alcohol (1.67 g, 15.6 mmol, 2.00 
equiv.), and anhydrous THF (80 mL).  The mixture was stirred at 80 
o
C for 12 hrs, then filtered 
through a silica gel plug eluting with DCM to remove 18-crown-6 and concentrated.  Te residue 
was purified by short path distillation (60 
o
C, 0.008 torr) to afford the title compound as clear oil.  
Yield 1.75 g (7.09 mmol, 87%), dr 6:1 (GC).  
1
H NMR (500.13 MHz, CDCl3) δ 7.41-7.29 (m, 
5H), 4.64 (d, J = 11.7 Hz, 1H), 4.57 (d, J = 11.7 Hz, 1H), 3.73 (ddd, J = 6.4 Hz, 4.0 Hz, 2.2 Hz, 
1H), 3.46-3.31 (m, 4H), 1.91 (ddd, J = 9.5 Hz, 5.8 Hz, 2.0 Hz, 1H), 1.31 (ddd, J = 6.4 Hz, 5.8 
Hz, 5.4 Hz, 1H), 1.24 (t, J = 7.3 Hz, 3H), 1.19 (ddd, J = 9.1 Hz, 5.4 Hz, 4.1 Hz, 1H), 1.12 (t, J = 
7.1 Hz, 3H); 
13
C NMR (125.76 MHz, CDCl3) δ 170.4, 137.6, 128.4 (+, 2C), 128.0 (+, 2C), 127.8 
(+), 73.2 (-), 60.5 (+), 42.1 (-), 40.6 (-), 19.8 (+), 15.1 (-), 14.8 (+), 13.2 (+); IR (film, cm
-1
): 
3030, 2974, 2931, 1632, 1483, 1454, 1379, 1362, 1321, 1254, 1209, 1167, 1138, 1095, 1053, 
955, 739, 698; GC: 11.73 min (major); 11.83 min (minor); HRMS (TOF ES): found 248.1665 
calculated for C15H22NO2 (M+H) 248.1651 (5.6 ppm). 
 
4-Morpholino((1R*,2R*)-2-(pent-4-enyloxy)cyclopropyl)-
methanone (72f): An oven-dried 10 mL Weaton vial was 
charged with bromocyclopropane 70c (117 mg, 0.50 mmol), 18-crown-6 (13.2 mg, 0.05 mmol, 
10 mol%), powdered KOH (98 mg, 1.75 mmol, 3.50 equiv.), 4-pentene-1-ol (86 mg, 1.00 mmol, 
2.00 equiv), and anhydrous THF (5 mL).  The mixture was stirred at 85 
o
C  for 13 hrs.  The 
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solvent was removed in vacuum, and the residue was purified by flash column chromatography 
on silica gel (eluent hexane/EtOAc 5:1, Rf: 4-pentene-1-ol 0.3, major 0.15 minor 0.04).  After 
seperation of 4-pentene-1-ol the eluent polarity was increased (hexane/EtOAc 1:1; Rf: major 
0.38 minor 0.15) to afford the title compound as clear oil.  Yield 100 mg (0.42 mmol, 84%).  
1
H 
NMR (500.13 MHz, CDCl3) δ 5.79 (ddt, J = 17.1 Hz, 10.3 Hz, 6.6 Hz, 1H), 5.01 (dq, J = 17.0 
Hz, 1.6 Hz, 1H), 4.97 (dq, J = 10.4 Hz, 1.6 Hz, 1H), 3.70-3.60 (br.  m., 8H), 3.59 (ddd, J = 6.3 
Hz, 4.4 Hz, 2.5 Hz, 1H), 3.54 (dt, J = 9.5 Hz, 6.5 Hz, 1H), 3.48 (dt, J = 9.5 Hz, 6.6 Hz, 1H), 2.09 
(q, J = 7.0 Hz, 2H), 1.86 (ddd, J = 9.4 Hz, 5.9 Hz, 2.1 Hz, 1H), 1.66 (quin, J = 7.0 Hz, 2H), 1.30 
(ddd, J = 6.3 Hz, 5.9 Hz, 5.0 Hz, 1H), 1.14 (dt, J = 9.4 Hz, 5.0 Hz, 4.4 Hz, 1 H); 
13
C NMR 
(125.76 MHz, CDCl3) δ 170.2, 137.9 (+), 114.9 (-), 70.3 (-), 66.7 (-, 2C), 60.5 (+), 46.0 (-), 42.3 
(-), 30.1 (-), 28.5 (-), 19.1 (+), 15.2 (-); GC: 11.33 min (major), 11.38 min (minor); IR (film, cm
-
1
): 2959, 2922, 2897, 2856, 1639, 1462, 1445, 1429, 1364, 1300, 1271, 1234, 1205, 1167, 1117, 
1099, 1068, 1041, 995, 953, 914, 872, 847, 571; HRMS (TOF ES): found 262.1425, calculated 
for C13H21NO3Na (M+Na) 262.1419 (2.3 ppm). 
 
 ((1R,2R)-2-(Allyloxy)cyclopropyl)(piperidin-1-yl)methanone (72k):  
Was prepared according to Typical Procedure I, employing (2-
bromocyclopropyl)(piperidin-1-yl)methanone (70d) (70 mg, 0.3 mmol, 1.0 equiv) and allylic 
alcohol (19.9 mg, 0.36 mmol, 1.2 equiv).   The reaction was carried out at 50 
o
C  for 12 hrs.   
Preparative column chromatography of a residue on silica gel afforded the title compound as a 
colorless oil, Rf 0.40 (hexane/EtOAc 2:1).  Yield 59 mg (0.29 mmol, 95%).   
1
H NMR (400.13 
MHz, CDCl3) δ 5.91 (ddt, J = 17.3 Hz, 10.4 Hz, 5.8 Hz, 1H), 5.28 (dq, J = 17.3 Hz, 1.6 Hz, 1H), 
5.19 (dq, J = 10.4 Hz, 1.3 Hz, 1H), 4.07 (ddt, J = 12.6 Hz, 5.6 Hz, 1.3 Hz, 1H), 4.02 (m, J = 12.6 
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Hz, 5.8 Hz, 1.5 Hz, 1H), 3.63 (ddd, J = 6.3 Hz, 3.8 Hz, 2.3 Hz, 1H), 3.62-3.52 (m, 4H), 1.97 
(ddd, J = 9.5 Hz, 5.9 Hz, 2.0 Hz, 1H), 1.71-1.58 (m, 4H), 1.58-1.49 (m, 2H), 1.29 (td, J = 6.3 Hz, 
5.9 Hz, 5.3 Hz, 1H), 1.14 (ddd, J = 9.5 Hz, 5.3 Hz, 3.9 Hz, 1H); 
13
C NMR (100.67 MHz, CDCl3) 
δ 169.4, 134.0 (+), 117.5 (-), 72.0 (-), 60.2 (+), 46.7 (-), 43.1 (-), 26.6 (-), 25.5 (-), 24.6 (-), 19.3 
(+), 14.9 (-);  FT IR (KBr, cm
-1
): 3081, 2935, 2854, 1632, 1454, 1445, 1352, 1250, 1225, 1169, 
1136, 1128, 1094, 1053, 1014, 943, 924, 874;  HRMS (TOF ES): found 210.1496, calculated for 
C12H20NO2 (M+H) 210.1494 (1.0 ppm). 
 
((1R*,2R*)-2-(Cinnamyloxy)cyclopropyl)(piperidin-1-
yl)methanone (72l):  Was prepared according to Typical 
Procedure I, employing (2-bromocyclopropyl)(piperidin-1-yl)methanone (70d) (62 mg, 0.30 
mmol, 1.0 equiv) and cinnamyl alcohol (44 mg, 0.36 mmol, 1.2 equiv).   The reaction was 
carried out at 60 
o
C  for 12 hrs.   Preparative column chromatography of a residue on silica gel 
afforded the title compound as a colorless oil, Rf 0.40 (hexane/EtOAc 2:3).  Yield 69 mg (0.24 
mmol, 81%).   
1
H NMR (400.13 MHz, CDCl3) δ 7.43-7.37 (m, 2H), 7.37-7.30 (m, 2H), 7.30-
7.23 (m, 1H), 6.63 (d, J = 15.9 Hz, 1H), 6.30 (dt, J = 15.9 Hz, 6.2 Hz, 1H), 4.27 (ddd, J = 12.5 
Hz, 5.9 Hz, 1.3 Hz, 1H), 4.20 (ddd, J = 12.4 Hz, 6.4 Hz, 1.4 Hz, 1H), 3.71 (ddd, J = 6.4 Hz, 4.0 
Hz, 2.0 Hz, 1H), 3.66-3.47 (m, 4H), 2.02 (ddd, J = 9.6 Hz, 5.9 Hz, 2.1 Hz, 1H), 1.70-1.49 (m, 
6H), 1.33 (ddd, J = 6.4 Hz, 5.9 Hz, 5.3 Hz, 1H), 1.19 (ddd, J = 9.5 Hz, 5.3 Hz, 3.9 Hz, 1H);  
13
C 
NMR (100.67 MHz, CDCl3) δ 169.5, 136.4, 132.9 (+), 128.5 (+, 2C), 127.8 (+), 126.5 (+, 2C), 
125.2 (+), 71.6 (-), 60.3 (+), 46.7 (-), 43.1 (-), 26.6 (-), 25.5 (-), 24.6 (-), 19.5 (+), 14.9 (-);  FT IR 
(KBr, cm
-1
): 3059, 3024, 2935, 2855, 1634, 1446, 1225;  HRMS (TOF ES): found 286.1801, 
calculated for C18H24NO2 (M+H) 286.1807 (2.1 ppm). 
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(1R*,2R*)-N-(tert-Butyl)-2-(prop-2-yn-1-
yloxy)cyclopropanecarboxamide (72m):  Was prepared according to 
Typical Procedure I, employing 2-bromo-N-(tert-butyl)cyclopropanecarboxamide (70a) (66 mg, 
0.30 mmol, 1.0 equiv) and propargyl alcohol (21 mg, 0.32 mmol, 1.2 equiv).  The reaction was 
carried out at 60 
o
C  for 3 hrs.   Preparative column chromatography of a residual oil on silica gel 
afforded the title compound as a colorles oil, Rf 0.30 (hexane/EtOAc, 4:1).  Yield 46 mg (0.23 
mmol, 78%).   
1
H NMR (500.13 MHz, CDCl3) δ 5.46 (br.  s., 1 H), 4.24-4.19 (m, 1H), 4.19-4.14 
(m, 1H), 3.71 (ddd, J = 6.4 Hz, 4.0 Hz, 2.2 Hz, 1H), 2.46 (t, J = 2.5 Hz, 1H), 1.55 (ddd, J = 9.6 
Hz, 6.0 Hz, 2.0 Hz, 1H), 1.35 (s, 9H), 1.24 (q, J = 6.0 Hz, 1H), 1.10 (ddd, J = 9.5 Hz, 5.6 Hz, 4.1 
Hz, 1H);  
13
C NMR (100.67 MHz, CDCl3) δ 170.0, 79.3, 74.7 (+), 59.4 (+), 58.2 (-), 51.3, 28.9 
(+, 3C), 23.5 (+), 13.6 (-);  FT IR (NaCl, cm
-1
): 3308, 3078, 2968, 2930, 2870, 1724, 1643, 1549, 
1537, 1479, 1454, 1394, 1364, 1331, 1256, 1227, 1202, 1153, 1097, 1061, 1043, 1026, 995, 986, 
955, 926, 910, 893, 878, 764, 737, 665, 635;  HRMS (TOF ES): found 196.1341, calculated for 
C11H18NO2 (M+H) 196.1338 (1.5 ppm). 
 
(1R,2R)-2-(Benzyloxy)-N-methoxy-N-
methylcyclopropanecarboxamide (72q): An oven dried 5 mL 
Wheaton vial was charged with t-BuOK (135 mg, 1.20 mmol, 2.5 equiv.), 18-crown-6 (13 mg, 
50 μmol, 10 mol%), benzyl alcohol (124 mL, 130 mg, 1.20 mmol, 2.50 equiv), and anhydrous 
THF (3 mL).   The mixture was stirred at room temperature and bromocyclopropane 70e (100 
mg, 0.48 mmol) was injected via syringe.   The resulting dark-brown mixture was stirred at room 
temperature for 1 hr, then the formed precipitate of KBr was filtered off using a short plug of 
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celite, and the filtrate was concentrated in vacuum.   Flash column chromatography of a residual 
dark crude oil silica gel afforded the title compound as colorless oil, Rf 0.33 (hexane/EtOAc 1:1).   
Yield 50 mg (0.21 mmol, 44%).   
1
H NMR (500.13 MHz, CDCl3) δ 7.38-7.24 (m, 5H), 4.60 (d, J 
= 11.7 Hz, 1H), 4.57 (d, J = 11.7 Hz, 1H), 3.73 (s, 3H), 3.70 (ddd, J = 6.5 Hz, 4.3 Hz, 1.9 Hz, 
1H), 3.19 (s, 3H), 2.36 (br.  s., 1H), 1.35-1.24 (m, 2H);  
13
C NMR (125.76 MHz, CDCl3) δ 172.6, 
137.3, 128.4 (+, 2C), 127.9 (+, 2C), 127.8 (+), 73.2 (-), 61.5 (+), 60.7 (+), 32.4 (+), 18.6 (+), 15.4 
(-);  FT IR (film, cm
-1
): 3030, 3005, 2964, 2935, 2897, 2866, 1661, 1643, 1495, 1454, 1445, 
1418, 1385, 1350, 1211, 1175, 1155, 1113, 1086, 1047, 1028, 1005, 972, 951, 897, 872, 741, 
698, 611, 440;  HRMS (TOF ES): found 258.1117, calculated for C13H17NO3Na (M+Na) 
258.1106 (4.3 ppm). 
(1R*,2R*)-N-(tert-Butyl)-2-(3-
(cyclohexylamino)propoxy)cyclopropanecarboxamide 
(72j) (Typical Procedure I): An oven-dried 10 mL Weaton 
vial was charged with 2-bromo-N-(tert-butyl)cyclopropanecarboxamide (70a) (110 mg, 0.5 
mmol), 18-crown-6 (13 mg, 50 μmol, 10 mol%), powdered KOH (62 mg, 1.1 mmol, 2.2 equiv.), 
N-cyclohexylaminopropanol  (157 mg, 1.0 mmol, 2.0 equiv), and anhydrous THF (5 mL).  The 
mixture was stirred at 85 
o
C for 12 hrs, then filtered through a fritted funnel and concentrated.   
The residue was purified by flash chromatography on silica gel, eluting with a mixture 
EtOAc/triethylamine 95:5.   The title compound was isolated as an amorphous yellow solid, Rf 
0.26.   Yield 116 mg (0.39 mmol, 78%).   
1
H NMR (500.13 MHz, CDCl3) δ 5.68 (br.  s., 1H), 
3.53 (t, J = 6.1 Hz, 2H), 3.44 (ddd, J = 6.5 Hz, 4.1 Hz, 2.0 Hz, 1H), 2.73-2.62 (m, 2H), 2.43 (tt, J 
= 10.6 Hz, 3.6 Hz, 1H), 1.91-1.82 (m, 2H), 1.82-1.63 (m, 4H), 1.56 (dt, J = 12.5 Hz, 3.2 Hz, 1H), 
1.43 (ddd, J = 9.6 Hz, 5.8 Hz, 1.9 Hz, 1H), 1.27 (s, 9H), 1.24-1.01 (m, 7H), 0.94 (ddd, J = 9.5 
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Hz, 5.4 Hz, 4.1 Hz, 1H);  
13
C NMR (125.76 MHz, CDCl3) δ 170.5, 69.2 (-), 59.5 (+), 57.0 (+), 
51.2, 43.7 (-), 32.71 (-), 32.65 (-), 29.4 (-), 28.9 (+, 3C), 25.9 (-), 24.9 (-, 2C), 23.5 (+), 13.9 (-);  
FTIR (NaCl, film, cm
1
): 3300, 2928, 2854, 1643, 1549, 1454, 1391, 1381, 1364, 1333, 1258, 
1225, 1200, 1169, 1099, 1078, 1047, 1034, 964, 889, 802, 764, 748, 702, 405;  HRMS (TOF 
ES): found 319.2362, calculated for C17H32N2O2Na (M+Na) 319.2361 (0.3 ppm). 
 
2.6.6. Phenoxide adducts 
 
 
(1R*,2R*)-N-(tert-butyl)-2-phenoxycyclopropanecarboxamide 
(73a): An oven-dried 10 mL Weaton vial was charged with 
bromocyclopropane 70a (220 mg, 1.00 mmol), 18-crown- 6 (26.4 mg, 0.10 mmol, 10 mol%), 
powdered KOH (196 mg, 3.50 mmol, 3.5 equiv.), phenol (188.2 mg, 2.00 mmol, 2 equiv.), and 
anhydrous THF (7 mL).  The mixture was stirred at 80 
o
C  for 14 hrs.  The mixture was 
partitioned between 3N aqueous NaOH (20 mL) and EtOAc (10 mL).  Organic layer was 
separated and washed with NaOH solution (2 x 10 mL).  Combined aqueous phases were 
extracted with EtOAc (3 x 10 mL).  Combined organic phases were washed with brine (10 mL), 
dried with MgSO4, filtered and concentrated.  The residue was purified by flash column 
chromatography on silica gel (eluent hexane/EtOAc 6:1; Rf: 0.45) to afford the title compound as 
colorless solid, mp.  73-74 
o
C .  Yield 185 mg (0.79 mmol, 79%).  
1
H NMR (500.13 MHz, 
CDCl3) δ 7.33-7.30 (m, 2H), 7.03-6.99 (m, 3H), 5.57 (br.s, 1H), 4.04 (ddd, J = 6.0 Hz, 3.8 Hz, 
2.2 Hz, 1H), 1.60 (ddd, J = 9.5 Hz, 6.0 Hz, 2.2 Hz, 1H), 1.51 (ps.-q, J = 6.3 Hz, 6.0 Hz, 1H), 
1.41 (s, 9H), 1.30-1.26 (m, 1H); 
13
C NMR (125.76 MHz, CDCl3) δ 169.8, 158.2, 129.5 (+, 2C), 
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121.4 (+), 114.8 (+, 2C), 56.5 (+), 51.5, 28.9 (+, 3C), 24.0 (+), 14.3 (-); IR (KBr, cm
-1
): 3319, 
3083, 2966, 2930, 2870, 2856, 1641, 1601, 1560, 1497, 1458, 1437, 1396, 1364, 1242, 1221, 
978, 752; GC: 10.86 min (major), 10.96 min (minor).  HRMS (TOF ES): found 234.1502, 
calculated for C14H20NO2 (M+H) 234.1494 (3.4 ppm). 
 
N-(tert-butyl)-2-(4-
methoxyphenoxy)cyclopropanecarboxamide (73b): An oven-
dried 10 mL Weaton vial was charged with bromocyclopropane 70a (220 mg, 1.00 mmol), 18-
crown-6 (26.4 mg, 0.10 mmol, 10 mol%), powdered KOH (280 mg, 5.00 mmol, 5 equiv.), p-
methoxyphenol (372.4 mg, 3.00 mmol, 3 equiv), and anhydrous THF (7 mL).  The mixture was 
stirred at 60 
o
C  for 14 hrs.  The mixture was partitioned between between 3N aqueous NaOH 
(20 mL) and EtOAc (10 mL).  Further work up was performed in the same way as described in 
protocol for the preparation of compound 73a.  The residue was purified by flash column 
chromatography on silica gel (eluent hexane/EtOAc 5:1) to afford the title compound as white 
crystalline solid, mp.  93-94 
o
C .  Yield 196 mg (0.75 mmol, 75%).  (1R*,2R*-73b), major: 
1
H 
NMR (500.13 MHz, CDCl3) δ 6.92 (d, J = 9.1 Hz, 2H), 6.86 (d, J = 9.1 Hz, 2H), 5.55 (br.s, 1H), 
4.00 (ddd, J = 6.6 Hz, 3.8 Hz, 2.2 Hz, 1H), 3.80 (s, 3H), 1.58 (ddd, J = 9.5 Hz, 6.0 Hz, 2.2 Hz, 
1H), 1.48 (ps.-q, J = 6.0 Hz, 1H), 1.40 (s, 9H), 1.25 (ddd, J = 9.5 Hz, 5.4 Hz, 3.8 Hz, 1H); 
13
C 
NMR (125.76 MHz, CDCl3) δ 169.8, 154.3, 152.2, 115.5 (+, 2C), 114.7 (+, 2C), 56.9 (+), 55.7 
(+), 51.5, 28.9 (+, 3C), 24.0 (+), 14.4 (-); IR (KBr, cm
-1
): 3329, 2997, 2970, 2935, 2908, 1659, 
1639, 1553, 1506, 1460, 1433, 1394, 1366, 1232, 1215, 1177, 1034, 1026, 966, 827; GC: Rt 
12.18 min; HRMS (TOF ES): found 264.1606, calculated for C15H22NO3 (M+) 264.1600 (2.3 
ppm). 
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(1R*,2S*-73b), minor: 
1
H NMR (500.13 MHz, CDCl3) δ 6.99 (d, J = 9.1 Hz, 2H), 6.86 (d, J = 
9.1 Hz, 2H), 5.60 (br.s, 1H), 3.89 (td, J = 6.3 Hz, 4.4 Hz, 1H), 3.79 (s, 3H), 1.78 (dt, J = 9.8 Hz, 
6.8 Hz, 1H), 1.42 (td, J = 6.9 Hz, 4.1 Hz, 1H), 1.31 (dt, J = 10.1 Hz, 6.3 Hz, 1H), 1.17 (s, 9H); 
13
C NMR (125.76 MHz, CDCl3) δ 168.2, 154.6, 151.9, 115.6 (+, 2C), 114.7 (+, 2C), 55.7 (+), 
55.1 (+), 50.9, 28.5 (+, 3C), 23.5 (+), 12.7 (-); GC: Rt 12.23 min. 
 
(1R*,2R*)-2-(4-bromophenoxy)-N-tert-
butylcyclopropanecarboxamide (73c): An oven-dried 10 mL 
Weaton vial was charged with bromocyclopropane 70a (110 mg, 0.50 mmol), 18-crown-6 (13.2 
mg, 0.05 mmol, 10 mol%), powdered KOH ( 98 mg, 1.75 mmol, 3.5 equiv.), 4-bromophenol 
(173 mg, 1.00 mmol, 2.00 equiv) and anhydrous THF (5 mL).  The mixture was stirred at 80 
o
C  
for 13hrs.  The solvent was removed in vacuum, and the mixture was partitioned between base (5 
N NaOH, 5 mL) and diethyl ether (15 mL).  Combined organic phases were washed 
consecutively with aqueous NaOH (3N, 3 x 5 mL) and brine (10 mL), and then dried with 
MgSO4, filtered, and concentrated.  The residue was purified by flash column chromatography 
on silica gel (eluent hexane/EtOAc 6:1 Rf major 0.32 minor 0.02) to afford the title compound as 
clear crystalline solid, mp.  122-125 
o
C .  Yield 135 mg (0.43 mmol, 86%).  
1
H NMR (500.13 
MHz, CDCl3) δ 7.41 (d, J = 8.8 Hz, 2H), 6.87 (d, J = 9.1 Hz, 2H), 5.58 (br.s., 1H), 4.01 (ddd, J = 
6.4 Hz, 4.0 Hz, 2.2 Hz, 1H), 1.59 (ddd, J = 9.6 Hz, 6.1 Hz, 2.2 Hz, 1H), 1.50 (ddd, J = 6.4 Hz, 
6.1 Hz, 5.7 Hz, 1H), 1.40 (s, 9H), 1.25 (ddd, J = 9.8 Hz, 5.7 Hz, 4.1 Hz, 1H); 
13
C NMR (125.76 
MHz, CDCl3) δ 169.5, 157.4, 132.3 (+, 2C), 116.6 (+, 2C), 113.7, 56.7 (+), 51.6, 28.9 (+, 3C), 
23.8 (+), 14.3 (-); IR (KBr, cm
-1
): 3315, 3074, 3067, 2962, 2924, 2852, 1643, 1549, 1485, 1433, 
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1394, 1364, 1283, 1238, 1070, 821; GC: 12.38 min (major), 12.49 min (minor); HRMS (TOF 
ES): found 312.0605, calculated for C14H19BrNO2 (M+H) 312.0599 (1.9 ppm). 
 
(1R*,2R*)-N-tert-butyl-2-(4-
iodophenoxy)cyclopropanecarboxamide (73d): An oven-dried 10 
mL Weaton vial was charged with bromocyclopropane 70a (110 mg, 0.5 mmol), 18-crown-6 
(13.2 mg, 0.05 mmol, 10 mol%), powdered KOH (98 mg, 1.75 mmol, 3.5 equiv.), 4-iodophenol 
(220 mg, 1.0 mmol, 2 equiv), and anhydrous THF (5 mL).  The mixture was stirred at 105 
o
C  for 
8 hrs.  The solvent was evaporated, then the mixture was partitioned between aqueous NaOH 
(3N, 10 mL) and diethyl ether (10 mL).  Organic layer was washed consecutively with 3N NaOH 
(3 x 4 mL) and brine (5 mL), dried with MgSO4, filtered and concentrated.  The residue was 
purified by flash column chromatography on silica gel, eluting first with mixture hexane/EtOAc 
6:1 to separate the major diastereomer (Rf 0.30), then with mixture hexane/EtOAc 1:1 to obtain 
the minor diastereomer (Rf 0.32).  The title compound was afforded as clear crystalline solid, 
mp.  101-102 
o
C .  Yield 144 mg (0.40 mmol, 80%).  
1
H NMR (500.13 MHz, CDCl3) δ 7.57 (d, J 
= 8.8 Hz, 2H), 6.75 (d, J = 8.8 Hz, 2H), 5.57 (br.  s., 1H), 3.99 (ddd, J = 6.5 Hz, 3.9 Hz, 2.2 Hz, 
1H), 1.57 (ddd, J = 9.8 Hz, 6.3 Hz, 2.2 Hz, 1H), 1.47 (ddd, J = 6.5 Hz, 6.3 Hz, 5.7 Hz, 1H), 1.38 
(s, 9H), 1.23 (ddd, J = 9.6 Hz, 5.7 Hz, 3.9 Hz, 1H); 
13
C NMR (125.76 MHz, CDCl3) δ 169.5, 
158.1, 138.3 (+, 2C), 117.2 (+, 2C), 83.6, 56.6 (+), 51.6, 28.9 (+, 3 
o
C), 23.8 (+), 14.3 (-); IR 
(KBr, cm
-1
): 3306, 2961, 2918, 1637, 1551, 1485, 1429, 1393, 1335, 1281, 1261, 1236, 1217, 
1171, 1028, 1001, 978, 845, 792; GC: 12.96 min (major), 13.05 min (minor); HRMS (TOF ES): 
found 360.0565, calculated for C14H19INO2 (M+H) 360.0461 (1.1 ppm). 
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(1R*,2R*)-N-tert-Butyl-2-[4-(phenylcarbonyl)-
phenoxy]cyclopropanecarboxamide (73e): Anoven-dried 10 
mL Weaton vial was charged with bromocyclopropane 70a 
(110 mg, 0.5 mmol), 18-crown-6 (13.2 mg, 0.05 mmol, 10 mol%), powdered KOH (98 mg, 1.75 
mmol, 3.5 equiv.), 4-hydroxy-benzophenone (198 mg, 1.0 mmol, 2 equiv.), and anhydrous THF 
(5 mL).  The mixture was stirred at 105 
o
C  for 14 hrs.  The solvent was removed by rotary 
evaporation.  The residue was purified by flash column chromatography on silica gel elueting 
first with mixture hexane/EtOAc 5:1.  After seperation of the major diasteromer (Rf 0.19), 4-
hydroxy-benzophenone the minor diasteromer were flushed out with EtOAc.  The title 
compound was afforded as white crystalline solid, mp.  72-74 
o
C ..  Yield 152 mg (0.45 mmol, 
90%).  
1
H NMR (500.13 MHz, CDCl3) δ 7.79-7.85 (m, 2H), 7.74-7.78 (m, 2H), 7.58 (t, J = 7.4 
Hz, 1H), 7.48 (t, J = 7.6 Hz, 2H), 7.01-7.07 (m, 2H), 5.63 (br.  s, 1H), 4.11 (ddd, J = 6.4 Hz, 4.0 
Hz, 2.2 Hz, 1H), 1.64 (ddd, J = 9.6 Hz, 6.1 Hz, 2.2 Hz, 1H), 1.53 (ps.-q, J = 6.4 Hz, 6.1 Hz, 5.8 
Hz, 1H), 1.39 (s, 9H), 1.28 (ddd, J = 9.7 Hz, 5.8 Hz, 3.8 Hz, 2H); 
13
C NMR (125.76 MHz, 
CDCl3) δ 195.5, 169.4, 161.9, 138.1, 132.4 (+, 2C), 132.0 (+), 130.9, 129.7 (+, 2C), 128.2 (+, 
2C), 114.5 (+, 2C), 56.8 (+), 51.6, 28.9 (+, 3C), 23.9 (+), 14.3 (-); IR (KBr, cm
-1
): 3331, 2964, 
2924, 2856, 1647, 1601, 1576, 1541, 1504, 1420, 1394, 1364, 1310, 1281, 1263, 1244, 1227, 
1171, 1151, 1088, 1028, 974, 922, 891, 845, 793, 741, 700, 619; GC: 17.05 min (major), 17.35 
min (minor); HRMS (TOF ES): found 344.1842, calculated for C21H23NO3Li (M+Li) 344.1838 
(1.2 ppm). 
 
(1R*,2R*)-N-tert-butyl-2-(4-
cyanophenoxy)cyclopropanecarboxamide (73f): An oven-dried 
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5 mL Weaton vial was charged with bromocyclopropane 70a (110 mg, 0.5 mmol), 18-crown-6 
(13.2 mg, 0.05 mmol, 10 mol%), powdered KOH (98 mg, 1.75 mmol, 3.5 equiv.), p-cyanophenol 
(119 mg, 1.00 mmol, 2 equiv) and anhydrous THF (3 mL).  The mixture was stirred at 110 
o
C  
for 12 hrs.  The mixture was partitioned between water (10 mL) and EtOAc (10 mL).  Aqueous 
layer was extracted with EtOAc (3 x 10 mL).  Combined organic phases were washed with brine 
(10 mL), dried with MgSO4, filtered and concentrated.  The residue was purified by flash column 
chromatography on silica gel (eluent hexane/EtOAc 1:1) to afford the title compound as white 
fluffy crystalline solid, mp.  106-108 
o
C .  Yield 96 mg (0.37 mmol, 74%).  
1
H NMR (500.13 
MHz, CDCl3) δ 7.55 (d, J = 8.8 Hz, 2H), 7.01 (d, J = 8.8 Hz, 2H), 5.91 (br.s, 1H), 4.02 (ddd, J = 
6.6 Hz, 4.4 Hz, 2.2 Hz, 1H), 1.68 (ddd, J = 9.8 Hz, 6.0 Hz, 2.2 Hz, 1H), 1.47 (ps.-q, J = 6.6 Hz, 
6.3 Hz, 6.0 Hz, 1H), 1.36 (s, 9H), 1.22 (ddd, J = 9.8 Hz, 6.3 Hz, 4.4 Hz, 1H); 
13
C NMR (125.76 
MHz, CDCl3) δ 169.2, 161.6, 133.8 (+, 2C), 118.8, 115.6 (+, 2C), 104.5, 56.7 (+), 51.4, 28.7 (+, 
3C), 23.4 (+), 14.0 (-); IR (KBr, cm
-1
): 3304, 3094, 2976, 2961, 2932, 2228, 1645, 1605, 1560, 
1504, 1454, 1435, 1393, 1362, 1337, 1269, 1248, 1225, 1171, 1086, 837; GC: Rt 12.65 min 
(major), 12.82 min (minor); HRMS (TOF ES): found 258.1363, calculated for C15H18N2O2 (M+) 
258.1368 (1.9 ppm). 
 
(1R*,2R*)-N-(tert-butyl)-2-(2,4-di-tert-
butylphenoxy)cyclopropanecarboxamide (73m) (Typical 
Procedure II):  An oven-dried 5 mL Weaton vial was charged 
with bromocyclopropane 70a (110 mg, 0.5 mmol), 18-crown-6 (13.2 mg, 0.05 mmol, 10 mol%), 
powdered KOH (98 mg, 1.75 mmol, 3.5 equiv.), 2,4-di-tert-butylphenol (206 mg, 1.00 mmol, 2 
equiv), and anhydrous THF (3 mL).  The mixture was stirred at 80 
o
C  for 14 hrs.  The mixture 
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was partitioned between water (10 mL) and EtOAc (10 mL).  Aqueous layer was extracted with 
EtOAc (3  10 mL).   Combined organic phases were washed with brine (10 mL), dried with 
MgSO4, filtered and concentrated.  The residue was purified by flash column chromatography on 
silica gel eluting first with a mixture hexane/EtOAc 10:1 until separation of 2,4-di-tert-
butylphenol.  Then polarity of the eluent was increased (hexane/EtOAc 4:1) and two fractions of 
diastereomeric products were collected, Rf 0.50 (155 mg); 0.38 (10 mg).   Both compounds were 
white crystalline solids.  Combined yield 165 mg (0.48 mmol, 95%).   73m (major): 
1
H NMR 
(500.13 MHz, CDCl3) δ 7.35 (d, J = 2.5 Hz, 1H), 7.21 (dd, J = 8.5 Hz, 2.5 Hz, 1H), 7.05 (d, J = 
8.5 Hz, 1H), 5.69 (br.s, 1H), 4.06 (ddd, J = 6.3 Hz, 4.1 Hz, 2.2 Hz, 1H), 1.61 (ddd, J = 9.5 Hz, 
6.0 Hz, 2.2 Hz, 1H), 1.54 (ps.-q, J = 6.3 Hz, 6.0 Hz, 1H), 1.42 (s, 9H), 1.37 (s, 9H), 1.34 (s, 9H), 
1.33-1.30 (m, 1H);  
13
C NMR (125.76 MHz, CDCl3) δ 170.1, 154.6, 143.2, 136.9, 123.9 (+), 
123.3 (+), 112.1 (+), 56.2 (+), 51.5, 34.9, 34.3, 31.6 (+, 3C), 29.8 (+, 3C), 28.9 (+, 3C), 24.2 (+), 
14.5 (-);  IR (KBr, cm
-1
): 3298, 3090, 2964, 2907, 2868, 1641, 1560, 1495, 1485, 1454, 1433, 
1394, 1360, 1234, 1204, 1165, 1095;  GC: Rt 13.01 min;  HRMS (TOF ES): found 345.2661, 
calculated for C22H35NO2 (M
+
) 345.2668 (2.0 ppm).   cis-73m (minor): 
1
H NMR (500.19 MHz, 
CDCl3) δ 7.33 (d, J = 2.2 Hz, 1H), 7.19 (dd, J = 8.5 Hz, 2.2 Hz, 1H), 7.16 (d, J = 8.5 Hz, 1H), 
5.50 (br.s, 1H), 3.82 (td, J = 6.6 Hz, 4.4 Hz, 1H), 1.82 (dt, J = 9.5 Hz, 6.9 Hz, 1H), 1.58 (td, J = 
6.3 Hz, 4.4 Hz, 1H), 1.38 (s, 9H), 1.32 (s, 9H), 1.25 (dt, 9.5 Hz, 6.3 Hz, 1H), 1.17 (s, 9H); 
13
C 
NMR (125.76 MHz, CDCl3) δ  167.2, 154.6, 143.6, 137.3, 123.9 (+), 123.1 (+), 112.6 (+), 55.2 
(+), 51.1, 35.0, 34.3, 31.6 (+, 3C), 30.0 (+, 3C), 28.6 (+, 3C), 23.6 (+), 11.6 (-);  GC: Rt 13.10 
min;  IR (KBr, cm
-1
): 3277, 3074, 2959, 2926, 2866, 1651, ,1556, 1489, 1456, 1435, 1392, 1362, 
1339, 1265, 1234, 1205, 1161, 1142, 1126, 1092, 1026, 1007, 970, 932, 889, 841, 806, 787, 748, 
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721, 704, 644;  GC: Rt 13.10 min;  HRMS (TOF ES): found 346.2754, calculated for C22H36NO2 
(M+H) 346.2746 (2.3 ppm). 
 
 (1R*,2R*)-N-tert-butyl-2-(2-
fluorophenoxy)cyclopropanecarboxamide (73g):  Was prepared 
according to Typical Procedure II, employing bromocyclopropane 70a (110 mg, 0.5 mmol) and 
2-flurophenol (112 mg, 1.0 mmol, 2 equiv).   The reaction was carried out at 110 
o
C  for 13 hrs.   
Flash column chromatography on silica gel, eluting first with mixture hexane/EtOAc 12:1 to 
separate 2-flurophenol (Rf 0.34), then with mixture hexane/EtOAc 3:1 (Rf 0.36 (major), 0.10 
(minor)) afforded the title compound as white crystalline solid.   Yield 111 mg (0.44 mmol, 
89%).   
1
H NMR (500.13 MHz, CDCl3) δ 7.13-7.20 (m, 1H), 7.03-7.10 (m, 2H), 6.90-6.96 (m, 
1H), 5.70 (br.  s., 1H), 4.08 (ddd, J = 6.3 Hz, 3.9 Hz, 2.0 Hz, 1H), 1.70 (ddd, J = 9.7 Hz, 6.2 Hz, 
2.0 Hz, 1H), 1.49 (ddd, J = 6.3 Hz, 6.2 Hz, 5.8 Hz, 1H), 1.37 (s, 9H), 1.28 (ddd, J = 9.7 Hz, 5.8 
Hz, 3.8 Hz, 1H);  
13
C NMR (125.76 MHz, CDCl3) δ 169.6, 152.1 (d, 
1
JCF = 245.6 Hz), 146.2 (d, 
2
JCF = 10.1 Hz), 124.3 (d, 
3
JCF = 3.8 Hz, +), 121.6 (d, 
3
JCF = 6.8 Hz, +), 116.1 (d, 
2
JCF = 18.3 Hz, 
+), 115.0 (+), 57.3 (+), 51.5, 28.8 (+, 3C), 23.7 (+), 14.2 (-);  
19
F NMR (376.50 MHz, CDCl3) 
δ -135.2;  IR (KBr, cm
-1
): 3294, 3090, 3074, 2993, 2962, 1638, 1560, 1502, 1400, 1340, 1279, 
1254, 1205, 1111, 1080, 974, 928, 912, 773, 739; GC: 10.86 min (major), 11.00 min (minor); 
HRMS (TOF ES): found 258.1490, calculated for C14H18FNO2Li (M+Li) 258.1481 (3.5 ppm). 
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(1R*,2R*)-N-tert-butyl-2-((2-
trifluoromethoxy)phenoxy)cyclopropanecarboxamide (73h):  Was 
prepared according to Typical Procedure II, employing bromocyclopropane 70a (110 mg, 0.5 
mmol) and 2-(trifluoromethoxy)phenol (178 mg, 1.0 mmol, 2 equiv).   The reaction was carried 
out at 105 
o
C  for 4 hrs.  Flash column chromatography on silica gel eluting with hexane/EtOAc 
1:1 (Rf 0.49 (major), 0.30 (minor)) afforded the title compound as white crystalline solid.  Yield 
133 mg (0.42 mmol, 84%).   
1
H NMR (500.13 MHz, CDCl3) δ 7.28 (ddd, J = 8.5 Hz, 7.3 Hz, 1.6 
Hz, 1H), 7.21-7.25 (m, 2 H), 6.99 (ddd, J = 7.9 Hz, 7.6 Hz, 1.6 Hz, 1H), 5.69 (br.s., 1H), 4.11 
(ddd, J = 6.3 Hz, 3.9 Hz, 2.0 Hz, 1H), 1.69 (ddd, J = 9.7 Hz, 6.2 Hz, 2.0 Hz, 1H), 1.50 (ddd, J = 
6.3 Hz, 6.2 Hz, 5.8 Hz, 1H), 1.39 (s, 9H), 1.26 (ddd, J = 9.7 Hz, 5.8 Hz, 3.8 Hz, 1H);  
13
C NMR 
(125.76 MHz, CDCl3) δ 169.5, 150.8, 137.8, 127.9 (+), 123.0 (+), 121.4 (+), 120.6 (q, 
1
JCF = 
257.5 Hz), 114.7 (+), 57.1 (+), 51.5, 28.8 (+, 3C), 23.8 (+), 14.4 (-);  
19
F NMR (376.50 MHz, 
CDCl3) δ -58.3;  IR (KBr, cm
-1
): 3300, 3092, 2968, 2930, 2908, 2872, 1639, 1607, 1564, 1501, 
1456, 1435, 1396, 1362, 1339, 1302, 1285, 1269, 1225, 1196, 1161, 1150, 1115, 978, 750, 403;  
GC: 10.49 min (major), 10.68 min (minor);  HRMS (TOF ES): found 340.1127, calculated for 
C15H18F3NO3Na (M+Na) 340.1136 (2.6 ppm). 
 
 (1R*,2R*)-N-tert-butyl-2-(3,5-
dimethylphenoxy)cyclopropanecarboxamide (73j): Was 
prepared according to Typical Procedure II, employing 
bromocyclopropane 70a (110 mg, 0.5 mmol) and 3,5-dimethylphenol (122 mg, 1.00 mmol, 2 
equiv).   The reaction was carried out at 100 
o
C  for 13 hrs.   Flash column chromatography on 
silica gel (eluent hexane/EtOAc 3:1, Rf  0.56 (major), 0.13 (minor)) afforded the title compound 
77 
 
as colorless crystalline solid.  Yield 124 mg (0.47 mmol, 95%).   
1
H NMR (500.13 MHz, CDCl3) 
δ 6.67 (s, 1H), 6.63 (s, 2H), 5.56 (br.s, 1H), 4.00-3.98 (m, 1H), 2.31 (s, 6H), 1.56-1.50 (m, 2H), 
1.41 (s, 9H), 1.30-1.26 (m, 1H);  
13
C NMR (125.76 MHz, CDCl3) δ 169.9, 158.3, 139.3 (2C), 
123.1 (+), 112.5 (+, 2C), 56.6 (+), 51.5, 28.9 (+, 3C), 24.2 (+), 21.4 (+), 14.2 (-);  IR (KBr, cm
-1
): 
3300, 3207, 3092, 2966, 2918, 2870, 1641, 1614, 1595, 1564, 1474, 1458, 1433, 1396, 1364, 
1342, 1317, 1296, 1261, 1231, 1205, 1167, 1144, 1097, 982, 891, 831; GC: Rt 11.66 min 
(major), 11.83 min (minor); HRMS (TOF ES): found 262.1805, calculated for C16H24NO2 
(M+H) 262.1807 (0.8 ppm). 
 
(1R*,2R*)-2-(3,5-bis(trifluoromethyl)phenoxy)-N-tert-
butylcyclopropanecarboxamide (73l):  Was prepared according 
to Typical Procedure II, employing bromocyclopropane 70a (110 
mg, 0.5 mmol), and 3,5-bis(trifluromethyl)phenol (230 mg, 1.0 mmol, 2 equiv).   The reaction 
was carried out at 100 
o
C  for 6.5 hrs.  Flash column chromatography on silica gel, eluting first 
with hexane/EtOAc mixture 10:1, then after separation of the residual phenol (Rf 0.25) with 
hexane/EtOAc mixture 3:1 (Rf 0.43 (major), 0.40 (minor)) afforded the title compound as white 
crystalline solid.   Yield 157 mg (0.43 mmol, 85%).   
1
H NMR (500.13 MHz, CDCl3) δ 7.53 (s, 
1H), 7.42 (s, 2H), 5.62 (br.s, 1H), 4.11-4.07 (m, 1H), 1.64-1.58 (m, 2H), 1.41 (s, 9H), 1.37-1.34 
(m, 1H);  
13
C NMR (125.76 MHz, CDCl3) δ 168.9, 159.0, 133.0 (q, 
2
JCF = 33.0 Hz, 2C), 123.1 
(q, 
1
JCF = 272.2 Hz, 2C), 115.3 (q, 
3
JCF = 3.7 Hz, 2C), 115.0 (septet, 
3
JCF = 4.1 Hz), 57.4 (+), 
51.8, 28.8 (+, 3C), 23.9 (+), 14.1 (-);  
19
F NMR (376.50 MHz, CDCl3) δ -63.1; IR (KBr, cm
-1
): 
3306, 3097, 2989, 2974, 2939, 1637, 1560, 1464, 1400, 1377, 1342, 1321, 1277, 1231, 1188, 
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1128, 1092, 959;  GC: 10.03 min (major), 9.99 min (minor);  HRMS (TOF ES): found 392.1055, 
calculated for C16H17F6NO2Na (M+Na) 392.1061 (1.5 ppm). 
 
(1R*,2R*)-N,N-Diethyl-2-(2-
fluorophenoxy)cyclopropanecarboxamide (73i): Was prepared 
according to Typical Procedure II, employing bromocyclopropane 70b (110 mg, 0.50 mmol) and 
2-flurophenol (112 mg, 1.00 mmol, 2.00 equiv).   The reaction was carried out at 110 
o
C  for 14 
hrs.   Flash column chromatography on silica gel (eluent hexane/EtOAc 12:1, Rf 2-flurophenol 
0.34, major 0.11, minor 0.03) after elution of 2-flurophenol the eluent polarity was increased 
(hexane/EtOAc 3:1, Rf  0.19 (major), 0.06 (minor)) afforded the title compound as colorless oil.  
Yield 103 mg (0.41 mmol, 82%).   
1
H NMR (500.13 MHz, CDCl3) δ 7.18 (td, J = 8.1 Hz, 1.4 Hz, 
1H), 7.07 (t, J = 9.1 Hz, 2H), 6.96 - 6.90 (m, 1H), 4.20 (ddd, J = 6.4 Hz, 3.9 Hz, 2.0 Hz, 1H), 
3.50 - 3.39 (m, 4H), 2.09 (ddd, J = 9.7 Hz, 6.2 Hz, 2.0 Hz, 1H), 1.53 (ddd, J = 6.4 Hz, 6.2 Hz, 
5.8 Hz, 1H), 1.40 (ddd, J = 9.7 Hz, 5.8 Hz, 3.8 Hz, 1H), 1.21 (t, J = 7.3 Hz, 3H), 1.14 (t, J = 7.1 
Hz, 3H);  
13
C NMR (125.76 MHz, CDCl3) δ 169.6, 152.3 (d, 
1
JCF = 245.6 Hz), 146.3 (d, 
2
JCF = 
11.0 Hz), 124.3 (d, JCF = 4.6 Hz, +), 121.7 (d, JCF = 7.3 Hz, +), 116.2 (d, 
3
JCF = 17.4 Hz, +), 
115.4 (+), 58.3 (+), 42.2 (-), 40.8 (-), 19.9 (+), 15.5 (-), 14.8 (+), 13.2 (+);  GC: 11.18 min 
(major), 11.34 min (minor);  FTIR (NaCl, film, cm
-1
): 2976, 2934, 1634, 1504, 1458, 1265, 
1254, 1209, 1136, 748; HRMS (TOF ES): found 252.1398, calculated for C14H19FNO2 (M+H) 
252.1400 (0.8 ppm).  
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((1R*,2R*)-2-(3,5-Dimethylphenoxy)cyclopropyl)(4-
morpholino)methanone (73k):  Was prepared according to 
Typical Procedure II, employing bromocyclopropane 70c (117 
mg, 0.50 mmol) and 3,5-dimethyl-phenol (122 mg, 1.00 mmol, 2.00 equiv), and anhydrous THF 
(5 mL).   The reaction was carried out at 100 
o
C  for 13 hrs.   Flash column chromatography on a 
silica gel (eluent hexane/EtOAc 3:1, Rf 0.16) afforded the title compound as colorless crystalline 
solid.  Yield 120 mg (0.44 mmol, 87%).   
1
H NMR (500.13 MHz, CDCl3) δ 6.67 (s, 1H), 6.62 (s, 
2H), 4.08 (ddd, J = 6.5 Hz, 3.9 Hz, 2.2 Hz, 1H), 3.82-3.58 (m, 8H), 2.32 (s, 6H), 2.02 (ddd, J = 
9.5 Hz, 6.2 Hz, 2.2 Hz, 1H), 1.61 (ddd, J = 6.5 Hz, 6.2 Hz, 5.4 Hz, 1H), 1.38 (ddd, J = 9.5 Hz, 
5.4 Hz, 3.9 Hz, 1H);  
13
C NMR (125.76 MHz, CDCl3) δ 169.5, 158.2, 139.3 (2C), 123.3 (+), 
112.5 (+, 2C), 66.9 (-), 66.8 (-), 57.4 (+), 46.1 (-), 42.5 (-), 21.4 (+), 19.6 (+), 15.4 (-);  GC: 
13.27 min (major), 13.42 min (minor);  FTIR (NaCl, film, cm
1
) 2961, 2918, 2854, 1639, 1443, 
1319, 1294, 1117, 1032, 835, 689; HRMS (TOF ES): found 276.1612, calculated for C16H22NO3 
(M+H) 276.1600 (4.3 ppm). 
 
((1R*,2R*)-2-(2,6-
Dimethylphenoxy)cyclopropyl)(morpholino)methanone (73n):  Was 
prepared according to Typical Procedure II, employing bromocyclopropane 70c (117 mg, 0.50 
mmol), and 2,6-dimethylphenol (122 mg, 1.00 mmol, 2.0 equiv).  The reaction was carried out at 
90 
o
C  for 14 hrs.   Flash column chromatography on silica gel afforded a title compound as a 
colorless oil, Rf 0.17 (eluent hexane/EtOAc 3:1), Yield 114 mg (0.42 mmol, 83%).   
1
H NMR 
(500.13 MHz, CDCl3) δ 6.94 (d, J = 7.6 Hz, 2H), 6.86 (dd, J = 8.2 Hz, 6.6 Hz, 1H), 3.99 (ddd, J 
= 6.5 Hz, 3.9 Hz, 2.2 Hz, 1H), 3.66-3.49 (m, 4H), 3.48-3.30 (m, 4H), 2.20 (s, 6H), 2.02 (ddd, J = 
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9.6 Hz, 6.1 Hz, 2.2 Hz, 1H), 1.40 (ddd, J = 6.5 Hz, 6.2 Hz, 5.6 Hz, 1H), 1.31 (ddd, J = 9.5 Hz, 
5.6 Hz, 4.1 Hz, 1H);  
13
C NMR (125.76 MHz, CDCl3) δ 169.4, 155.0, 130.3 (2C), 128.9 (+, 2C), 
124.1 (+), 66.7 (-), 66.6 (-), 62.1 (+), 45.9 (-), 42.3 (-), 19.4 (+), 17.0 (+, 2C), 15.1 (-);  FTIR 
(NaCl, film, cm
1
): 2961, 2920, 2854, 1643, 1443, 1371, 1265, 1236, 1211, 1188, 1117, 932, 851;  
HRMS (TOF ES): found 275.1524, calculated for C16H21NO3 (M
+
) 275.1521 (1.1 ppm).   
 
Piperidin-1-yl((1R*,2R*)-2-(quinolin-8-
yloxy)cyclopropyl)methanone (73o): Was prepared according to 
Typical Procedure II, employing bromocyclopropane 70d (116 mg, 0.50 mmol) and 8-hydroxy-
quinoline (145 mg, 1.00 mmol, 2.00 equiv).   Flash column chromatography on silica gel (eluent 
EtOAc, Rf  0.73 (8-hydroxyquinoline), 0.23 (title product)) afforded a colorless amorphous solid.   
Yield 144 mg (0.49 mmol, 97%).   
1
H NMR (400.13 MHz, CDCl3) δ 8.95 (dd, J = 4.0 Hz, 1.8 
Hz, 1H), 8.16 (dd, J = 8.2 Hz, 1.6 Hz, 1H), 7.53-7.41 (m, 4H), 4.37 (ddd, J = 6.3 Hz, 4.6 Hz, 2.3 
Hz, 1H), 3.75-3.55 (m, 4H), 2.34 (ddd, J = 9.3 Hz, 6.9 Hz, 2.3 Hz, 1H), 1.79-1.56 (m, 8H);  
13
C 
NMR (100.67 MHz, CDCl3) δ 168.9, 154.2, 149.4 (+), 139.7, 135.9 (+), 129.3, 126.6 (+), 121.6 
(+), 120.3 (+), 110.1 (+), 58.0 (+), 46.8 (-), 43.1 (-), 26.5 (-), 25.5 (-), 24.5 (-), 19.6 (+), 15.5 (-);  
FT IR (NaCl, film, cm
-1
): 3007, 2935, 2854, 1628, 150, 1470, 1375, 1247, 1209, 1184, 1103, 
1022, 825, 792; HRMS (TOF ES): found 297.1603, calculated for C18H21N2O2 (M+H) 297.1603 
(0.0 ppm). 
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2.6.7. Thiolate Adducts 
 
(1S*,2R*)-N-Butyl-2-(phenylthio)cyclopropanecarboxamide 
(82g) (Typical Procedure III):  An oven-dried 10 mL Weaton vial 
was charged with bromocyclopropane 70f (110 mg, 0.5 mmol, 1 equiv), 18-crown-6 (13.2 mg, 
0.05 mmol, 10 mol%), KOH (98 mg, 1.75 mmol, 3.5 equiv.), thiophenol (110 mg, 1 mmol, 2 
equiv), and anhydrous THF (5 mL).  The mixture was stirred at 85 
o
C  for 12 hrs.   The crude 
mixture was filtered through a fritted funnel and the filtrate was concentrated in vacuum.   The 
residual crude material, containing a mixture of diastereomeric cyclopropylsulfides (trans:cis = 
2:1) was combined potassium tert-butoxide (168 mg, 1.50 mmol, 3.0 eq) in 10 mL Weaton vial, 
the mixture was dissolved in dry THF (total volume of 8 mL) and heated at 85 
o
C  for 6 hr.   The 
resulting mixture was filtered through a fritted funnel into an evaporating flask, and the filtrate 
was concentrated in vacuum.   The residue was purified by flash column chromatography on 
silica gel to obtain the individual trans-isomer fo a title compound as white solid, mp 95-97 
o
C , 
Rf : 0.29 (eluent hexane/EtOAc 3:1).   Yield 121 mg (0.483 mmol, 97%).   
1
H NMR (500.13 
MHz, CDCl3) δ 7.33-7.27 (m, 4H), 7.21-7.15 (m, 1H), 5.82 (br.  s., 1H), 3.42-3.21 (m, 2H), 2.76 
(ddd, J = 8.2 Hz, 5.4 Hz, 3.5 Hz, 1H), 1.70 (dt, J = 8.2 Hz, 5.0 Hz, 1H), 1.59 (ddd, J = 8.5 Hz, 
5.2 Hz, 3.6 Hz, 1H), 1.57-1.47 (m, 2H), 1.39 (dq, J = 14.9 Hz, 7.4 Hz, 2H), 1.16 (ddd, J = 8.5 
Hz, 5.4 Hz, 4.7 Hz, 1H), 0.96 (t, J = 7.4 Hz, 3H); 
13
C NMR (125.76 MHz, CDCl3) δ 170.6, 
137.5, 128.8 (+, 2C), 126.6 (+, 2C), 125.3 (+), 39.6 (-), 31.7 (-), 26.2 (+), 20.7 (+), 20.0 (-), 16.3 
(-), 13.7 (+);  IR (NaCl, cm
-1
): 3296, 3223, 3202, 3196, 3084, 3055, 2955, 2922, 2851, 2826, 
1636, 1583, 1558, 1479, 1466, 1456, 1439, 1423, 1396; HRMS (TOF ES): found 250.1268, 
calculated for C14H20NOS (M+H) 250.1266 (0.8 ppm). 
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(1S*,2S*)-N-Butyl-2-(phenylthio)cyclopropanecarboxamide 
(cis-82g) was isolated as a reference sample in a separate 
experiment by column chromatography of the crude reaction micture prior to re-equilibration 
with t-BuOK, Rf 0.15 (eluent hexane/ EtOAc 3:1).   Yield 37 mg (0.15 mmol, 30%).   
1
H NMR 
(500.13 MHz, CDCl3) δ 7.37 (d, J = 7.3 Hz, 2H), 7.32-7.27 (m, 2H), 7.20-7.15 (m, 1H), 5.81 (br.  
s., 1H), 3.24-3.16 (m, 2H), 2.64 (td, J = 8.0 Hz, 6.3 Hz, 1H), 2.09 (td, J = 8.0 Hz, 6.6 Hz, 1H), 
1.47 (td, J = 8.4 Hz, 5.4 Hz, 1H), 1.40 (q, J = 6.3 Hz, 1H), 1.35-1.27 (m, 2H), 1.26-1.17 (m, 2H), 
0.84 (t, J = 7.3 Hz, 3H);  
13
C NMR (125.76 MHz, CDCl3) δ ppm 168.5, 137.2, 128.8 (+, 2C), 
127.3 (+, 2C), 125.6 (+), 39.5 (-), 31.5 (-), 23.5 (+), 20.7 (+), 19.9 (-), 13.7 (+), 12.9 (-);  
 
 ((1S*,2R*)-2-(Benzylthio)cyclopropyl)(morpholino)methanone 
(82b): The reaction was performed according to Typical Procedure 
III, employing bromocyclopropane 70c (117 mg, 0.50 mmol) and 
benzylmercaptan (124 mg, 1.00 mmol) to produce the title compound as a yellow oil, Rf 0.28 
(eluent hexane/EtOAc 1:1, yield 128 mg (0.46 mmol, 92%).  Initial dr 2:1, after equilibration 
was upgraded to >30:1.   
1
H NMR (500.13 MHz, CDCl3) δ 7.33-7.30 (m, 4H), 7.29-7.24 (m, 
1H), 3.82 (d, J = 13.6 Hz, 1H), 3.77 (d, J = 13.6 Hz, 1H), 3.72-3.58 (m, 5H), 3.56-3.34 (m, 3H), 
2.44 (ddd, J = 8.4 Hz, 5.3 Hz, 3.6 Hz, 1H), 1.66 (ddd, J = 8.7 Hz, 5.2 Hz, 3.5 Hz, 1H), 1.43 (dt, J 
= 8.2 Hz, 5.2 Hz, 4.5 Hz, 1H), 0.97 (ddd, J = 8.4 Hz, 5.3 Hz, 4.8 Hz, 1H);  
13
C NMR (125.76 
MHz, CDCl3) δ 169.8, 138.5, 128.7 (+, 2C), 128.4 (+, 2C), 126.9 (+), 66.7 (-), 66.5 (-), 45.7 (-), 
42.3 (-), 37.9 (-), 22.1 (+), 22.0 (+), 16.2 (-);  IR (NaCl, cm
-1
): 3001, 2961, 2918, 2899, 2854, 
1637, 1603, 1495, 1454, 1439, 1389, 1362, 1329, 1300, 1273, 1231, 1194, 1115, 1070, 1041, 
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1026, 966, 918, 868, 845, 771, 744, 702, 667, 642, 567, 440, 419;  HRMS (TOF ES): found 
300.1033, calculated for C15H19NO2SNa (M+Na) 300.1034 (0.3 ppm). 
 
((1S*,2S*)-2-(Benzylthio)cyclopropyl)(morpholino)methanone 
(cis-82b), was isolated as a reference sample in a separate 
experiment by column chromatography of the crude reaction 
micture prior to re-equilibration with t-BuOK, Rf 0.15 (eluent hexane/ EtOAc 1:1).   Yield 42 
mg (0.15 mmol, 30%).   
1
H NMR (500.13 MHz, CDCl3) δ 7.36-7.31 (m, 4H), 7.30-7.25 (m, 1H), 
3.86 (ddd, J = 13.2 Hz, 5.4 Hz, 3.2 Hz, 1H), 3.77 (s, 2H), 3.76-3.62 (m, 5H), 3.58 (ddd, J = 13.2 
Hz, 6.9 Hz, 3.8 Hz, 1H), 3.52 (ddd, J = 13.4 Hz, 7.4 Hz, 3.2 Hz, 1H), 2.20 (td, J = 8.0 Hz, 6.0 
Hz, 1H), 2.02 (td, J = 8.3 Hz, 6.1 Hz, 1H), 1.45 (q, J = 5.8 Hz, 1H), 1.25 (td, J = 8.0 Hz, 5.2 Hz, 
1H);  
13
C NMR (125.76 MHz, CDCl3) δ ppm 167.1, 138.2, 128.8 (+, 2C), 128.5 (+, 2C), 127.0 
(+), 66.9 (-), 66.8 (-), 45.9 (-), 42.5 (-), 37.8 (-), 21.8 (+), 19.8 (+), 13.1 (-);  HRMS (TOF ES): 
found 278.1219, calculated for C15H20NO2S (M+H) 278.1215 (1.4 ppm). 
 
 (1S*,2R*)-N-Butyl-2-
(dodecylthio)cyclopropanecarboxamide (82a): The 
reaction was performed according to Typical Procedure III, employing bromocyclopropane 70f 
(110 mg, 0.50 mmol) and dodecanethiol (202 mg, 1.00 mmol) to produce the title compound as a 
white solid (mp 50-52 
o
C ), Rf 0.23 (eluent hexane/EtOAc 3:1).   Yield 162 mg (0.48 mmol, 
95%).   Initial dr 1:1, after equilibration was upgraded to 16:1.   
1
H NMR (500.13 MHz, CDCl3) 
δ 5.84 (br.  s., 1H), 3.32-3.22 (m, 2H), 2.64-2.52 (m, 2H), 2.45-2.36 (m, 1H), 1.69-1.56 (m, 2H), 
1.55-1.44 (m, 4H), 1.42-1.33 (m, 4H), 1.44-1.20 (m, 16H), 1.02-0.96 (m, 1H), 0.94 (t, J = 7.4 
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Hz, 3H), 0.89 (t, J = 6.9 Hz, 3H);  
13
C NMR (125.76 MHz, CDCl3) δ 171.1, 39.5 (-), 33.4 (-), 
31.9 (-), 31.7 (-), 29.62 (-), 29.60 (-), 29.58 (-), 29.57 (-), 29.5 (-), 29.3 (-), 29.2 (-), 28.8 (-), 25.9 
(+), 22.6 (-), 21.4 (+), 20.0 (-), 16.3 (-), 14.1 (+), 13.7 (+);  IR (KBr, cm
-1
):  3271, 2955, 2918, 
2849, 1636, 1558, 1456, 1277, 1232, 746, 719, 658, 501, 403;  HRMS (TOF ES): found 
342.2833, calculated for C20H40NOS (M+H) 342.2831 (0.6 ppm). 
 
(1S*,2R*)-N-Butyl-2-((2-
(phenylamino)ethyl)thio)cyclopropanecarboxamide 
(82f):  This compound was prepared according to Typical Procedure III starting from bromo-
cyclopropane 70f (55 mg, 0.25 mmol) and 2-anilinoethanthiol (78 mg, 0.50 mmol, 2.0 equiv).   
The product was isolated by column chromatography on silica gel (eluent hexane/EtOAc 3:1, 
gradually changed to 1:1) as yiellowish oil, Rf 0.28 (hexane/EtOAc, 1:1).   Yield 128 mg (0.46 
mmol, 92%).  Initial dr 2:1, after equilibration was upgraded to >30:1.   
1
H NMR (500.13 MHz, 
CDCl3) δ ppm 7.23 (t, J = 7.9 Hz, 2H), 6.77 (t, J = 7.3 Hz, 1H), 6.67 (d, J = 8.5 Hz, 2H), 5.40 
(br.  s., 1H), 4.12 (br.  s., 1H), 3.40 (t, J = 6.3 Hz, 2H), 3.25 (dq, J = 13.4 Hz, 6.8 Hz, 1H), 3.15 
(dq, J = 12.6 Hz, 6.9 Hz, 1H), 2.95 (dt, J = 13.6 Hz, 6.0 Hz, 1H), 2.85 (dt, J = 13.6 Hz, 6.6 Hz, 
1H), 2.39 (ddd, J = 8.4 Hz, 5.3 Hz, 3.6 Hz, 1H), 1.49 (dt, J = 8.2 Hz, 4.7 Hz, 1H), 1.44 (dq, J = 
15.4 Hz, 6.9 Hz, 2H), 1.40 (ddd, J = 8.5 Hz, 5.0 Hz, 3.5 Hz, 1H), 1.33 (dq, J = 14.9 Hz, 7.2 Hz, 
2H), 0.99 (dt, J = 8.4 Hz, 5.0 Hz, 1H), 0.94 (t, J = 7.4 Hz, 3H);  
13
C NMR (125.76 MHz, CDCl3) 
δ 170.6, 147.7, 129.4 (+, 2C), 117.8 (+), 113.1 (+, 2C), 42.3 (-), 39.5 (-), 32.8 (-), 31.7 (-), 26.4 
(+), 20.9 (+), 20.0 (-), 15.6 (-), 13.7 (+);  IR (KBr, cm
-1
):  3304, 2957, 2930, 1641, 1603, 1556, 
1506, 1466, 1433, 1394, 1373, 1323, 1288, 1261, 1225, 1196, 1180, 1153, 1113, 1095, 1072, 
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1030, 989, 962, 920, 868, 852, 804, 748, 692, 652, 617, 554, 538, 511;  HRMS (TOF ES): found 
293.1685, calculated for C16H25N2OS (M+H) 293.1688 (1.0 ppm).   
 
(1S*,2R*)-N-Benzyl-2-((3-
(benzylthio)propyl)thio)cyclopropanecarboxamide 
(82c): The reaction was performed according to 
Typical Procedure III employing bromocyclopropane  70g (127 mg, 0.50 mmol) and 3-
(benzylthio)propane-1-thiol (198 mg, 1.00 mmol, 2.0 equiv) to produce the title compound as a 
white solid, mp 78-80 
o
C ,  Rf  0.40  (hexane/EtOAc, 3:1).   Yield 107 mg (0.44 mmol, 87%).   
Initial dr 2:1, after equilibration was upgraded to >30:1.   
1
H NMR (500.13 MHz, CDCl3) δ 7.40-
7.24 (m, 10H), 6.00 (br.  s., 1H), 4.52-4.41 (m, 2H), 3.71 (s, 2H), 2.74-2.61 (m, 2H), 2.60-2.49 
(m, 2H), 2.43 (ddd, J = 8.2 Hz, 5.7 Hz, 3.8 Hz, 1H), 1.94-1.85 (m, 2H), 1.55 (dt, J = 8.2 Hz, 4.7 
Hz, 1H), 1.47 (ddd, J = 8.5 Hz, 5.0 Hz, 3.5 Hz, 1H), 1.02 (ddd, J = 8.5 Hz, 5.7 Hz, 4.4 Hz, 1H);  
13
C NMR (100.67 MHz, CDCl3) δ 170.9, 138.3, 138.0, 128.8 (+, 2C), 128.7 (+, 2C), 128.5 (+, 
2C), 127.8 (+, 2C), 127.5 (+), 127.0 (+), 43.9 (-), 36.2 (-), 32.2 (-), 29.9 (-), 28.6 (-), 25.9 (+), 
21.5 (+), 16.2 (-);  FT IR (NaCl, film, cm
-1
): 3290, 3061, 3028, 2918, 1641, 1603, 1551, 1495, 
1452, 1423, 1394, 1356, 1298, 1273, 1227, 1196, 1157, 1109, 1082, 1070, 1040, 1028, 1003, 
966, 918, 860, 841, 802, 768, 731, 698, 656, 621, 600, 565, 538, 509, 474, 447, 432;  HRMS 
(TOF ES): found 371.1374, calculated for C21H25NOS2 (M
+
) 371.1374 (1.1 ppm);  
 
(1S*,2R*)-N-tert-Butyl-2-(2-
hydroxyethylthio)cyclopropanecarboxamide (82d) (Typical 
Procedure IV):  An oven-dried 5 mL Weaton vial was charged with bromocyclopropane 70a 
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(110 mg, 0.50 mmol), 18-crown-6 (13 mg, 0.05 mmol, 10%), powdered KOH (140 mg, 2.5 
mmol, 5.0 equiv.), 2-mercaptoethanol (70 μL, 78 mg, 1.00 mmol, 2.0 equiv.), and anhydrous 
THF (5 mL).   The mixture was stirred at 85 
o
C for 12 hrs, then filtered through a fritted funnel 
and concentrated.   The residue was purified by flash chromatography on silica gel (eluent 
hexane/EtOAc 1:1) to afford the title compound as a colorless oil, Rf  0.40 (hexane/EtOAc 1:3).   
Yield 108 mg (0.49 mmol, 97%).   
1
H NMR (500.13 MHz, CDCl3) δ 5.59 (br.  s., 1H), 3.82 (t, J 
= 6.0 Hz, 2H), 2.89-2.75 (m, 2H), 2.43-2.33 (m, 1H), 2.22 (br.  s., 1H), 1.50 - 1.43 (m, 2H), 1.37 
(s, 9H), 1.03-0.93 (m, 1H);  
13
C NMR (125.76 MHz, CDCl3) δ ppm 170.0, 60.4 (-), 51.5, 36.4 
(-), 28.8 (+, 3C), 26.5 (+), 20.4 (+), 16.1 (-);  IR (KBr, cm
-1
): 3315, 2966, 2928, 1651, 1553, 
1456, 1425, 1393, 1364, 1283, 1244, 1225, 1196, 1047, 1016;  HRMS (TOF ES): found 
240.1031, calculated for C10H19NO2SNa (M+Na) 240.1034 (1.2 ppm). 
 
(1S*,2R*)-2-((2-hydroxyethyl)thio)-N-
phenylcyclopropanecarboxamide (82e): Was prepared according 
to Typical Procedure IV, employing bromocyclopropane 70h  (120 mg, 0.50 mmol).   The 
reaction was carried out at 60 
o
C  for 14 hrs.   Flash column chromatography on silica gel 
afforded a title compound as colorless crystals, mp 87-88 
o
C , Rf  0.38 (hexane/EtOAc 1:3).  
Yield 101 mg (0.43 mmol, 85%).   
1
H NMR (400.13 MHz, CD3CN) δ 8.78 (br.  s., 1H), 7.58 (d, 
J = 8.1 Hz, 2H), 7.33 (t, J = 8.0 Hz, 2H), 7.10 (t, J = 7.5 Hz, 1H), 3.72 (q, J = 6.3 Hz, 2H), 3.10 
(t, J = 5.7 Hz, 1H), 2.77 (t, J = 6.6 Hz, 2H), 2.44 (ddd, J = 8.3 Hz, 5.3 Hz, 3.5 Hz, 1H), 1.84 
(ddd, J = 8.5 Hz, 5.2 Hz, 3.5 Hz, 1H), 1.47 (dt, J = 8.3 Hz, 4.8 Hz, 1H), 1.08 (ddd, J = 8.6 Hz, 
5.6 Hz, 4.6 Hz, 1H);  
13
C NMR (100.67 MHz, CDCl3) δ ppm 169.4, 137.8, 129.0 (+, 2C), 124.3 
(+), 119.8 (+, 2C), 60.5 (-), 36.5 (-), 27.1 (+), 21.8 (+), 16.8 (-);  FT IR (NaCl, film, cm
-1
): 3286, 
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2922, 2872, 1655, 1601, 1549, 1447, 1393, 1313, 1190, 1036, 756, 692;  HRMS (TOF ES): 
found 260.0714, calculated for C12H15NO2SNa (M+Na) 260.0721 (2.7 ppm). 
 
2.6.8. Cyclization precursors 
 
3-Cyclohexylamino-1-propanol
82
: Three neck round bottom flask (250 mL) 
equipped with a reflux condenser, a thermometer, and addition funnel (100 
mL) was charged with LiAlH4 (1.30 g, 38.4 mmol, 1.50 eq) and anhydrous THF (30 mL).   The 
resulting suspension was stirred at 0 
o
C and a solution of methyl 3-(cyclo-
hexylamino)propanoate
83
 (4.40 g, 23.2 mmol, 1.00 equiv) in dry THF (50 mL) was added drop 
wise over 30 min.    Once addition was complete the mixture was stirred at reflux overnight, then 
quenched at 0 
o
C consecutively with water (20 mL) and a concentrated aqueous solution of 
NaOH (5.0 g in 5 mL of water).   The resulting suspension was diluted with water (30 mL) and 
THF (50 mL) and filtered through a fritted funnel.   The filter cake was washed with THF (3 x 20 
ml), and the washing liquids were combined with the filtrate.   The resulting solution was 
saturated with NaCl and extracted with THF (3 x 20 ml).  The combined organic phases were 
dried with Na2SO4, filtered, and concentrated.  The crude product was purified by vacuum 
distillation (bp 60 
o
C at 15 torr) to afford the titled compound as colorless oil, solidifying upon 
standing.  Yield 2.4 g (15.1 mmol, 65%). 
 
1
H NMR (400.13 MHz, CDCl3) δ 3.80 (t, J = 5.2 Hz, 2H), 2.89 (t, J = 5.7 Hz, 2H), 2.41 (tt, J = 
10.3 Hz, 3.6 Hz, 1H), 2.05 (br.  s, 2H), 1.97-1.79 (m, 2 H), 1.77-1.52 (m, 5H), 1.31-1.13 (m, 3H), 
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1.11-0.99 (m, 2H);  
13
C NMR (100.67 MHz, CDCl3) δ 64.5 (-), 56.6 (+), 46.9 (-), 33.4 (-, 2C), 
31.2 (-), 26.0 (-), 24.9 (-, 2C);  
 
3-(Hexylamino)propan-1-ol
83
:  Three neck round bottom flask (250 mL) 
equipped with a reflux condenser, a thermometer, and addition funnel (100 ml) 
was charged with LiAlH4 (1.50 g, 38.4 mmol, 1.5 equiv) and anhydrous THF (30 mL).   The 
resulting suspension was stirred at 0 
o
C, a solution of methyl 3-(hexylamino)propanoate
84
 (4.80 
g, 25.6 mmol, 1.00 equiv) in dry THF (50 mL) and was added dropwise over 30 min.   Once 
addition was complete the mixture was stirred at reflux overnight, and then quenched 
consecutively with water (20 mL) and a concentrated solution of NaOH (5.00 g in 5 ml of water) 
at 0 
o
C.   The mixture was diluted with THF (50 mL) and of water (30 mL) and the resulting 
suspension was filtered through a fritted funnel.   The filter cake was washed with THF (3 x 20 
mL), and the washing liquid was combined with the filtrate.   The resulting filtrate was saturated 
with NaCl and extracted with THF (3 x 20 mL).  The combined organic phases were dried with 
Na2SO4, filtered and concentrated.  The resulting yellowish oil was purified by vacuum 
distillation to afford the titled compound as colorless oil.  Yield 2.80 g (15.9 mmol, 62%). 
1
H NMR (400.13 MHz, CDCl3) δ 3.77 (t, J = 5.6 Hz, 2H), 2.84 (t, J = 5.8 Hz, 2H), 2.57 (t, J = 
7.1 Hz, 2H), 1.67 (quin, J = 5.6 Hz, 2H), 1.44 (quin, J = 7.1 Hz, 2H), 1.35-1.19 (m, 6H), 0.86 (t, 
J = 6.5 Hz, 3H);  
13
C NMR (100.67 MHz, CDCl3) δ 64.1 (-), 49.9 (-), 49.8 (-), 31.6 (-), 30.7 (-), 
29.8 (-), 26.9 (-), 22.5 (-), 13.9 (+);    
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3-((Furan-2-ylmethyl)amino)propan-1-ol
85
: To a stirred solution of 
furfural (5.00 g, 52.0 mmol, 1.00 equiv) in MeOH (30 mL) was added 
3-aminopropan-1-ol (4.00 g, 53.3 mmol, 1.00 equiv), and the mixture was stirred for 30 min at 
room temperature, then cooled to 0 
o
C and NaBH4 (2.90 g, 76.6 mmol, 1.50 equiv) was added by 
small portions over 10 min.   The suspension was stirred for 4 hrs at room temperature and the 
solvent was removed in vacuum.   An aqueous solution of KOH (5.00 g, 47.8 mmol, 1.7 equiv in 
20 mL of water) was added and the solution was partitioned between EtOAC and brine.   The 
aqueous layer was extracted with EtOAc (3 x 30 mL).   The combined organic phases were dried 
with Na2SO4, filtered, and concentrated.  The resulting crude oil was distilled (130 
o
C) to afford 
the title compound as a colorless viscous oil.  Yield 7.50 g (48.4 mmol, 93%).   
 
1
H NMR (400.13 MHz, CDCl3) δ 7.32 (dd, J = 1.8 Hz, 0.8 Hz, 1H), 6.27 (dd, J = 3.2 Hz, 1.9 Hz, 
1H), 6.14 (d, J = 3.0 Hz, 1H), 3.74 (s, 2H), 3.71 (t, J = 5.6 Hz, 2H), 2.78 (t, J = 6.1 Hz, 2H), 1.66 
(quin, J = 5.9 Hz, 2H);  
13
C NMR (100.67 MHz, CDCl3) δ 153.2, 141.7 (+), 110.0 (+), 106.9 (+), 
63.0 (-), 48.0 (-), 45.7 (-), 30.9 (-);  
 
2-((n-Hexylamino)methyl)phenol: A solution of salicyl aldehyde 
(1.22 g, 10.0 mmol, 1.0 equiv.) and n-hexylamine (2.02 g, 20.0 
mmol, 2.0 equiv.) was stirred in dry MeOH (40.0 mL) for 1 hour.   NaBH4 (600 mg, 16.0 mmol, 
1.6 equiv.) was added causing a color change from yellow to clear over the course of 10 minutes, 
after which the reaction was quenched with 5% aqueous HCl (15 mL).   The resulting mixture 
was then partitioned between Et2O (25 mL) and brine (25 mL).  The aqueous layer was extracted 
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with ether (3 x 20 mL).  The combined organic layers were dried with MgSO4, filtered, and 
concentrated affording 2-((hexylamino)methyl)phenol as a light-brown viscous oil.  Yield 1.53 g 
(7.40 mmol, 74%).  
1
H NMR (400.13 MHz, CDCl3) δ 7.18 (t, J = 7.7 Hz, 1H), 7.01 (d, J = 7.3 
Hz, 1H), 6.86 (d, J = 8.1 Hz, 1H), 6.79 (t, J = 7.4 Hz, 1H), 4.00 (s, 2H), 2.69 (t, J = 7.1 Hz, 2H), 
1.56 (p, J = 6.9 Hz, 2H), 1.42 – 1.26 (m, 6H), 0.91 (t, J = 6.5 Hz, 3H).  
13
C NMR (100.67 MHz, 
CDCl3) δ 158.4, 128.7 (+), 128.4 (+), 122.5, 118.9 (+), 116.4 (+), 52.6 (-), 48.7 (-), 31.6 (-), 29.4 
(-), 26.8 (-), 22.6 (-), 14.1 (+); FT IR (NaCl, film, cm
-1
): 3292, 3008, 2954, 2927, 2856, 1589, 
1458, 1515, 1257, 754; HRMS (TOF ES): found 208.1703, calculated for C13H22NO (M+H) 
208.1701 (0.1 ppm). 
 
2-((c-Hexylamino)methyl)phenol: A solution of salicyl aldehyde (1.22 g, 
10.0 mmol, 1.0 equiv.) and cyclohexylamine (1.98 g, 20.0 mmol, 2.0 
equiv.) was stirred in dry MeOH (40.0 mL) for 1 hour.   NaBH4 (600 mg, 
16.0 mmol, 1.6 equiv.) was added causing a color change from yellow to clear over the course of 
10 minutes, after which the reaction was quenched with 5% aqueous HCl (15 mL).   The 
resulting mixture was then partitioned between Et2O (25 mL) and brine (25 mL).  The aqueous 
layer was extracted with ether (3 x 20 mL).  The combined organic layers were dried with 
MgSO4, filtered, and concentrated affording 2-((cyclohexylamino)methyl)phenol as a crystalline 
solid (mp 28-30 
o
C).  Yield 1.30 g (6.34 mmol, 63%).  
1
H NMR (400.13 MHz, CDCl3) δ 7.18 (t, 
J = 7.7 Hz, 1H), 7.00 (d, J = 7.4 Hz, 1H), 6.85 (d, J = 8.1 Hz, 1H), 6.79 (t, J = 7.4 Hz, 1H), 4.04 
(s, 2H), 2.56 (tt, J = 10.2, 3.8 Hz, 1H), 2.00 (m, 2H), 1.77 (m, 2H), 1.65 (ddd, J = 12.1, 4.9, 3.2 
Hz, 1H), 1.39 – 1.07 (m, 5H).  
13
C NMR (100.67 MHz, CDCl3) δ 158.52, 128.57 (+), 128.07 (+), 
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123.08, 118.87 (+), 116.45 (+), 55.60 (+), 49.67 (-), 33.02 (-, 2C), 25.91 (-, 2C), 24.83 (-, 2C).   
FT IR (NaCl, film, cm
-1
): 3265, 2930, 2899, 1591, 1497, 1444, 1421, 1267, 754; HRMS (TOF 
ES): found 206.1549, calculated for C13H20NO (M+H) 206.1545 (0.2 ppm). 
 
 2-((tert-Butylamino)methyl)phenol
86
:  A solution of salicyl aldehyde (1.22 
g, 10.0 mmol, 1.00 equiv.) and tert-butyl amine (1.46 g, 20.0 mmol, 2.00 
equiv.) was stirred in dry MeOH (40 mL) for 1 hr.  NaBH4 (600 mg, 16.0 mmol, 1.60 equiv.) 
was added causing a color change from yellow to clear over the course of 10 min,  after which 
the reaction was quenched with 5% aqueous HCl (15 mL).   The resulting mixture was then 
partitioned between Et2O (25 mL) and brine (25 mL).  The aqueous layer was extracted with 
ether (3 x 20 mL).  The combined organic layers were dried with MgSO4, filtered and 
concentrated.  The obtained crystalline material was pure enough to be used for the following 
transformations without additional purification.  Yield 1.45 g (8.01 mmol, 81%).  
1
H NMR 
(400.13 MHz, CDCl3) δ 7.17 (td, J = 8.0 Hz, 1.8 Hz, 1H), 6.98 (d, J = 7.3 Hz, 1H), 6.84 (dd, J = 
8.1 Hz, 1.0 Hz, 1H), 6.79 (td, J = 7.4 Hz, 1.1 Hz, 1H), 3.92 (s, 2H), 1.23 (s, 9H);  
13
C NMR 
(100.67 MHz, CDCl3) δ ppm 158.3, 128.2 (+), 127.7 (+), 123.4, 118.6 (+), 116.2 (+), 50.8, 45.8 
(-), 28.3 (+);  HRMS (TOF ES): found 180.1383, calculated for C11H18NO (M+H) 180.1388 (2.8 
ppm). 
 
2-Bromo-N,N-bis(2-hydroxyethyl)cyclopropanecarboxamide (74): To a 50 
mL round bottom flask containing 15 mL of dry THF was added 
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diethanolamine (252 mg, 2.4 mmol) and triethylamine (242 mg, 2.4 mmol).  To this stirring 
mixture was added via syringe 5 mL of a THF solution containing 2-
bromocyclopropanecarbonyl chloride (200 mg, 1.2 mmol).  The resulting mixture was stirred at 
RT for 1h, then filtered through a glass filter to remove salts.  The THF was removed in vacuum 
and resulting oil was partitioned between dilute aqueous acid (10 mL, 5% HCl) and EtOAc (10 
mL).  The aqueous layer was extracted with EtOAc (3 x10 mL).  The organic layer was dried 
with MgSO4 and volatiles were removed to yield 263 mg (1.04 mmol, 87%) of colorless oil used 
without further purification.  
1
H NMR (500.13 MHz, CDCl3) δ 3.90 (s, 2H), 3.84 (t, J = 4.9 Hz, 
2H), 3.79 – 3.66 (m, 2H), 3.65 – 3.52 (m, 4H), 3.25 (ddd, J = 7.8, 4.7, 3.1 Hz, 1H), 2.29 (ddd, J 
= 9.2, 6.0, 3.2 Hz, 1H), 1.69 (ddd, J = 7.6, 5.9 Hz, 1H), 1.39 (ddd, J = 9.1, 5.3 Hz, 1H);  
13
C 
NMR (125.76 MHz, CDCl3) δ 172.22, 61.36 (-), 61.30 (-), 52.32 (-), 51.36 (-), 23.16 (+), 19.97 
(+), 18.24 (-);  FT IR (NaCl, film, cm
-1
): 3328, 2983, 2974, 1646, 1488, 1460,1437, 1379, 1343, 
1275, 1228, 1130.  HRMS (TOF ES): found 250.0079, calculated for C8H13BrNO3 (M-H) 
250.0081 (1.3 ppm). 
 
N-Benzyl-2-bromo-N-(3-hydroxypropyl)cyclopropanecarboxamide 
(77a): To a stirred solution of (3-benzylamino)propane-1-ol (550 mg, 
3.3 mmol, 1.1 equiv) and triethylamine (610 mg, 6 mmol, 2 equiv) in 
dry THF (30 mL) was added 2-bromocyclopropanecarbonyl chloride (550 mg, 3.0 mmol).   The 
mixture was stirred for 1 hr at room temperature, then the solvent was removed in vacuum.  The 
residue was partitioned between 10% aqueous HCl (20 mL) and EtOAc (20 mL).  The organic 
layer was separated and washed consecutively with 10% aqueous HCl (3 x 10 mL) and 4N 
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aqueous NaOH (5 mL), dried with MgSO4, filtered, and concentrated.   The title compound was 
obtained as colorless oil, mixture of diastereomers, 2:1.  This material was pure enough to be 
used for the following transformations without additional purification.  Yield 690 mg (2.22 
mmol, 74%).  
1
H NMR (400.13 MHz, CDCl3) δ ppm [7.48-7.36 (m) & 7.36-7.27 (m) & 7.26-
7.19 (m), 5H], [4.74 (d, J = 17.2 Hz) & 4.65 (d, J = 14.9 Hz), 1H], [4.66 (d, J = 17.4 Hz) & 4.54 
(d, J = 14.9 Hz), 1H], 3.88 (br.  s., 1 H), 3.71-3.42 (m, 4H), [3.30 (ddd, J = 7.6 Hz, 4.6 Hz, 3.0 
Hz) & 3.27 (ddd, J = 7.8 Hz, 4.8 Hz, 3.0 Hz), 1H], [2.37 (ddd, J = 9.2 Hz, 5.9 Hz, 3.0 Hz) & 
2.17 (ddd, J = 9.2 Hz, 5.9 Hz, 3.2 Hz), 1H], [1.83 (tt, J = 7.1 Hz, 6.1 Hz) & (1.78-1.64 (m), 3H], 
[1.37 (ddd, J = 9.4 Hz, 5.6 Hz, 4.8 Hz) & 1.33 (ddd, J = 9.1 Hz, 5.6 Hz, 4.8 Hz), 1H];  
13
C NMR 
(100.67 MHz, CDCl3) δ major: 171.9, 136.0, 128.9 (+, 2C), 127.8 (+), 126.2 (+, 2C), 58.2 (-), 
51.0 (-), 42.8 (-), 29.8 (-), 22.6 (+), 19.9 (+), 18.3 (-), minor: 170.4, 137.3, 128.4 (+, 2C), 127.9 
(+, 2C), 127.3 (+), 58.9 (-), 49.0 (-), 43.9 (-), 31.5 (-), 22.3 (+), 20.2 (+), 18.1 (-);  FTIR (NaCl, 
film, cm
1
) 3387, 2930, 2874, 1620, 1450, 1215, 1055, 731, 698, 581; HRMS (TOF ES): found 
334.0217, calculated for C14H18NO2BrNa (M+Na) 334.0419 (0.6 ppm);   
 
2-Bromo-N-hexyl-N-(3-hydroxypropyl)cyclopropanecarboxamide 
(77b): mixture of diastereomers, 5:1.  To a solution of (3-
hexylamino)propan-1-ol (350 mg, 2.2 mmol, 1.1 equiv) and 
triethylamine (410 g, 4.0 mmol, 2.0 equiv)  in dry THF (15 mL) stirred at 0 
o
C was added a 
solution of 2-bromocyclopropanecarbonyl chloride (370 mg, 2.0 mmol, 1.0 equiv.) in dry THF 
(15 mL).   The mixture was stirred for 5 hr at RT, then the solvent was removed in vacuum.  The 
residue was partitioned between 10% aqueous HCl (20 mL) and EtOAc (20 mL).  The organic 
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layer was separated and washed consecutively with 10% aqueous HCl (3 x 10 mL) and 4N 
aqueous NaOH (5 mL), dried with MgSO4, filtered, and concentrated.  The title compound was 
obtained as colorless oil, mixture of diastereomers, 5:1.   This material was pure enough to be 
used for the following transformations without additional purification.  Yield 527 mg (1.72 
mmol, 86%).  
1
H NMR (400.13 MHz, CDCl3) δ 3.90 (br.  s., 2H), [3.68 (t, J = 5.7 Hz) & 3.56 
(sxt, J = 6.8 Hz) & 3.49 (td, J = 6.1 Hz, 2.3 Hz) & 3.44 (t, J = 5.3 Hz) & 3.41-3.34 (m) & 3.34-
3.23 (m) & 3.20 (ddd, J = 7.8 Hz, 4.7 Hz, 3.2 Hz), 7H], [2.26 (ddd, J = 9.2 Hz, 5.9 Hz, 3.0 Hz) & 
2.12 (ddd, J = 9.2 Hz, 6.0 Hz, 3.0 Hz), 1H], [1.85 (quin, J = 6.3 Hz) & 1.77-1.56 (m) & 1.56-
1.43 (m), 5H], 1.43-1.19 (m, 7H), [0.89 (t, J = 7.1 Hz) & 0.86 (t, J = 6.8 Hz), 3H];  
13
C NMR 
(100.67 MHz, CDCl3) δ major: 171.2, 58.0 (-), 48.2 (-), 42.6 (-), 31.3 (-), 30.2 (-), 29.4 (-), 26.4 
(-), 22.5 (+), 22.4 (-), 19.9 (+), 18.1 (-), 13.9 (+); minor: 169.7, 59.0 (-), 46.7 (-), 44.7 (-), 32.0 (-
), 31.5 (-), 27.6 (-), 26.5 (-), 22.4 (+), 22.3 (-), 20.2 (+), 17.8 (-), 13.9 (+);  FT IR (NaCl, film, 
cm
1
) 3408, 2955, 2930, 2858, 1620 1462, 1377, 1229, 1190, 1057, 725, 588;  HRMS (TOF ES): 
found 328.0887, calculated for C13H24BrNO2Na (M+Na) 328.0888 (0.3 ppm); 
 
2-Bromo-N-(furan-2-ylmethyl)-N-(3-hydroxypropyl)cyclo-
propanecarboxamide (79c):  To a stirred solution of 3-((furan-2-
ylmethyl)amino)propan-1-ol (282 mg, 1.81 mmol, 1.10 equiv) and 
triethylamine (686 µL, 500 mg, 4.95 mmol, 3.00 equiv) in dry THF (5 mL) a solution of 2-
bromo-1-methylcyclopropanecarbonyl chloride (300 mg, 1.65 mmol, 1.00 equiv) in dry THF (5 
mL) was added dropwise over 10 min.   The resulting suspension was stirred for 30 min at room 
temperature, and then filtered through a fritted funnel.   The filter cake was washed with EtOAc 
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(3 x 10 ml).   Combined organic solution was concentrated in vacuum.   Preparative column 
chromatography of a crude residue on silica gel afforded the title compound as a colorless oil, Rf 
0.50 (DCM-EtOAc, 3:1).  Yield 310 mg (1.02 mmol, 62%), mixture of two diastereomers, 2:1. 
1
H NMR (400.13 MHz, CDCl3) δ [7.36 (s) & 7.29 (s), 1H], [6.35-6.28 (m) & 6.25 (d, J = 3.0 Hz) 
& 6.19 (d, J = 3.0 Hz), 2H], [4.59 (d, J = 16.9 Hz) & 4.53 (d, J = 15.4 Hz) & 4.53 (d, J = 16.9 
Hz) & 4.48 (d, J = 15.4 Hz), 2H], [3.63-3.53 (m) & 3.54-3.44 (m) & 3.40 (t, J = 5.6 Hz) & 3.20 
(ddd, J = 7.5 Hz, 4.7 Hz, 2.9 Hz), 4H], [2.35 (ddd, J = 9.1 Hz, 5.9 Hz, 3.2 Hz) & 2.28 (ddd, J = 
9.1 Hz, 5.9 Hz, 3.2 Hz), 1H), [1.76 (quin, J = 6.5 Hz) & 1.69-1.55 (m), 3H], [1.34 (dt, J = 9.1 
Hz, 5.6 Hz, 1H) & 1.29 (dt, J = 9.1 Hz, 5.3 Hz), 1H);  
13
C NMR (100.67 MHz, CDCl3) δ major: 
171.5, 149.5, 142.6 (+), 110.3 (+), 108.2 (+), 58.0 (-), 44.7 (-), 42.8 (-), 29.8 (-), 22.6 (+), 19.7 
(+), 18.1 (-);  minor: 170.1, 150.6, 141.9 (+), 110.2 (+), 108.4 (+), 58.6 (-), 44.3 (-), 42.1 (-), 31.4 
(-), 22.1 (+), 20.1 (+), 18.0 (-);  FT IR (NaCl, film, cm
1
): 3414, 3117, 2932, 2876, 2341, 1626, 
1504, 1477, 1454, 1373, 1356, 1229, 1188, 1072, 1055, 1013, 922, 741, 598, 586;  HRMS (TOF 
ES): found 302.0391, calculated for C12H17NO3Br (M+H) 302.0392 (0.3 ppm);  
 
2-Bromo-N-(n-hexyl)-N-(2-hydroxybenzyl)cyclopropanecarbox-
amide (80a): A solution of Me3SiCl (21.5 mg, 0.197 mmol, 1.20 
equiv), NEt3 (28 mg, 80 mL, 0.57 mmol, 3.5 equiv), and 2-((n-
hexylamino)methyl)phenol (37.3 mg, 0.18 mmol, 1.10 equiv) was stirred in dry THF (4 mL) 
overnight under a nitrogen atmosphere.  Then 2-bromocyclopropanecarbonyl chloride (30 mg, 
0.16 mmol, 1.0 equiv) was added and allowed to stir for 3 hours.  The solvent was removed by 
rotary evaporation and then partitioned between 10 mL 5% HCl & 10 mL EtOAc.  The organic 
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layer was washed with 5% HCl (3 x 15 mL) then dried with MgSO4, filtered, and concentrated 
which afforded 2-bromo-N-n-hexyl-N-(2-hydroxybenzyl)cyclopropanecarboxamide (80a) as a 
viscous oil.   The obtained material was pure enough for the following transformation with no 
additional purification.  Yield 23 mg (0.065 mmol, 40%).  
1
H NMR (500.13 MHz, CDCl3) δ 7.25 
(t, J = 7.7 Hz, 1H), 7.13 (d, J = 7.5 Hz, 1H), 6.93 (d, J = 8.1 Hz, 1H), 6.84 (t, J = 7.4 Hz, 1H), 
4.47 (s, 2H), 3.49 (t, J = 7.9 Hz, 2H), 3.30 (ddd, J = 7.7, 4.8, 3.1 Hz, 1H), 2.14 (ddd, J = 9.0, 5.8, 
3.1 Hz, 1H), 1.79 – 1.69 (m, 3H), 1.44 – 1.35 (m, 7H), 0.97 – 0.93 (m, 3H).  
13
C NMR (125.76 
MHz, CDCl3) δ 172.2, 156.3, 131.4 (+), 130.4 (+), 122.1, 119.3 (+), 117.6 (+), 48.0 (-), 47.4 (-), 
31.5 (-), 28.8 (-), 26.5 (-), 22.7 (+), 22.6 (-), 20.2 (+), 18.7 (-), 14.0 (+);  FT IR (NaCl, film, cm
-
1
): 3321, 2954, 2925, 1633, 1589, 1454, 1446, 1352, 1215, 1108, 1070, 754; HRMS (TOF ES): 
found 353.0994, calculated for C17H24BrNO2 (M+) 353.0990 (1.1 ppm). 
 
2-Bromo-N-(c-hexyl)-N-(2-hydroxybenzyl)cyclopropanecarboxamide 
(80b): A solution of Me3SiCl (65 mg, 0.60 mmol, 1.20 equiv), NEt3 (177 
mg, 243μL, 1.75 mmol, 3.50 equiv), and 2-((cyclohexyl-
amino)methyl)phenol (113 mg, 0.55 mmol, 1.10 equiv) was stirred in dry 
THF (30 mL) overnight under a nitrogen atmosph ere.  Then 2-bromocyclopropanecarbonyl 
chloride (91 mg, 0.50 mmol, 1.0 equiv) was added and allowed to stir for 3 hours.  The solvent 
was removed by rotary evaporation and then partitioned between 10 mL 5% HCl & 10 mL 
EtOAc.  The organic layer was washed with 5% HCl (3 x 15 mL) then dried with MgSO4, 
filtered, and concentrated which afforded 2-bromo-N-cyclohexyl-N-(2-hydroxybenzyl)-
cyclopropanecarboxamide (80b) as a viscous oil.   The obtained material was pure enough for 
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the following transformation with no additional purification.  Yield 75 mg (0.21 mmol, 42%).  
1
H NMR (400.13 MHz, CDCl3) δ 7.25 – 7.18 (m, 2H), 6.93 – 6.87 (m, 1H), 6.86 – 6.79 (m, 1H), 
4.51 (d, J = 6.1 Hz, 2H), 4.02 – 3.89 (m, 1H), 3.32 (ddd, J = 7.8, 4.9, 3.1 Hz, 1H), 2.24 (ddd, J = 
9.1, 6.0, 3.1 Hz, 1H), 2.00 – 1.63 (m, 8H), 1.56 – 1.06 (m, 4H).  
13
C NMR (100.67 MHz, CDCl3) 
δ 172.6, 156.4, 131.6 (+), 129.9 (+), 123.1, 119.2 (+), 117.7 (+), 77.3 (+), 59.2 (+), 32.7 (-), 32.5 
(-), 26.2 (-), 26.0 (-), 25.3 (-), 23.5 (+), 20.13 (+), 18.5 (-, 2C);  FTIR (NaCl, film, cm
-1
): 3258, 
2932, 1614, 1593, 1456, 1444, 1375, 1261, 1231, 1095, 1043, 754; HRMS (TOF ES): found 
352.0906, calculated for C17H23BrNO2 (M+H) 352.0912 (1.7 ppm). 
 
2-Bromo-N-(tert-butyl)-N-(2-hydroxybenzyl)cyclopropanecarboxamide 
(80c) A solution of Me3SiCl (261 mg, 2.40 mmol, 1.20 equiv), NEt3 (708 
mg, 975 μL, 7.00 mmol, 3.50 equiv), and 2-((tert-butylamino)-
methyl)phenol (394 mg, 2.20 mmol, 1.10 equiv) was stirred in dry THF (30 mL) overnight under 
a nitrogen atmosphere.  Then 2-bromocyclopropanecarbonyl chloride (367 mg, 2 mmol, 1 equiv)  
was added and allowed to stir for 3 hours.  The solvent was removed by rotary evaporation and 
then partitioned between 10 mL 5% HCl & 10 mL EtOAc.  The organic layer was washed with 
5% HCl (3 x 15 mL) then dried with MgSO4, filtered, and concentrated.  The obtained crystalline 
material (mp 165-168 
o
C) was pure enough for the following transformation with no additional 
purification.  Yield 583 mg (1.78 mmol, 89%).  
1
H NMR (500.13 MHz, CD3OD) δ ppm 7.04 (d, 
J = 7.6 Hz, 1H), 6.99 (t, J = 7.6 Hz, 1H), 6.76 (t, J = 7.6 Hz, 1H), 6.69 (d, J = 8.2 Hz, 1H), 4.67 
(d, J = 19.2 Hz, 1H), 4.62 (d, J = 19.2 Hz, 1H), 3.04 (ddd, J = 7.6 Hz, 4.4 Hz, 3.2 Hz, 1H), 1.88 
(ddd, J = 9.0 Hz, 6.0 Hz, 3.0 Hz, 1H), 1.41 (ddd, J = 7.6 Hz, 6.0 Hz, 5.0 Hz, 1H), 1.29 (s, 9H), 
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1.09 (dt, J = 9.5 Hz, 5.0 Hz, 1H);  
13
C NMR (125.76 MHz, CD3OD) δ ppm 174.0, 155.4, 129.2 
(+), 127.7 (+), 126.6, 120.8 (+), 116.0 (+), 59.3, 45.4 (-), 28.8 (+, 3C), 26.6 (+), 20.4 (+), 18.6 (-
);  FT IR (NaCl, film, cm
1
): 3300, 2964, 2930, 1622, 1595, 1456, 1427, 1364, 1227, 1192, 754;  
HRMS (TOF ES): found 325.0670, calculated for C15H20BrNO2 (M
+
) 325.0677 (2.2 ppm).    
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2.6.9. Cyclization products 
 
 (1S*,8R*)-6-Benzyl-2-oxa-6-azabicyclo[6.1.0]nonan-7-one (79a):  An 
oven-dried 50 mL round bottom flask was charged with 
bromocyclopropane 77a (140 mg, 0.45 mmol, 1.0 equiv), 18-crown-6 
(11.8 mg, 0.045 mmol, 10 mol%), KOH ( 88 mg, 1.57 mmol, 3.5 equiv) and anhydrous THF (10 
mL).  The mixture was stirred at RT for 2.25 hrs.  The solvent was removed by rotary 
evaporation.   The residue was purified by flash column chromatography on silica gel (Rf 0.28, 
eluent EtOAc) to obtain a title compound as a colorless crystalline solid, mp 51-55 
o
C.   Yield 91 
mg (0.40 mmol, 88%)  
1
H NMR (500.13 MHz, CDCl3) δ ppm 7.29-7.23 (m, 2H), 7.23-7.17 (m, 
3H), 5.24 (d, J = 14.8 Hz, 1H), 3.85 (d, J = 15.1 Hz, 1H), 3.60 (td, J = 12.8 Hz, 3.2 Hz, 1H), 3.45 
(ddd, J = 6.9 Hz, 6.1 Hz, 4.1 Hz, 1H), 3.17 (dd, J = 15.4 Hz, 6.9 Hz, 1H), 1.96 - 1.80 (m, 1H), 
1.63 (dt, J = 10.2 Hz, 6.5 Hz, 1H), 1.53 (ddd, J = 15.2 Hz, 7.2 Hz, 3.2 Hz, 1H), 1.17 (td, J = 6.9 
Hz, 3.9 Hz, 1H), 1.03 (dt, J = 10.2 Hz, 7.1 Hz, 1H);  
13
C NMR (125.76 MHz, CD3Cl) δ 169.7, 
137.5, 128.5 (+, 2C), 128.1 (+, 2C), 127.3 (+), 72.8 (-), 61.0 (+), 48.6 (-), 46.0 (-), 30.1 (-), 22.7 
(+), 10.5 (-);  FTIR (NaCl, film, cm
1
) 2928, 2870, 1634, 1481, 1439, 1229, 1080, 735, 698;  
HRMS (TOF ES): found 232.1332, calculated for C14H18NO2 (M+H) 232.1338 (2.6 ppm). 
 
 
(1S*,8R*)-6-Hexyl-2-oxa-6-azabicyclo[6.1.0]nonan-7-one (79b):  An 
oven-dried 50 mL round bottom flask was charged with 
bromocyclopropane 77b (165 mg, 0.53 mmol, 1.0 equiv), 18-crown-6 (14 
mg, 0.053 mmol, 10 mol%), KOH (74 mg, 1.33 mmol, 2.5 equiv.) and anhydrous THF (10 mL).  
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The mixture was stirred at RT for 2.25 hrs.  The solvent was removed by rotary evaporation.   
The residue was purified by flash column chromatography on silica gel, eluting first with 
mixture EtOAc/hexane 3:1, and then with mixture EtOAc/MeOH 3:1, to obtain a title compound 
as a colorless amorphous solid, Rf  0.83 (EtOAc/MeOH 3:1).  Yield 107 mg (90%, 0.48 mmol).  
1
H NMR (400.13 MHz, CDCl3) δ ppm 4.22-4.06 (m, 2H), 3.88 (dddd, J = 13.4 Hz, 8.1 Hz, 6.6 
Hz, 1.0 Hz, 1H), 3.66 (td, J = 12.7 Hz, 3.2 Hz, 1H), 3.48 (td, J = 6.7 Hz, 4.0 Hz, 1H), 3.28 (dd, J 
= 15.3 Hz, 6.9 Hz, 1H), 2.76 (ddd, J = 13.9 Hz, 8.8 Hz, 5.6 Hz, 1H), 2.02-1.86 (m, 1H), 1.71-
1.43 (m, 4H), 1.13-1.21 (m, 6H), 1.15 (td, J = 6.8 Hz, 3.8 Hz, 1H), 1.03 (dt, J = 10.2 Hz, 7.0 Hz, 
1H), 0.88 (t, J = 6.4 Hz, 3H);  
13
C NMR (100.67 MHz, CDCl3) δ 169.1, 72.8 (-), 61.0 (+), 46.8 (-
), 45.9 (-), 31.6 (-), 30.7 (-), 27.6 (-), 26.6 (-), 22.9 (+), 22.6 (-), 14.0 (+), 10.3 (-);  FTIR (NaCl, 
film, cm
1
) 2955, 2930, 2858, 1626, 1485, 1462, 1373, 1225, 1095, 725;  HRMS (TOF ES): found 
226.1807, calculated for C13H24NO2 (M+H) 226.1807 (0.0 ppm). 
 
 
(1S*,8R*)-6-(Furan-2-ylmethyl)-2-oxa-6-azabicyclo[6.1.0]nonan-7-one 
(79c): To a stirred suspension of powdered KOH (46 mg, 0.83 mmol, 2.5 
equiv) and 18-crown-6 ether (8.7 mg, 0.033 mmol, 10 mol%) in dry THF (3 
mL) was added bromocyclopropane 77c (100 mg, 0.33 mmol, 1.0 equiv).   The mixture was 
vigorously stirred at 25 
o
C for 3 hrs.   The KBr precipitate was filtered off on a fritted funnel and 
the filtrate was concentrated in vacuum.  Preparative column chromatography of a residual oil on 
silica gel afforded the title compound as a crystalline solid, Rf 0.30 (CH2Cl2-EtOAc, 3:1).  Yield 
69 mg (0.31 mmol, 95%). 
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1
H NMR (400.13 MHz, CDCl3) δ ppm 7.37 (d, J = 1.0 Hz, 1H), 6.37-6.31 (m, 1H), 6.29 (d, J = 
3.3 Hz, 1H), 5.06 (d, J = 15.4 Hz, 1H), 4.22-4.08 (m, 2H), 3.68 (td, J = 12.6 Hz, 3.3 Hz, 1H), 
3.55-3.48 (m, 1H), 3.41 (dd, J = 15.4 Hz, 6.8 Hz, 1H), 1.95-1.80 (m, 1H), 1.74-1.59 (m, 3H), 
1.22 (td, J = 6.9 Hz, 3.9 Hz, 1H), 1.08 (dt, J = 10.2 Hz, 6.9 Hz, 1H);  
13
C NMR (100.67 MHz, 
CDCl3) δ ppm 169.5, 151.0, 142.1 (+), 110.5 (+), 108.6 (+), 72.8 (-), 60.9 (+), 46.4 (-), 41.7 (-), 
30.2 (-), 22.7 (+), 10.4 (-);  FT IR (NaCl, film, cm
1
): 3115, 2959, 2932, 2872, 1728, 1634, 1504, 
1479, 1464, 1423, 1393, 1362, 1337, 1281, 1248, 1225, 1200, 1165, 1148, 1121, 1107, 1080, 
1041, 1011, 982, 964, 932, 885, 833, 762, 743, 600, 540, 417;  HRMS (TOF ES): found 
222.1129, calculated for C12H16NO3 (M+H) 222.1130 (0.5 ppm).    
 
 (1aR*,9aS*)-3-hexyl-1,3,4,9a-tetrahydrobenzo[b]cyclopropa[g][1,5]ox-
azocin-2(1aH)-one (81a): To a stirred solution of 2-bromo-N-hexyl-N-(2-
hydroxybenzyl)cyclopropanecarboxamide (80a) (70 mg, 0.20 mmol) and 18-
crown-6 (5.6 mg,  0.019 mmol, 0.1 equiv) in dry tetrahydrofuran (4.0 mL) was 
added potassium hydroxide (33 mg, 0.60 mmol, 3.0 equiv).   The mixture was stirred for 3.5 
hours at 50
o
C, filtered through a Pasteur pipette with a cotton plug, and then the solvent was 
removed in vacuum.   Column chromatography on basic alumina oxide (eluent hexan-EtOAc 
3:1) afforded the titled compound as an amorphous colorless solid.   Yield 16 mg (0.058 mmol, 
29%).   FTIR (NaCl, film, cm
-1
): 2954, 2925, 1643, 1604, 1591, 1469, 1454, 1229, 1190, 1107, 
756; HRMS (TOF ES): found 273.1729, calculated for C17H23NO2 (M+) 273.1729 (0.0 ppm). 
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(1aR*,9aS*)-3-cyclohexyl-1,3,4,9a-tetrahydrobenzo[b]cyclopropa[g][1,5]-
oxazocin-2(1aH)-one (81b): To a stirred solution of 2-bromo-N-cyclohexyl-
N-(2-hydroxybenzyl)cyclopropanecarboxamide 80b (67 mg, 0.190 mmol) and 
18-crown-6 (5.0 mg,  0.019 mmol, 0.1 equiv) in dry tetrahydrofuran (4.0 mL) 
was added potassium hydroxide (32 mg, 0.57 mmol, 3.0 equiv).   The mixture was stirred for 3.5 
hours at 50
o
C, filtered through a Pasteur pipette with a cotton plug, and then the solvent was 
removed in vacuum.   Column chromatography on basic alumina oxide (eluent hexane-EtOAc 
3:1) afforded the titled compound as a white solid.   Yield 16 mg (0.059 mmol, 31%).   FTIR 
(NaCl, film, cm
-1
): 2926, 2856, 1643, 1605, 1578, 1487, 1454, 1429, 1227, 1111, 756; HRMS 
(TOF ES): found 271.1563, calculated for C17H21NO2 (M+) 271.1572 (3.3 ppm). 
 
(1aR*,9aS*)-3-(tert-Butyl)-1,3,4,9a-tetrahydrobenzo[b]cyclopropa[g]-
[1,5]oxazocin-2(1aH)-one (81c): An oven-dried 50 mL round bottom flask 
was charged with bromocyclopropane 81c (184mg, 0.56 mmol, 1 equiv), 18-
crown-6 (14.9 mg, 0.056 mmol, 10 mol%), KOH (78.6 mg, 1.4 mmol, 2.5 equiv.) and anhydrous 
THF (15 mL).  The mixture was stirred at 50 
o
C for 12 hrs.  The solvent was removed by rotary 
evaporation.   The residue was absorbed onto silica gel and then purified by flash column 
chromatography on silica gel being flushed (eluent EtOAc/hexane 1:2 Rf :.3 product).  Yield 129 
mg (93%, 0.52 mmol) clear crystalline solid, mp 115-116 
o
C.  
1
H NMR (400.13 MHz, CDCl3) δ 
7.24 (td, J = 7.6 Hz, 1.8 Hz, 1H), 7.15 (dd, J = 7.6 Hz, 1.5 Hz, 1H), 7.09-7.03 (m, 2H), 5.59 (d, J 
= 17.2 Hz, 1H), 4.35 (d, J = 16.9 Hz, 1H), 3.79 (td, J = 6.2 Hz, 3.0 Hz, 1H), 2.22 (dt, J = 10.1 
Hz, 6.3 Hz, 1H), 1.41 (td, J = 6.9 Hz, 3.2 Hz, 1H), 1.35 (s, 9H), 1.15 (dt, J = 10.1 Hz, 6.7 Hz, 
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1H);  
13
C NMR (100.67 MHz, CDCl3) δ ppm 169.9, 157.5, 130.8 (+), 128.9 (+), 128.7, 123.6 
(+), 121.8 (+), 57.7, 56.9 (+), 48.9 (-), 28.5 (+, 3C), 26.6 (+), 10.4 (-); FT IR (NaCl, film, cm
1
): 
3456, 2993, 2966, 2924, 1651, 1489, 1408, 1358, 1225, 1194, 1111, 754;  HRMS (TOF ES): 
found 268.1311, calculated for C15H19NO2Na (M+Na) 268.1313 (0.7 ppm). 
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Chapter 3. Nitrogen-centered nucleophile 
3.1. Introduction 
 
Having successfully demonstrated that strain-release activation can be utilized to activate 
α,β-unsaturated amides, enabling the addition of a variety of oxygen and sulfur based 
nucleophiles; we directed our focus towards expanding the methodology to include nitrogen-
based nucleophiles.  The rationale for this objective stems from the fact that the aza-Michael 
reaction is a heavily explored and extremely useful synthetic tool,
87
 and nitrogen-substituted 
cyclopropane derivatives constitute a variety of useful molecules.  For example, natural and 
synthetic analogs of α-aminocyclopropanecarboxylic acid (α-ACC) are ubiquitous; they have 
been extensively explored and find a widespread application in medicinal, chemical and 
agricultural research.
88
 β-ACC derivatives are emerging as important tools for investigation of 
conformational preferences in peptides,
 89
 key elements of multiple natural products,
90
 
organocatalysts
91
 and prospective drug candidates.
89,92
 This is also evidenced by the 
incorporation of this key structural element into the structure of potent antiviral,
93
 antitumor,
94
 
and antihypertensive agents.
95
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Scheme 34 
 
 
Cyclopropylamine derivatives, including β-ACC scaffolds are traditionally accessed by Michael-
initiated ring closure reactions (Scheme 34, route A),
96
  [2 + 1]-cyclopropanation of acrylates 
with α-nitrodiazocompounds (route B),
97
 and to a much lesser extent, diazo transfer onto 
enamines (route C).
101
 At the same time, approaches that allow direct and efficient installation of 
an amine function in a pre-existing three-membered ring (route D) remain scarce and typically 
involve the installation of an achiral cyclopropane ring.
98,99
  Several previously reported attempts 
on the addition of such nucleophiles to cyclopropenes resulted in cleavage of the small ring 
and
100
 the direct diastereoselective synthesis of this moiety remains a challenge.
101
  
3.2. Carbonyl activation of nitrogen nucleophiles. 
 
Our first insight into the behavior of nitrogen-based nucleophiles was gathered from 
bifunctional oxygen and sulfur-based nucleophiles bearing a 2
o
 amino group.  It was observed 
that in both cases the addition occured through the O (Table 5, entry 9), or S (Table 8, entry 6) 
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terminus with perfect chemoselectivity over the N terminus (Scheme 36).  This observation was 
rationalized to be a result of the disparity between N-H acidity and O-H or S-H acidity, resulting 
in selective deprotonation of the more acidic heteroatom followed by addition of the more 
reactive thiolate or alkoxide species.   
Scheme 35 
 
 
A similar reactivity pattern was observed when isolable cyclopropene 65 was used, exclusively 
forming alkoxy-ether adducts 66f-66gg when reacted with bifunctional amino alcohol 
nucleophiles (Scheme 35). 
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Unfortunately, when the possibility of a competing reaction was eliminated by employing 
ammonia as well as 1  or 2  alkylamines, cyclopropane starting material was consumed but no 
amine adducts were observed (Scheme 36).   
 
Scheme 36 
 
 
Again, lack of acidity could be blamed for the apparent low reactivity of nitrogen nucleophiles 
leading to the postulation of two possible solutions: (a) employing stronger base, or (b) installing 
electron-withdrawing activating groups enhancing the N-H acidity.  The first idea was evaluated 
previously by Taylor,
102
 who attempted synthesis of amino acid derivative 90 via 
dehydrobromination of bromocyclopropane 88 in the presence of K[N(SiMe3)2] followed by 
trapping of intermediate cyclopropene 89 with ammonia (Scheme 37).  This approach proved 
totally inefficient, leading to the formation in low yields of metoxycyclopropane 91 as the only 
isolable product, with the methoxide nucleophile originating from base-assisted cleavage of the 
cyclopropyl ester function.
102
 
108 
 
Scheme 37 
  
 
Despite the fact that α,β-unsaturated ester 89 has a higher degree of activation towards conjugate 
addition as compared to unsaturated cyclopropenecarboxamides, we rationalized that the amide 
may be a viable candidate for the addition of 1  or 2  alkyl amides due to the fact that the 
carboxamide function should be less prone to hydrolysis.  To test this hypothesis, 
bromocyclopropane 70c was added to premixed solutions of metal hydride or alkyl lithium and 
1  or 2  alkyl amines (Scheme 38).  Initially we observed the formation of cycloropene 71c to be 
sluggish, and upon heating; starting material was consumed but aminocyclopropane 93 was not 
observed.   
Scheme 38 
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This outcome may be explained as deprotonation of the relatively acidic C(sp
2
)-H bond of 
cyclopropene 70c resulting in cyclopropenyl anion 92 which has severely diminished aptitude 
towards conjugate addition.  Therefore a nucleophile was unable to add and the unstable 
intermediate decomposed. 
 The implication of these findings is that we must activate nitrogen nucleophiles with 
electron withdrawing groups in order to modulate the N-H acidity into a range that is appropriate 
for our standard reaction conditions.   
Scheme 39 
  
 
Initial tests employed carbonyl activated N-methylacetamide (NMA, 94aa) in the reaction with 
arylcyclopropene 65 using t-BuOK as base to affect dehydrobromination of bromocyclopropane 
64 in the presence of catalytic 18-crown-6.  We were pleased to find that these conditions lead to 
amide adduct 93aa in high yield and excellent diastereoselectivity (Scheme 39).  In persuit of β-
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ACC derivatives, we also tested these same conditions with carboxamide cyclopropane 70a 
yielding trans-diamide 95aaa in equally high yield and good diastereoselectivity.    
 
 
Table 9.  Steric effect in the formal substitution of bromocyclopropane 70a with secondary 
amides  
 
 
 
no. R
1
 R
2
 NuH product
a
 yield, %
b
 dr
c
 
1 Me Me 94aa 95aaa 88 11:1 
2 n-Pr n-Bu 94bd 95abd 51 25:1 
3 n-Pr i-Pr 94bc 95abc 28
d
 25:1 
4 i-Pr n-Bu 94cd 95acd 31
d
 17:1 
5 n-Bu t-Bu 94de 95ade NR - 
6 t-Bu n-Bu 94ed 95aed NR - 
7 Ph Me 94fa 95afa 75 >25:1 
8 Ph n-Bu 94fd 95afd 72 >25:1 
 
a) Reactions performed in 0.5 mmol scale.   b) Isolated yields of diastereomeric mixtures unless specified otherwise.   
c) dr (trans:cis) determined by GC or 1H NMR analyses of crude reaction mixtures.   d) NMR yields determined by 
analyses of crude reaction mixtures.   Bromocyclopropane 1a was consumed completely. 
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To further understand the role of sterics in carboxamide addition, we probed the reaction 
with carboxamides 94ba-94ed, carrying substituents with variable steric demands.  It was found 
that increased steric hindrance at the N- or C- terminus of the pronucleophile resulted in an 
adverse effect on reaction efficacy.  Indeed, installation of primary alkyl substituents to both 
termini diminished the yield of product 95abd to 51% (Table 9, entry 2) while secondary alkyl 
substituents on either terminus result in poor yields (entries 3, 4).   Installation of a tertiary alkyl 
substituent to either terminus completely inhibited the nucleophilic additions (entries 5, 6). 
We rationalized that the effective nucleophilicity (which for this process has the same 
trend as N-H acidity) of the sterically hindered amide species can be enhanced by adjusting their 
electronic properties.  To test this idea, we substituted an alkyl group at the C-terminus of the 
pronucleophile with a phenyl ring.  Gratifyingly, the reaction between bromocyclopropane 70a 
and benzamides 94fa and 94fd afforded the corresponding diamides 94afa and 94afd with high 
yields and excellent diastereoselectivities (Table 9, entries 7, 8).   Next, we tested 70a in 
reactions with a series of differently substituted N-butylbenzamides 94gd-md to further explore 
the effect of electronic factors on reactivity (Table 10).   Interestingly, introduction of an electron 
donating p-MeO group completely shut down the reaction with 94gd (Table 10, entry 2).     
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Table 10.   Electronic effect in the formal substitution of bromocyclopropane 1a with secondary 
benzamides  
 
 
no. X-C6H4- NuH Product
a
 yield, %
b
 dr
c
 
1 Ph 94fd 95afd 72 >25:1 
2 p-MeOC6H4 94gd 95agd NR - 
3 o-ClC6H4 94hd 95ahd 80
d
 >25:1 
4 p-ClC6H4 94id 95aid 81 >25:1 
5 p-CNC6H4 94jd 95ajd 80 >25:1 
6 p-NO2C6H4 94kd 95akd 80 >25:1 
7 p-CF3C6H4 94ld 95ald 85 >25:1
e
 
8 3,5-(CF3)2C6H3 94md 95amd 87 >25:1
e
 
 
a) Typical reaction conditions: bromocyclopopane 70a (0.5 mmol), amide 94 (1.0 mmol), powdered KOH (1.75 
mmol), 18-crown-6 (0.05 mmol), THF (5 mL) - stirred at 85 °C for 12 h.  b) Isolated yields of trans-diamide.   c) dr 
(trans:cis) determined by GC or 
1
H NMR analysis of crude reaction mixtures.  The notation >25:1 is used when no 
minor diastereomer was detected.   d) NMR yields determined by analysis of a crude reaction mixture.   e) dr 
(trans:cis) determined by 
19
F NMR analysis of crude reaction mixtures. 
 
On the other hand, incorporation of electron-withdrawing groups in the ortho- (entry 3) or para- 
(entries 4-7) positions of the aromatic ring in the benzamide pronucleophile allowed for 
improved reactivity.  The best results were achieved with p-CF3- (95ald, entry 7) and 3,5-
bis(CF3)2-substituted aryl groups (95amd, entry 8).  It should be mentioned that no diamide 
product was observed in the reaction with primary amide (94l) despite complete consumption of 
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the bromocyclopropane 70a.
103
 This outcome could potentially result from addition of the 
primary amide, followed by subsequent deprotonation of secondary amide adduct 95al resulting 
in ring-opening to form several possible products.  Initial ring opening would result in imine 96c 
which could isomerize to olefinic products 96b or 96d (Scheme 40).  Cyclization could also 
occur between electrophilic imine and secondary tert-butyl amide to form aminal 96a.  
1
H NMR 
shows evidence for all of these as possible outcomes (Figure 4, peaks in olefinic region from 
5.33-6.22 ppm), but was inconclusive as to which outcome(s) predominated.   
Scheme 40 
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Figure 4: 
1
H NMR showing evidence for product mixture potentially containing 96a-d. 
 
We envisioned that the described methodology, utilizing secondary amides as 
nucleophiles, could be efficiently applied toward convergent synthesis of conformationaly 
constrained trans-cyclopropyl amino acid derivatives, with the possibility for a three-
dimensional diversification (Scheme 41).  Thus, readily available acyl chlorides can be converted 
into an array of amides 70 by varying the primary or secondary amines.  At the same time, a 
variety of pronucleophiles 94 can be obtained from primary amines and different carboxylic 
acids.  As shown above, amides 94 derived from linear aliphatic and electron-defficient benzoic 
acids usually provide the highest yields in this transformation (Tables 1 and 2).   Notably, 
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installation of the CF3-groups in the benzamide derivatives 94ld, 94md significantly facilitated 
isolation and purification of the corresponding products 95ald and 95amd due to their improved 
solubility in organic solvents compared to other N-butyl benzamide derivatives (95ahd-95akd, 
Table 10).  The presence of fluorine-containing groups also allowed for accurate assessment of 
the selectivity by 
19
F NMR, as severe line broadening in proton spectra resulting from slow 
conformational rotation made 
1
H NMR data inapplicable for the analysis.  Accordingly, CF3-
substituted benzamides were used for more detailed investigations of the scope and limitation of 
this reaction.  It was found that p-CF3-substituted benzamides possessing primary N-alkyl groups 
rendered efficient nucleophilic addition to give n-octyl- (95ale), benzyl- (95alf), and 2-phenethyl 
benzamides (95alg) in high yields and perfect diastereoselectivites (Table 11, entries 1-3).  At 
the same time, nucleophilic addition of a more sterically hindered N-cyclohexyl 4-(trifluoro-
methyl)benzamide (94lh) proceeded sluggishly, resulting in marginal yield of the corresponding 
diamide 95alh (Table 11, entry 4).   In contrast, amides 94mc, 94mg-mi derived from 3,5-
bis(trifluoromethyl)benzoic acid reacted with bromocyclopropane 70a much more readily.   
Improved product yields were obtained not only for the less sterically hindered derivative 95amg 
(Table 11, entry 8), but also for more challenging bulky products 95amh, 95amc, 95ami (entries 
5-7), bearing secondary N-alkyl substituents.   However, very bulky N-tert-butylamide 94me did 
not provide any product in the reaction with 70a (entry 9).    
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Scheme 41 
 
Table 11.  Convergent approach to conformationally constrained trans-cyclopropyl amino acid 
derivatives via formal substitution of bromocyclopropanes with nucleophilic carboxamides   
 
R
3
,R
4
 (70) R
1
 R
2
 (94) (95) yield, %
a
 
1 
t
Bu, H (70a) p-CF3C6H4 n-Oct 94le 95ale 85 
2 
t
Bu, H (70a) p-CF3C6H4 PhCH2 94lf 95alf 80 
3 
t
Bu, H (70a) p-CF3C6H4 Ph(CH2)2 94lg 95alg 82 
4 
t
Bu, H (70a) p-CF3C6H4 c-Hex 94lh 95alh 45 
5 
t
Bu, H (70a) 3,5-(CF3)2C6H3 c-Hex 94mh 95amh 83 
6 
t
Bu, H (70a) 3,5-(CF3)2C6H3 i-Pr 94mc 95amc 61 
7 
t
Bu, H (70a) 3,5-(CF3)2C6H3 c-Pr 94mi 95ami 59 
8 
t
Bu, H (70a) 3,5-(CF3)2C6H3 Ph(CH2)2 94mg 95amg 94 
9 
t
Bu, H (70a) 3,5-(CF3)2C6H3 t-Bu 94me 95ame - 
10 -(CH2)5- (70c) 3,5-(CF3)2C6H3 Ph(CH2)2 94mg 95cmg 76 
11 -(CH2)2O(CH2)-( 70b) 3,5-(CF3)2C6H3 Ph(CH2)2 94mg 95bmg 76 
12 c-Hex, H (70d) 3,5-(CF3)2C6H3 c-Hex 94mh 95dmh 66 
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Table 11 (Continued) 
 R
3
,R
4
 (70) R
1
 R
2
 (94) (95) yield, %
a
 
13 -(CH2)5- (70c) 3,5-(CF3)2C6H3 PhCH2 94mf 95cmf 68 
14 Me, OMe (70e) 3,5-(CF3)2C6H3 PhCH2 94mf 95emf 31 
15 
t
Bu, H (70a) 4-NO2-C6H4 PhCH2 94kf 95akf 63 
16 
t
Bu, H (70a) 4-NO2-C6H4 ThCH2
b
 94kj 95akj 52 
17 
t
Bu, H (70a) 4-CN-C6H4 PhCH2 94jf 95ajf 47 
18 
t
Bu, H (70a) 4-CN-C6H4 FuCH2
c
 94jk 95ajk 81 
a) Isolated yields.   In all cases dr > 25:1 was obtained.    b) Th = 2-thienyl.   C) Fu = 2-furyl. 
 
The scope of the cyclopropylcarboxamides 70 was also investigated.  Bromocyclo-
propylcarboxamide derivatives of piperidine (70c), morpholine (70b), and cyclohexylamine 
(70d), afforded diamides 95cmg, 95cmf, 95bmg, and 95dmh in good to high yields (Table 11, 
entries 10-13).   Weinreb amide 70e was also tested in this reaction; however, the corresponding 
product 95emf was obtained in 31% yield only, presumably, due to a decreased stability of the 
intermediate cyclopropene species (Table 11, entry 14).   As discussed above, efficient activation 
of the nitrogen atom for nucleophilic attack is possible by almost any electron-withdrawing 
group (Table 10).   Thus, derivatives of 4-nitro- (94kf, 94kj) and 4-cyanobenzoic (94jf, 94jk) 
acids were successfully employed for activation of benzylamine and hetarylmethylamines (Table 
11, entries 15-18).    
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Figure 5.   ORTEP drawing of diamide 95bmg showing 50% probability amplitude 
displacement ellipsoids. 
 
Similarly to the formal nucleophilic substitution reaction with alkoxides and phenoxides, 
the diastereoselectivity in the described transformation was governed by a base-assisted 
epimerization.  However, additional treatment of the reaction mixture with t-BuOK was 
unnecessary in this case, as the thermodynamically more favored trans-diastereomer was 
produced exclusively under the standard reaction conditions.   It should be mentioned that 
accurate assignment of the product configuration by 
1
H NMR based on the analysis of 
3
JHH 
coupling constants of the cyclopropyl proton signals was impeded by severe broadening of the 
corresponding resonance lines.   Careful optimization of the sample temperature provided 
acceptable resolution for measuring the coupling constants in 95aba in DMSO-d6.  As additional 
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evidence, trans-configuration of diamide 95bmg was unambiguously assigned by X-ray 
crystallography (Figure 5).  These data were used to assign the structures of all other products by 
analogy. 
3.3. Sulfonyl activation of nitrogen nucleophiles. 
 
 Despite having found success with addition of carboxamide nucleophiles, carbonyl 
activation was found to have several drawbacks.  The two largest being the necessity of strong 
withdrawing groups such as a trifluoromethyl or nitro substituted aryl ring on the C-terminus as 
well as the severe line broadening in the 
1
H NMR.  These hindrances, coupled with the growing 
literature precedence for bioactive cyclopropyl sulfonamides,
95,104
 lead us to pursue N-sulfonyl 
activation for nucleophilic addition to conjugated cyclopropanes.  Indeed, sulfonamides are 
broadly employed as N-H acidic surrogates of amines in various C-N bond forming processes, 
for example, classical nucleophilic displacements
105
 (including Mitsunobu coupling),
105,106
  
conjugate addition reactions,
107
  and transition metal catalyzed couplings involving both C-Hal
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and C-H bond activation.
109
 Initially we attempted to employ sulfonamide nucleophile 97ad 
under reaction conditions previously optimized for addition of alkoxides.  This reaction, 
however, did not proceed at all, allowing for recovery of unreacted bromocyclopropane 70a 
(Scheme 42).  We rationalized the lack of reactivity by insufficient amount of base as an effect of 
the increased acidity of sulfonamides as compared to alcohol-based nuclephiles.  This type of 
behavior was previously observed in reactions of relatively acidic pronucleophiles (such as 
phenols and thiols). The overall basicity of the media was not sufficient to achieve the base-
assisted epimerizations into thermodynamically more stable trans-products, calling for a 
requisite additional treatment of crude products with stronger base.  For the reactions with 
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sulfonamides, the basicity seems to be insufficient to ensure the initial dehydrobromination step.  
Accordingly, in attempt to  
 
Scheme 42 
 
Table 12.  Convergent approach to conformationally constrained trans-cyclopropyl amino acid 
derivatives via formal substitution of bromocyclopropanes with nucleophilic sulfonamides 
 
 
 R
1
,R
2
 70 R
3
,R
4
 97 98 Yield (%) dr 
1 t-Bu, H 70a 4-MeC6H4, n-Bu 97ad 98aad 90 16:1 
2 t-Bu, H 70a 4-MeOC6H4, n-Bu 97ed 98aed 95 11:1 
3 tBu, H 70a 4-MeC6H4, Bn 97af 98aaf 75 11:1 
4 c-Hex, H 70d 4-MeC6H4, n-Bu 97ad 98dad 89 15:1 
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Table 12 (Continued) 
 R
1
,R
2
 70 R
3
,R
4
 97 98 Yield (%) dr 
5 tBu, H 70a 4-MeC6H4, Furfuryl 97ak 98aak 84 25:1 
6 t-Bu, H 70a Ph, n-Bu 97fd 98afd 73 10:1 
7 t-Bu, H 70a -C10H8, n-Bu 97gd 98agd 78 10:1 
8 c-Hex, H  70d -C10H8, n-Bu 97gd 98dgd 94 25:1 
9 tBu, H 70a Me, n-Hex 97he 98ahe 90 9:1 
10 tBu, H 70a Me, Bn 97hf 98ahf 83 15:1 
11 tBu, H 70a Me, c-Hex 97hh 98ahh 67 11:1 
12 tBu, H 70a 4-FC6H4, n-Bu 97id 98aid 96 19:1 
13 c-Hex, H 70d 4-FC6H4, n-Bu 97id 98did 97 10:1 
14 -(CH2)2O(CH2)- 70b 4-FC6H4, n-Bu 97id 98bid 71 11:1 
15 tBu, H 70a 4-FC6H4, Furfuryl 97ik 98aik 93 si 
16 tBu, H 70a 4-ClC6H4, n-Bu 97jd 98ajd 94 11:1 
17 tBu, H 70a 4-ClC6H4, Bn 97jf 98ajf 72 25:1 
18 tBu, H 70a 4-BrC6H4, n-Bu 97kd 98akd 91 11:1 
 
 
 
force the reaction to completion we increased the base load to 7.0 equiv in the reaction with 
tosylamide 97ad, to obtain the desired product 98aad in excellent yield and high 
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diastereoselectivity (Scheme 42, Table 12, entry 1).   Encouraged by the promising reactivity of 
tosylamide 97ad, we set out to explore electronic influence on the efficacy of this reaction.   
Interestingly, in contrast to carboxamides, which require strong electron withdrawing groups, 
sulfonamides bearing an electron donating p-anisyl (97ed, Table 12, entry 2) and p-tolyl groups 
(97af, 97ad, 97ak, entries 3-5), as well as an electron-neutral phenyl (97fd -naphthyl 
substituent (97gd) added smoothly, affording the corresponding cyclopropylamine sulfonates in 
high yield (Table 12, entries 6-8).  The necessity of an aryl group was also probed and it was 
found that mesylamides 97he, 97hf, 97hh also added with good to excellent yield to provide the 
corresponding products  98ahe, 98ahf, and 98ahh (Table 12, entries 9-11).   Sulfonamides 
bearing mild inductively electron withdrawing groups, such as p-FC6H4 (97id, 97ik), p-ClC6H4 
(97jd, 97jf), and p-BrC6H4 (97kd) also proved viable in this reaction (Table 12, entries 12-18).   
At the same time, we failed to persuade the reaction of 70a with highly acidic 4-nitro- (97bd), 2-
nitro- (97cd), and 2,4-dinitro- (97dd) -benzenesulfonates of n-butylamine (Scheme 42).   When 
base equivalencies were increased to above 15 equivalents, the dehydrobromination occurs but 
the nucleophilicity of the nosylates does not seem sufficient to produce any observable quantity 
of adducts. 
3.4. Aromatic activation of nitrogen nucleophiles. 
 
Removal of the nitrogen activating group would allow us to further functionalize the 
generated secondary amine of our β-ACC derivatives.  Therefore the inability to utilize nosylates 
as nucleophilic amine surrogates was disappointing given their relative ease of deprotection 
under mild conditions.  However, we rationalized that the enhanced N-H acidity of anilines 
compared to alkylamines could allow them to be used to install pre-functionalized amines 
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without carbonyl or sulfonyl activators.  For this reason, we decided to investigate the possibility 
to employ them in the formal substitution reaction as N-based nucleophiles.  In our initial 
experiments, reaction in the presence of N-methylaniline (99a) resulted in formation of aldehyde 
103.  This compound can be viewed as product of formal addition of water to cyclopropene 71a, 
accompanied by a base-assisted cleavage of the intermediate cyclopropanol 101.   On the other 
hand, formation of 103 was never observed in the absence of secondary aniline, thus suggesting 
a crucial role of this promoter.  We believe the reaction begins with normal base-assisted 
conjugate addition of aniline species 99a across the C=C bond of cyclopropene 71a.  Then, due 
to the strong donating ability of the nitrogen substituent, ring cleavage of the donor-acceptor 
cyclopropane 100aa takes place, leading to the formation of iminium intermediate 102aa, 
undergoing further base-assisted hydrolysis into aldehyde 103 (Scheme 43).     
Scheme 43 
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Table 13.   Convergent approach to conformationally constrained trans-cyclopropyl amino acid 
derivatives via formal substitution of bromocyclopropanes with nucleophilic anilines. 
 
 
 R
1
,R
2
 (70) R
3
,R
4
 (99) 100 Yield (%) dr 
1 t-Bu, H (70a) 4-NO2C6H4, Me (99b)  100ab 99 >25:1 
2 t-Bu, H (70a) 4-NCC6H4, Bn (99c) 100ac 99 >25:1 
3 t-Bu, H (70a) 4-CF3C6H4, Bn (99d) 100ad 65 >25:1 
4 -(CH2)2O(CH2)2- (70b) 4-NO2C6H4, Bn (99e) 100be 75 >25:1 
5 t-Bu, H (70a) 3-NO2C6H4, Bn (99f) 100af 50 >25:1 
6 t-Bu, H (70a) Ph, Ph (99g) 100ag 96 >25:1 
7 t-Bu, H (70a) 10H-phenothiazine (99h) 100ah 59 >25:1 
 
We envisioned this aptitude to the ring cleavage could be dramatically diminished in 
cyclopropylamine intermediates with electron-deficient nitrogen.  To this end we tested reactions 
with both KOH and t-BuOK in the presence of p-nitroaniline 100b and catalytic 18-crown-6.   
To our delight the reaction with alkoxide base proceeded smoothly providing a single 
diastereomer of cyclopropylaniline 100ab in nearly quantitative yield (Table 13).  In a similar 
manner, several electron-deficient N-benzyl anilines, possessing cyano- (99c), trifluoromethyl- 
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(99d), and nitro- (99e) groups in para-positions were employed, having in mind a potential 
removal of the benzyl protecting group.  All these nucleophiles added smoothly, affording the 
corresponding aminocyclopropanes 100ac, 100ad, and 10ee in good to excellent yields and with 
perfect diastereoselectivities.  meta-Nitroaniline 99f possessing a less electron-deficient nitrogen 
atom provided the corresponding adduct 100af in lower yield, yet the diastereoselectivity 
remained perfect (entry 5).   Finally, diphenylamine (99g) and 10H-phenothiazine (99h) proved 
to be suitable pronucleophiles for the featured transformation.  In this case electron-withdrawing 
substituents are not necessary, and the individual trans-diastereomers of the corresponding 
cyclopropylamine derivatives 100ag and 100ah could be optained in good to excellent yields 
(Table 13, entries 6-7). 
3.4. Conclusions 
 
In conclusion the work presented in this thesis is useful to the synthetic community as a 
general diastereoselective method for synthesizing functionally diverse and stereochemically 
defined cyclopropane derivatives via metal-free, inter- and intramolecular formal nucleophilic 
substitution reactions of readily available bromocyclopropanes 70 (Figure 6).  The method 
hinges on the in-situ generation (path A) and trapping of unstable, conjugated cyclopropene 71 - 
which has no intrinsic shelf life - in a highly efficient elimination addition pathway.  
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Figure 6 
 
The formal substitution reactions exhibit a high degree of functional group tolerance, 
which allows for facile diversification leading to numerous derivatives bearing structural 
similarities to several biologically important classes of molecules.  For example, the addition of 
nitrogen-based nucleophiles results in cyclopropyl amine derivatives, a class of molecules which 
encompass compounds such as tranylcypromine, β-ACC’s 
89, 91
 and cyclopropyl suflonamides 
(Figure 7).
95, 104
  Utilizing the method described in this thesis allows efficient access to β-ACC’s 
127 
 
(Paths D, F and G), cyclopropyl sulfonamides (Path F) as well cyclopropanol derivatives (Paths 
B, E and H). 
 
 
Figure 7 
 
Along with a broad scope, the method benefits from generally high yields and is 
amenable to multi-gram scale.  This coupled with simple and expedient isolation and purification 
of products via preparative silica chromatography suggests that rapid library synthesis to aid in 
early stage drug discovery can be accomplished by utilizing this method; especially if work were 
to be undertaken to develop automated reaction protocols.  Given that the reaction is 
stereochemically oblative, the possibility exists for exploration into chiral catalysis and 
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diastereoselective additions with chiral nucleophiles or auxiliaries, potentially leading to 
enantiomerically enriched products such as β-ACC-based β-turns (Figure 8, eq. 1).  Utilizing an 
intramolecular approach, it may also be possible to synthesize β-strand mimetics (eq. 2). 
 
Figure 8: Potential Future directions 
 
 
Further work will be aimed at expanding the scope of the reaction to include inter- and 
intramolecular carbon-based nucleophilic addition of enolates, nitroalkanes, nitriles and 
grignards, which would serve to greatly increase the structural diversity of the generated 
scaffolds. These explorations, in conjunction with collaborative biological screening of the final 
products have a high potential for the discovery of new drug-like molecules and molecular 
probes. 
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3.5. Experimentals 
3.5.1. Synthesis of carbonyl-activated nucleophiles 
 
N-methylacetamide (94aa) and N-methylbenzamide (94fa) were commercially available and 
used as recieved.   
 
N-Butylbutyramide (94bd) (typical procedure): To a stirred solution of 
n-butylamine (2.42 mL, 1.78 g, 24.4 mmol) in 1M aqueous NaOH (50 
mL, 50 mmol, 2.36 equiv) was added butyryl chloride (4.19 mL, 4.33 g, 40.6 mmol, 1.67 equiv).  
The mixture was stirred for 2 hrs at room temperature, then aqueous layer was saturated with 
brine and extracted with EtOAc (3 x 25 mL).  Combined organic phases were dried with MgSO4, 
filtered, and concentrated in vacuum.  The residue was distilled in vacuum employing Kugelröhr 
apparatus to afford the title compound as colorless amorphous solid.  Yield 3.08 g (21.5 mmol, 
88%).  Physical and spectral properties of this material were identical to those previously 
reported in literature.
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N-Isopropylbutyramide (94bc): This compound was prepared according to a 
typical procedure starting from isopropylamine (2.09 mL, 1.44 g, 24.4 mmol) 
and butyryl chloride (4.19 mL, 4.33 g, 40.6 mmol, 1.67 equiv).  Kugelröhr distillation afforded 
the title compound as colorless oil.  Yield 2.52 g (19.5 mmol, 80%).  Physical and spectral 
properties of this material were identical to those previously reported in literature.
111
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N-Butylisobutyramide (94cd): This compound was prepared according to 
a typical procedure starting from n-butylamine (2.42 mL, 1.78 g, 24.4 
mmol) and isobutyryl chloride (4.26 mL, 4.33 g, 40.6 mmol, 1.67 equiv).  Kugelröhr distillation 
afforded the title compound as colorless oil.  Yield 2.65 g (20.5 mmol, 84%).  Physical and 
spectral properties of this material were identical to those previously reported in literature.
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N-tert-Butylbutyramide (94ed): This compound was prepared according 
to a typical procedure starting from t-butylamine (2.56 mL, 1.78 g, 24.4 
mmol) and butyryl chloride (4.19 mL, 4.33 g, 40.6 mmol, 1.67 equiv).  Kugelröhr distillation 
afforded the title compound as colorless oil.  Yield 2.94 g (20.5 mmol, 84%).  Physical and 
spectral properties of this material were identical to those previously reported in literature.
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N-Butylpivalamide (94de): This compound was prepared according to a 
typical procedure starting from n-butylamine (2.42 mL, 1.78 g, 24.4 mmol) 
and pivaloyl chloride (5.00 mL, 4.90 g, 40.6 mmol, 1.67 equiv).  Kugelröhr distillation afforded 
the title compound as colorless oil.  Yield 3.23 g (20.5 mmol, 84%).  Physical and spectral 
properties of this material were identical to those previously reported in literature.
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N-Butylbenzamide (94fd): This compound was prepared according to a 
typical procedure starting from n-butylamine (2.42 mL, 1.78 g, 24.4 
mmol) and benzoyl chloride (4.71 mL, 5.71 g, 40.6 mmol, 1.67 equiv).  
Kugelröhr distillation afforded the title compound as colorless oil.  Yield 3.63 g (20.5 mmol, 
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84%).  Physical and spectral properties of this material were identical to those previously 
reported in literature.
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N-Butyl-4-methoxybenzamide (94gd): To a stirred solution of 
dicyclohexyl carbodiimide (1.36 g, 6.57 mmol), DMAP (0.04 g, 
0.33 mmol), and p-anisic acid (1.03 g, 6.57 mmol) in dry CH2Cl2 
(15 mL) was added dry n-butylamine (0.82 mL, 600 mg, 8.21 mmol).  The mixture was stirred 
for 36 hrs at 30 
o
C, then quenched with 5N aqueous NaOH (25 mL) and extracted with ether (4 x 
15 mL).  Combined organic phases were dried with MgSO4, and concentrated.  Flash column 
chromatography afforded the title compound as colorless solid.  Yield 721 mg (3.48 mmol, 
53%).  Physical and spectral properties of this material were identical to those previously 
reported in literature.
115
 
 
N-Butyl-2-chlorobenzamide (94hd): was obtained from ochlorobenzoic 
acid (1.00 g, 6.57 mmol) according to a protocol, described for 
preparation of amide 94gd.  Yield 760 mg (3.61 mmol, 55%).  Physical 
and spectral properties of this material were identical to those previously reported in literature.
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N-Butyl-4-chlorobenzamide (94id): was obtained according to a 
typical procedure from n-butylamine (1.07 mL, 790 mg, 10.8 mmol) 
and 4-chlorobenzoyl chloride (547 μL, 753 mg, 4.30 mmol) as 
colorless crystalline solid, mp 62-64 
o
C.  Yield 865 mg (4.09 mmol, 95%); 
1
H NMR (500.13 
MHz, CD3OD) δ ppm 7.79 (d, J = 8.8 Hz, 2H), 7.47 (d, J = 8.8 Hz, 2H), 3.37 (t, J = 7.3 Hz, 2H), 
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1.60 (quin, J = 7.3 Hz, 2H), 1.41 (sxt, J = 7.3 Hz, 2H), 0.97 (t, J = 7.3 Hz, 3H); 
13
C NMR 
(125.76 MHz, CD3OD) δ  ppm 169.3, 138.7, 134.7, 130.1 (+, 2C), 129.8 (+, 2C), 41.0 (-), 32.8 (-
), 21.4 (-), 14.3 (+); FTIR (NaCl, film, cm-1): 3323, 2962, 2932, 2870, 2359, 2341, 1632, 1547, 
1472, 843, 654; HRMS (TOF ES): found 229.1109, calculated for C11H14ClN2O (M+NH4) 
229.1108 (0.4 ppm). 
 
N-Butyl-4-cyanobenzamide (94jd): was obtained according to a 
typical procedure from n-butylamine (1.07 mL, 790 mg, 10.8 mmol) 
and 4-cyanobenzoyl chloride (712 mg, 4.30 mmol) as colorless 
crystalline solid, mp 45-50 
o
C.  Yield 834 mg (4.13 mmol, 96%); 
1
H NMR (500.13 MHz, 
CD3OD) δ ppm 7.94 (d, J = 8.5 Hz, 2H), 7.84 (d, J = 8.5 Hz, 2H), 3.39 (t, J = 7.1 Hz, 2H), 1.61 
(quin, J = 7.3 Hz, 2H), 1.41 (sxt, J = 7.3 Hz, 2H), 0.97 (t, J = 7.3 Hz, 3H); 
13
C NMR (125.76 
MHz, CD3OD) δ ppm 168.5, 140.2, 133.7 (+, 2C), 129.3 (+, 2C), 119.2, 116.1, 41.1 (-), 32.7 (-), 
21.3 (-), 14.3 (+); FTIR (NaCl, film, cm-1): 3319, 2959, 2934, 2872, 2231, 1643, 1549, 1499, 
1306, 858; HRMS (TOF ES): found 209.1274, calculated for C12H14N2OLi (M+Li) 209.1266 
(3.8 ppm). 
 
N-Butyl-4-nitrobenzamide (94kd): was obtained according to a 
typical procedure from n-butylamine (1.07 mL, 790 mg, 10.8 
mmol) and 4-nitrobenzoyl chloride (522 μL, 798 mg, 4.30 mmol) 
as colorless crystalline solid, mp 135-140 
o
C.  Yield 668 mg (3.01 mmol, 70%); 
1
H NMR 
(400.13 MHz, CDCl3) δ ppm 8.30 (d, J = 8.8 Hz, 2H), 7.93 (d, J = 8.8 Hz, 2H), 6.14 (br.  s, 1H), 
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3.50 (td, J = 7.3 Hz, 5.8 Hz, 2H), 1.68- 1.59 (m, 2H), 1.49-1.40 (m, 2H), 0.99 (t, J = 7.3 Hz, 3H); 
1
H NMR (125.76 MHz, CD3OD) δ ppm 178.3, 151.1, 141.8, 129.8 (+, 2C), 124.8 (+, 2C), 41.1 (-
), 32.7 (-), 21.3(-), 14.3 (+); FTIR (NaCl, film, cm-1): 3304, 2955, 2932, 1643, 1601, 1526, 
1346, 868, 841, 719; HRMS (TOF ES): found 245.0901, calculated for C11H14N2O3Na (M+Na) 
245.0902 (0.4 ppm). 
 
N-Butyl-4-(trifluoromethyl)benzamide (94ld) To a solution of 4-
(trifuluoromethyl)benzoic acid (2.89 g, 13.0 mmol) in dry CH2Cl2 
(50 mL) was added 1,1-carbonyldiimidazole (2.53 g, 15.6 mmol, 
1.20 equiv).  The resulting suspension was stirred for 30 min at 0 
o
C, and then n-butylamine 
(3.03 mL, 2.23 g, 30.5 mmol, 2.35 equiv) was added dropwise.  The mixture was stirred at room 
temperature overnight, then filtered.  The filter cake was washed with CH2Cl2, the filtrate was 
washed consecutively with water and brine, dried with MgSO4, filtered and concentrated.  Crude 
material was filtered through a short plug of Silica gel, eluting with EtOAc to afford the title 
material as a colorless oil.  Yield 3.00 g (12.2 mmol, 94%).  This material was identical to the 
one previously described in literature.
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N-Butyl-3,5-bis(trifluoromethyl)benzamide (94md): was 
obtained according to a typical procedure from n-butylamine (1.07 
mL, 790 mg, 10.8 mmol) and 3,5-bis(trifluoromethyl)benzoyl 
chloride (780 μL, 1.19 g, 4.30 mmol) as colorless crystalline solid, mp 61- 63 
o
C.  Yield 1.28 g 
(4.09 mmol, 95%); 
1
H NMR (500.13 MHz, CD3OD) δ ppm 8.42 (s, 2H), 8.15 (s, 1H), 3.42 (t, J = 
6.8 Hz, 2H), 1.63 (qnt, J = 6.9 Hz, 2H), 1.43 (sxt, J = 7.3 Hz, 2H), 0.98 (t, J = 7.3 Hz, 3H); 
13
C 
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NMR (125.76 MHz, CD3OD) δ ppm 166.7, 138.4, 133.2 (q, 
2
JCF =33.6 Hz, 2C), 129.1 (+, 2C), 
126.0 (+), 124.7 (q, 
1
JCF =271.6 Hz, 2C), 41.2 (-), 32.6 (-), 21.4 (-), 14.3 (+); 
19
F NMR (376.50 
MHz, CD3OD) δ ppm -65.7 (s, 6F); FTIR (NaCl, film, cm-1): 3319, 3092, 2964, 2937, 1649, 
1556, 1381, 1335, 1182, 1134, 908, 845, 702, 681; HRMS (TOF ES): found 336.0809, calculated 
for C13H13F6NONa (M+Na) 336.0799 (3.0 ppm). 
 
N-Phenethyl-4-(trifluoromethyl)benzamide (94lg): was obtained 
according to a typical procedure from phenethylamine (1.36 mL, 1.31 
g, 10.8 mmol, 2.5 equiv.) and and 4-(trifluoromethyl) benzoyl chloride 
(640 μL, 897 mg, 4.30 mmol) as colorless crystalline solid, mp 140-142 
o
C.  Yield 1.15 g (3.91 
mmol, 91%); 
1
H NMR (500.13 MHz, CD3OD) δ ppm 7.92 (d, J = 8.5 Hz, 2H), 7.76 (d, J = 8.5 
Hz, 2H), 7.31-7.25 (m, 4H), 7.22-7.18 (m, 1H), 3.62 (t, J = 7.4 Hz, 2H), 2.93 (t, J = 7.4 Hz, 2H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 168.9, 140.7, 139.7, 134.1 (q, 
2
JCF =32.7 Hz), 130.1 (+, 
2C), 129.7 (+, 2C), 129.1 (+, 2C), 127.6 (+), 126.7 (q, 
3
JCF = 3.6 Hz, +, 2C), 125.5 (q, 
1
JCF 
=271.5 Hz), 42.9 (-), 36.6 (-); 
19
FNMR (376.50 MHz, CD3OD) δ ppm -65.7 (s, 3F); FTIR (NaCl, 
film, cm-1): 3319, 1641, 1549, 1337, 1165, 1155, 1111, 1072, 858, 748, 700, 685; HRMS (TOF 
ES): found 316.0923, calculated for C16H14F3NONa (M+Na) 316.0925 (0.6 ppm). 
 
N-Octyl-4-(trifluoromethyl)benzamide (94le): was obtained according 
to a typical procedure from n-octylamine (1.79 mL, 1.40 g, 10.8 mmol, 
2.5 equiv.) and 4-(trifluoromethyl)benzoyl chloride (640 μL, 897 mg, 
4.30 mmol) as colorless crystalline solid, mp 49-53 
o
C.  Yield 1.24 g (4.13 mmol, 96%); 
1
H 
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NMR (500.13 MHz, CD3OD) δ ppm 7.97 (d, J = 7.9 Hz, 2H), 7.74 (d, J = 7.9 Hz, 2H), 3.38 (t, J 
= 7.2 Hz, 2H), 1.62 (quint, J = 7.3 Hz, 2H), 1.41-1.25 (m, 10H), 0.88 (t, J = 6.9 Hz, 3H); 
13
C 
NMR (125.76 MHz, CD3OD) δ ppm 168.8, 139.7, 134.1 (q, 
2
JCF = 32.6 Hz), 129.2 (+, 2C), 126.6 
(+, 2C), 125.4 (q, 
1
JCF = 271.3 Hz), 41.3 (-), 33.1 (- ), 30.6 (-, 2C), 28.3 (-), 23.8 (-), 14.6 (-), 
14.5 (+); FTIR (NaCl, film, cm-1): 3339, 2920, 2849, 2957, 1541, 1468, 1335, 1169, 1130, 1107, 
1074, 1018, 860, 773; HRMS (TOF ES): found 308.1801, calculated for C16H22F3NOLi (M+Li) 
308.1814 (4.2 ppm). 
 
N-Benzyl-4-(trifluoromethyl)benzamide (94lf): was obtained 
according to a typical procedure from benzylamine (1.18 mL, 1.16 
g, 10.8 mmol) and and 4-(trifluoromethyl)benzoyl chloride (640 μL, 
897 mg, 4.30 mmol) as colorless crystalline solid, mp 149-151 
o
C.  Yield 1.12 g (4.00 mmol, 
93%); 
1
H NMR (500.13 MHz, CD3OD) δ ppm 8.02 (d, J = 8.2 Hz, 2H), 7.78 (d, J = 8.2 Hz, 2H), 
7.38-7.31 (m, 4H), 7.28-7.24 (m, 1H), 4.59 (s, 2H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 
168.7, 139.9, 139.4, 134.1 (q, 
2
JCF = 31.8 Hz), 129.6 (+, 2C), 129.1 (+, 2C), 128.6 (+, 2C), 128.3 
(+), 126.6 (q, 
3
JCF = 3.6 Hz, +, 2C), 125.3 (q, 
1
JCF = 271.6 Hz), 44.7 (-); 
19
F NMR (376.50 MHz, 
CD3OD) δ ppm -65.7 (s, 3F); FTIR (NaCl, film, cm-1): 3329, 3053, 2986, 1643, 1547, 1421, 
1265, 1167, 1157, 1124, 862, 739; HRMS (TOF ES): found 302.0783, calculated for 
C15H12F3NONa (M+Na) 302.0769 (4.6 ppm). 
 
N-Cyclohexyl-4-(trifluoromethyl)benzamide (94lh): was obtained 
according to a typical procedure from cyclohexylamine (1.23 mL, 1.07 
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g, 10.8 mmol) and and 4-(trifluoromethyl) benzoyl chloride (640 ƒÝL, 897 mg, 4.30 mmol) as 
colorless crystalline solid, mp 167-170 
o
C.  Yield 1.10 g (4.04 mmol, 94%); 
1
H NMR (500.13 
MHz, CD3OD) δ ppm 7.96 (d, J = 8.2 Hz, 2H), 7.76 (d, J = 8.2 Hz, 2H), 3.87 (tt, J = 11.0 Hz, 4.1 
Hz, 1H), 1.99-1.94 (m, 2H), 1.85-1.80 (m, 2H), 1.72-1.67 (m, 1H), 1.47-1.32 (m, 4H), 1.28-1.18 
(m, 1H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 168.1, 139.9, 133.9 (q, 
2
JCF = 32.7 Hz), 129.1 
(+), 126.4 (q, 
3
JCF = 3.6 Hz, +, 2C), 125.3 (q, 
1
JCF = 271.5 Hz), 50.8 (+), 33.7 (-, 2C), 26.6 (-), 
26.4 (-, 2C); 
19
F NMR (376.50 MHz, CD3OD) δ ppm -65.7 (s, 3F); FTIR (NaCl, film, cm-1): 
3312, 2941, 2908, 1634, 1545, 1325, 1161, 1124, 1065, 856; HRMS (TOF ES): found 272.1269, 
calculated for C14H17F3NO (M+H) 272.1262 (2.6 ppm). 
 
N-Cyclohexyl-3,5-bis(trifluoromethyl)benzamide (94mh): was 
obtained according to a typical procedure fromcyclohexylamine (1.23 
mL, 1.07 g, 10.8 mmol) and 3,5-bis(trifluoromethyl)benzoyl chloride 
(780 μL, 1.19 g, 4.30 mmol) as colorless crystalline solid, mp 150-152 
o
C.  Yield 1.37 g (4.04 
mmol, 94%); 
1
H NMR (500.13 MHz, CD3OD) δ ppm 8.42 (s, 2H), 8.14 (s, 1H), 3.92-3.87 (m, 
1H), 2.00-1.96 (m, 2H), 1.86-1.81 (m, 2H), 1.47-1.34 (m, 4H), 1.29-1.19 (m, 1H); 
13
C NMR 
(125.76 MHz, CD3OD) δ ppm 166.0, 138.6, 133.1 (q, 
2
JCF = 33.6 Hz, 2C), 129.2 (q, 
3
JCF =3.3 Hz, 
+, 2C), 125.9 (spt, 
3
JCF = 3.6 Hz, +), 124.8 (q, 
1
JCF = 272.5 Hz, 2C), 51.2 (+), 33.7 (-, 2C), 26.8 
(-), 26.6 (-, 2C); 
19
F NMR (376.50 MHz, CD3OD) δ ppm -65.7 (s, 6F); FTIR (NaCl, film, cm-1): 
3416, 2937, 2858, 1643, 1553, 1279, 1182, 1134, 908, 702, 681; HRMS (TOF ES): found 
362.0958, calculated for C15H15F6NONa (M+Na) 362.0956 (0.6 ppm).  
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N-Isopropyl-3,5-bis(trifluoromethyl)benzamide (94mc): was obtained 
according to a typical procedure from isopropylamine (924 μL, 638 mg, 
10.8 mmol) and 3,5-bis(trifluoromethyl)- benzoyl chloride (780 μL, 1.19 
g, 4.30 mmol) as colorless crystalline solid, mp 108-111 
o
C.  Yield 1.22 g (4.09 mmol, 95%); 
1
H 
NMR (500.13 MHz, CD3OD) δ ppm 8.43 (s, 2H), 8.14 (s, 1H), 4.24 (spt, J = 6.6 Hz, 1H), 1.28 
(d, J = 6.6 Hz, 6H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 165.9, 138.6, 133.2 (q, 
2
JCF = 33.5 
Hz, 2C), 129.2 (q, 
3
JCF =3.6 Hz, +, 2C), 125.9 (spt, 
3
JCF = 3.6 Hz, +), 124.8 (q, 
1
JCF = 271.6 Hz, 
2C), 43.8 (+), 22.5 (+, 2C); 
19
F NMR (376.50 MHz, CD3OD) δ ppm -65.7 (s, 6F); FTIR (NaCl, 
film, cm-1): 3339, 2986, 1641, 1556, 1452, 1369, 1344, 1279, 1134, 910, 741, 700, 681; HRMS 
(TOF ES): found 322.0640, calculated for C12H11F6NONa (M+Na) 322.0643 (0.9 ppm). 
 
N-Cyclopropyl-3,5-bis(trifluoromethyl)benzamide (94mi): was 
obtained according to a typical procedure from cyclopropylamine (748 
μL, 617 mg, 10.8 mmol) and 3,5-bis(trifluoromethyl)- benzoyl chloride 
(780 μL, 1.19 g, 4.30 mmol) as colorless crystalline solid, mp 90-94 
o
C.  Yield 1.12 g (3.78 
mmol, 88%); 
1
H NMR (500.13 MHz, CD3OD) δ ppm 8.41 (s, 2H), 8.14 (s, 1H), 2.91 (tt, J = 7.4 
Hz, 3.8 Hz, 1H), 0.87 - 0.80 (m, 2H), 0.72-0.66 (m, 2H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 
168.2, 138.1, 133.2 (q, 
2
JCF = 33.6 Hz, 2C), 129.1 (q, 
3
JCF = 3.6 Hz, +, 2C), 126.1 (spt, 
3
JCF = 3.6 
Hz, +), 124.7 (q, 
1
JCF = 271.6 Hz, 2C), 24.4 (+), 6.6 (-, 2C); 
19
F NMR (376.50 MHz, CD3OD) δ 
ppm -65.6 (s, 6F); FTIR (NaCl, film, cm-1): 3315, 3086, 3022, 2448, 1641, 1545, 1448, 1375, 
1354, 1277, 1136, 908, 698, 681; HRMS (TOF ES): found 297.0589, calculated for C12H9F6NO 
(M+) 297.0588 (0.3 ppm). 
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N-Phenethyl-3,5-bis(trifluoromethyl)benzamide (94mg), (typical 
procedure): To a stirred solution of phenethylamine (1.36 mL, 1.31 g, 
10.8 mmol, 2.5 equiv.) in dry THF (30 mL) was added 3,5-
bis(trifluoromethyl)benzoyl chloride (780 μL, 1.19 g, 4.30 mmol).  The mixture was stirred for 1 
hr at room temperature, than the solvent was removed in vacuum.  The residue was partitioned 
between 10% aqueous HCl (20 mL) and EtOAc (20 mL).  Organic layer was separated and 
washed consecutively with 10% aqueous HCL (3 x 20 mL) and 4N aqueous NaOH (5 mL), dried 
with MgSO4, filtered and concentrated.  The obtained crystalline material (colorless crystalline 
solid, mp 44-47 
o
C) was pure enough to be used for the following transformation without 
additional purification.  Yield 1.44 g (4.00 mmol, 93%).  
1
H NMR (500.13 MHz, CD3OD) δ ppm 
8.35 (s, 2H), 8.15 (s, 1H), 7.31- 7.25 (m, 4H), 7.22-7.19 (m, 1H), 3.64 (t, J = 7.4 Hz, 2H), 2.94 
(t, J = 7.4 Hz, 2H),; 
13
C NMR (125.76 MHz, CD3OD) δ ppm 166.8, 140.6, 138.4, 133.2 (q, 
2
JCF = 
33.6 Hz, 2C), 130.1 (+, 2C), 129.7 (+, 2C), 129.1 (q, 
3
JCF = 2.7 Hz, +, 2C), 127.6 (+), 126.1 (spt, 
3
JCF = 3.6 Hz, +), 124.7 (q, 
1
JCF = 272.5 Hz, 2C), 43.0 (-), 36.5 (-); 
19
F NMR (376.50 MHz, 
CD3OD) δ ppm -65.7 (s, 6F); FTIR (NaCl, film, cm-1): 3313, 3089, 1647, 1555, 1383, 1279, 
1184, 1134, 908, 700, 681; HRMS (TOF ES): found 384.0793, calculated for C17H13F6NONa 
(M+Na) 313.0901 (1.6 ppm 
 
N-Benzyl-3,5-bis(trifluoromethyl)benzamide (94mf): was 
obtained according to a typical procedure from benzylamine (1.18 
mL, 1.16 g, 10.8 mmol) and 3,5-bis(trifluoromethyl)- benzoyl 
chloride (780 μL, 1.19 g, 4.30 mmol) as colorless crystalline solid, mp 92-95 
o
C.  Yield 1.45 g 
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(4.17 mmol, 97%); 
1
H NMR (500.13 MHz, CD3OD) δ ppm 8.46 (s, 2H), 8.17 (s, 1H), 7.39-7.32 
(m, 4H), 7.28-7.24 (m, 1H), 4.61 (s, 2H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 166.7, 139.8, 
138.2, 133.3 (q, 
2
JCF = 33.6 Hz, 2C), 129.8 (+, 2C), 129.2 (q, 
3
JCF = 2.7 Hz, +, 2C), 128.9 (+, 
2C), 128.5 (+), 126.2 (spt, 
3
JCF = 3.6 Hz, +), 124.7 (q, 
1
JCF = 271.6 Hz, 2C), 45.0 (-); FTIR 
(NaCl, film, cm-1): 3292, 3090, 3069, 1647, 1553, 1454, 1381, 1279, 1184, 1136, 908, 698; 
HRMS (TOF ES): found 370.0645, calculated for C16H11F6NONa (M+Na) 370.0643 (0.5 ppm). 
 
N-tert-Butyl-3,5-bis(trifluoromethyl)benzamide: (94me): 
1
H NMR 
(500.13 MHz, CD3OD) δ ppm 8.34 (s, 2H), 8.11 (s, 1H), 1.48 (s, 9H); 
13
C 
NMR (126 MHz, CD3OD) δ ppm 166.9, 139.8, 133.0 (q, 2JСF = 33.6 Hz, 
2C), 129.2 (q, 
3
JCF = 3.6 Hz, +, 2C), 125.6 (spt, 
3
JCF = 3.6 Hz, +), 124.8 (q, 
1
JCF = 271.6 Hz, 2C), 
53.4, 28.9 (+, 3C); 
19
F NMR (376.50 MHz, CD3OD) δ ppm -65.6 (s, 6F); FTIR (NaCl, film, cm-
1): 3317, 3072, 1645, 1547, 1448, 1364, 1302, 1275, 1144, 1130, 906, 845, 702; HRMS (TOF 
ES): found 313.0896, calculated for C13H23F6NO (M+) 313.0901 (1.6 ppm). 
4-Nitro-N-(thiophen-2-ylmethyl)benzamide (94kj): To a stirred 
solution of 4-nitrobenzoyl chloride (930 mg, 5.0 mmol) in dry 
CH2Cl2 (50.0 mL) was added solution of 2-thiophenemethylamine 
(850 mg, 7.5 mmol) and triethylamine (510 mg, 5.0 mmol) in dry CH2Cl2 (8 mL).   The mixture 
was stirred for 2 h at room temperature, then quencged with 10% aqueous HCl (20 mL).   The 
organic phase was separated, washed consecutively with 10% NaOH and brine, then dried with 
and MgSO4 and concentrated to provide the titled compound pure enough to use at the following 
step without additional purification.   Yield 1.06 g (4.05 mmol, 81%).   
1
H NMR (400.13 MHz, 
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CDCl3) δ 8.29 (d, J = 8.8 Hz, 2H), 7.96 (d, J = 8.8 Hz, 2H), 7.35 – 7.24 (m, 1H), 7.08 (dd, J = 
3.3, 1.2 Hz, 1H), 7.00 (dd, J = 5.1, 3.5 Hz, 1H), 6.69 (s, 1H), 4.85 (dd, J = 5.7, 0.8 Hz, 2H); 
 13
C 
NMR (100.67 MHz, CDCl3) δ 165.20, 149.69, 139.79, 139.65, 128.27 (+, 2C), 127.14 (+), 
126.72 (+), 125.77 (+), 123.88 (+, 2C), 39.10 (-).   FTIR (NaCl, cm
-1
): 3311, 3097, 3068, 1643, 
1596, 1547, 1487, 1425, 1346, 1296, 1251, 1224, 1012, 870, 709 cm
-1
;
 
HRMS (TOF ES): found 
269.0569, calculated for C12H10N2O3SLi (M+Li) 269.0572 (1.1 ppm). 
 
4-Cyano-N-(furan-2-ylmethyl)benzamide (94jk): Compound was 
prepared by adding furfurylamine (850 mg, 8.8 mmol) to a stirred 
solution of 4-cyanobenzoyl chloride (580 mg, 3.5 mmol) in dry 
DCM (15 mL).   The mixture was stirred for 2h at room temperature, then worked up as 
described above for the synthesis of 94kj.   Yield 975 mg (4.3 mmol, 49%).   
1
H NMR (500.13 
MHz, CDCl3) δ 7.91 (d, J = 8.4 Hz, 2H), 7.75 (d, J = 8.4 Hz, 2H), 7.40 (s, 1H), 6.64 (br, 1H), 
6.37 (dd, J = 3.2, 1.9 Hz, 1H), 6.33 (d, J = 3.4 Hz, 1H), 4.66 (d, J = 5.6 Hz, 2H);  
13
C NMR 
(125.76 MHz, CDCl3) δ 165.46, 150.46, 142.56 (+), 138.05, 132.46 (+, 2C), 127.78 (+, 2C), 
117.95, 115.25, 110.63 (+), 108.14 (+), 77.30, 77.04, 76.79, 37.21 (-);  FTIR (NaCl, cm
-1
): 3292, 
3089, 2995, 2972, 1639, 1608, 1546, 1499, 1418, 1350, 1301, 1143, 1072, 1023, 883, 729 cm
-1
; 
 
HRMS (TOF ES): found 249.0637, calculated for C13H10N2O2Li (M+Li) 249.06402 (1.2 ppm).  
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3.5.4: Synthesis of sulfonamide nucleophiles 
 
N-Butylnaphthalene-2-sulfonamide (97gd):  Compound was prepared 
by adding N-butylamine (804 mg, 11 mmol) to a stirred solution of 2-
naphthylenesulfonyl chloride (1.00 g, 4.41 mmol) in dry CH2Cl2 (40 mL).   
The mixture was stirred for 2h followed by quench with 10% aqueous HCl.   The organic phase 
was washed consecutively with 10% NaOH and brine, dried with MgSO4 and concentrated to 
provide the titled compound as white crystalline solid, mp 54-58 
o
C.   Yield  1.06 g (4.01 mmol, 
91%).   
1
H NMR (400.13 MHz, CDCl3) δ 8.47 (s, 1H), 7.99 (d, J = 8.3 Hz, 2H), 7.94 (d, J = 7.7 
Hz, 1H), 7.88 (d, J = 8.6 Hz, 1H), 7.70 – 7.60 (m, 2H), 4.71 (s, 1H) 3.00 (q, J = 6.9 Hz, 2H), 
1.47 (p, J = 7.1 Hz, 2H), 1.30 (h, J = 14.3, 7.3 Hz, 2H), 0.85 (t, J = 7.3 Hz, 3H); 
13
C NMR 
(100.67 MHz, CDCl3) δ 136.73, 134.79, 132.17, 129.51 (+), 129.24 (+), 128.76 (+), 128.46 (+), 
127.92 (+), 127.56 (+), 122.35 (+), 43.02 (-), 31.63 (-), 19.69 (-), 13.53 (+);  FTIR (NaCl, cm
-1
): 
3273, 3053, 2958, 2931, 1587, 1502, 1464, 1427, 1348, 1317, 1244, 1130, 1078, 953, 825, 744, 
642 cm
-1
;
 
HRMS (TOF ES): found 286.0872, calculated for C14H17NO2SNa (M+Na) 286.0878 
(2.1 ppm). 
 
4-Fluoro-N-(furan-2-ylmethyl)benzenesulfonamide (97ik): 
Compound was prepared by adding furfural amine (1.3 g, 13 mmol) to 
a stirred solution of 4-fluorobenzenesulfonyl chloride (1.0 g, 5.3 
mmol) in dry CH2Cl2 (25 mL) and.  The mixture was stirred for 2h and then worked up as 
described above in the protocol for preparation of compound 97gd.   Yield 1.01 g (4.3 mmol, 
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81%).   
1
H NMR (400 MHz, CDCl3) δ 7.84 (dd, J = 8.9, 5.0 Hz, 2H), 7.23 (dd, J = 1.8, 0.9 Hz, 
1H), 7.16 (t, J = 8.6 Hz, 2H), 6.23 (dd, J = 3.2, 1.9 Hz, 1H), 6.11 – 6.09 (m, 1H), 4.98 (s, 1H), 
4.23 (d, J = 6.0 Hz, 2H);  
13
C NMR (101 MHz, Chloroform-d) δ 169.25 , 165.25 (d, J = 255.3 
Hz), 133.54 , 130.23 (d, J = 9.1 Hz, 2C), 116.46 (d, J = 22.5 Hz, 2C), 67.06 , 66.95 , 46.15 , 
42.61 , 38.61 , 30.23 , 21.36 , 20.06 , 14.97 , 13.70 .  
19
F NMR (376 MHz, Chloroform-d) δ -
104.67 – -104.78 (m).  .  Ir (salt plate): ν= 3331, 3087, 2962, 2872, 1645, 1585, 1547, 1475, 
1454, 1392, 1294, 1225, 1205, 1167, 1094 HRMS found C18H24FN2O4S (-H) 383.1441, (0.5 
ppm). 
3.5.2. Synthesis of β-ACC derivatives 
 
N-((1R*,2R*)-2-(tert-Butylcarbamoyl)cyclopropyl)-
Nphenethyl- 3,5-bis(trifluoromethyl)benzamide (95amg): 
(Typical procedure) An oven-dried 10 mL Weaton vial was 
charged with bromocyclopropane 70a (110 mg, 0.5 mmol, 1.0 
equiv), 18-crown-6 (13.2 mg, 0.05 mmol, 10 mol%), KOH (98 
mg, 1.75 mmol, 3.5 equiv), N-Phenethyl- 3,5-bis(trifluoromethyl)benzamide (94mg) (290 mg, 
1.0 mmol, 2.0 equiv), and anhydrous THF (5 mL).  The mixture was stirred at 85 
o
C for 12 hrs, 
then the reaction mixture was filtered into a 100 mL round bottom flask, both the reaction vessel 
and filter were rinsed consecutively with DCM (15 mL) and EtOAc (15 mL), which were 
combined with filtrate.  Silica gel (2.0 g) was added to a filtrate, and then the solvent was 
removed by rotary evaporation.  The residue absorbed onto silica gel was loaded on the top of 
the column packed with silica gel, which was eluted with hexane/EtOAc 1:1 to obtain two 
fractions.  The less polar fraction (Rf 0.54) was identified as non-reacted benzamide 94mg, and 
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the more polar one (Rf 0.23) as the title product, white amorphous solid.  Yield 236 mg (94%, 
0.47 mmol).  
1
H NMR (500.13 MHz, CD3OD)δ ppm 8.02 (s, 1H), 7.64 (s, 2H), 7.38-7.32 (m, 
4H), 7.28-7.25 (m, 1H), 4.11 (ddd, J = 13.7 Hz, 7.3 Hz, 6.0 Hz, 1H), 3.70 (ddd, J = 13.7 Hz, 6.9 
Hz, 6.0 Hz, 1H), 3.10-3.07 (m, 2H), 2.84 (br.  s, 1H), 1.61-1.55 (m, 1H), 1.12 (s, 9H), 1.06-1.01 
(m, 2H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 171.9, 171.0, 141.2, 140.1, 133.1 (q, 
2
JCF = 
33.6 Hz, 2C), 130.3 (+, 2C), 129.9 (+, 2C), 128.6 (q, 
3
JCF = 2.7 Hz, +, 2C), 128.0 (+), 124.5 (q, 
1
JCF = 272.5 Hz), 124.6 (spt, 
3
JCF = 3.6 Hz, +), 52.0, 48.4 (-), 39.3 (+), 34.6 (-), 28.9 (+, 3C), 
28.4 (+), 17.1 (-); 
19
F NMR (376.50 MHz, CD3OD) δ ppm -65.4 (s, 6F); FTIR (NaCl, film, cm-
1): 3342, 3065, 3030, 2970, 2934, 1651, 1545, 1456, 1366, 1281, 1178, 1140, 905, 741, 702, 
681; HRMS (TOF ES): found 501.1964, calculated for C25H27F6N2O2 (M+H) 501.1977 (2.6 
ppm). 
 
(1R*,2R*)-N-tert-butyl-2-(N-
methylacetamido)cyclopropanecarboxamide (95aaa): The reaction 
was performed according to the typical procedure, employing bromocyclopropane 70a (110 mg, 
0.50 mmol) and N-methylacetamide (94aa) (73.1 mg, 1.00 mmol).  The excess of N-
methylacetamide was distilled out in vacuum.  Flash column chromatography on Silica gel 
afforded the title compound as a viscous oil, Rf 0.31 (hexane-EtOAc 1:3).  Yield 106 mg (0.44 
mmol, 88%).  
1
H NMR (500.13 MHz, CDCl3) δ ppm 5.98 (br.  s, 1H), 3.10 (br.  s, 1H), 2.87 (s, 
3H), 2.15 (s, 3H), 1.64 (br.  s, 1H), 1.45 (br, sm 1H), 1.35 (s, 9H), 1.17-1.12 (m, 1H); 
13
C NMR 
(125.76 MHz, CDCl3) δ ppm 173.2, 169.2, 51.5, 38.9 (+), 33.5 (+), 28.8 (+, 3C), 26.2 (+), 22.3 
(+), 16.0 (-); FTIR (NaCl, film, cm-1): 3299, 2964, 2930, 1645, 1556, 1454, 1253, 1111, 960; 
HRMS (TOF ES): found 213.1609, calculated for C11H21N2O2 (M+H) 213.1603 (2.8 ppm). 
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(1R*,2R*)-N-tert-Butyl-2-(N-
butylbutyramido)cyclopropanecarboxamide (95abd): The reaction 
was performed according to the typical procedure, employing 
bromocyclopropane 5a (110 mg, 0.50 mmol) and N-butylbutyramide (94bd) (143 mg, 1.00 
mmol).  The excess of N-butylbutyramide was distilled out in vacuum (Kugelrhor oven 
temperature 110 
o
C at 0.05 torr for 4 hrs) to afford to produce the title compound as a viscous oil, 
which did not require further purification.  Yield 71 mg (0.25 mmol, 51%).  
1
H NMR (500.13 
MHz, DMSO-d6 at 370 K)δ ppm 7.85 (br.  s, 1H), 3.36 (ddd, J = 13.9 Hz, 7.3 Hz, 6.6 Hz, 1H), 
3.14 (ddd, J = 13.6 Hz, 7.9 Hz, 6.0 Hz, 1H), 2.74 (ddd, J = 7.6 Hz, 4.7 Hz, 2.8 Hz, 1H), 2.43 
(ddd, J = 15.5 Hz, 8.5 Hz, 6.9 Hz, 1H), 2.30 (dt, J = 15.5 Hz, 7.8 Hz, 1H), 1.90 (ddd, J = 8.8 Hz, 
6.0 Hz, 2.8 Hz, 1H), 1.54-1.47 (m, 2H), 1.41-1.34 (m, 2H), 1.26 (s, 9H), 1.24- 1.13 (m, 6H), 0.88 
(t, J = 7.3 Hz, 3H), 0.86 (t, J = 7.3 Hz, 3H); 
13
C NMR (125.76 MHz, DMSO-d6 at 370 K) δ ppm 
173.9, 169.1, 54.8 (-), 50.1, 44.0 (-), 36.1 (+), 35.4 (-), 29.6 (-), 28.5 (+), 25.5 (+), 19.5 (-), 17.9 
(-), 14.3 (-), 13.7 (+), 13.6 (+); FTIR (NaCl, film, cm-1): 3323, 2962, 2932, 1639, 1549, 1456, 
1402, 1259, 1094, 912; HRMS (TOF ES): found 370.0645, calculated for C16H11F6NONa 
(M+Na) 370.0643 (0.5 ppm). 
 
N-((1R*,2R*)-2-(tert-Butylcarbamoyl)cyclopropyl)-N-
methylbenzamide (95afa): The reaction was performed according 
to the typical procedure, employing bromocyclopropane 70a (110 
mg, 0.50 mmol) and N-methylbenzamide (94fa) (135 mg, 1.00 mmol).  Flash column 
chromatography on Silica gel (eluent hexane/EtOAc 1:1) afforded two fractions.  The less polar 
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one (Rf 0.28) was identified as non-reacted Nmethylbenzamide, and the more polar one (Rf 
0.14) as the title compound, colorless crystalline solid, mp 108-111 
o
C.  Yield 103 mg (0.375 
mmol, 75%).  
1
H NMR (500.13 MHz, CDCl3) δ ppm 7.52-7.40 (m, 5H), 4.57 (br.  s, 1H), 3.11 
(br.  s, 3H), 1.63 (br.  s, 1H), 1.34-1.25 (br.  m, 2H), 1.20 (br.  s, 9H), 0.92 (br.  m, 1H); 
13
C 
NMR (125.76 MHz, CDCl3) δ ppm 172.3, 168.6, 137.4, 129.7 (+), 128.4 (+, 2C), 127.2 (+, 2C), 
51.1, 39.4 (br, +), 35.0 (br, +), 28.7 (+, 3C), 27.6 (+), 15.0 (br, -); FTIR (NaCl, film, cm-1): 
3325, 2966, 2928, 1632, 1547, 1447, 1389, 1074, 704; HRMS (TOF ES): found 275.1764, 
calculated for C16H23N2O2 (M+H) 275.1760 (1.5 ppm). 
 
N-Butyl-N-((1R*,2R*)-2-(tert-Butylcarbamoyl)cyclopropyl) 
benzamide (95afd): The reaction was performed according to the 
typical procedure, employing bromocyclopropane 70a (110 mg, 
0.50 mmol) and N-butylbenzamide (94fd) (177 mg, 1.00 mmol).  Flash column chromatography 
on Silica gel (eluent hexane/EtOAc 1:1) afforded two fractions.  The less polar one (Rf 0.61) was 
identified as non-reacted N-butylbenzamide, and the more polar one (Rf 0.39) as the title 
compound, colorless crystalline solid, mp 95-97 
o
C.  Yield 115 mg (0.365 mmol, 73%).  
1
H 
NMR (500.13 MHz, DMSO-d6)δ ppm 7.44-7.36 (m, 5H), 7.27 (br.  s, 1H), 3.50-3.36 (br.  m, 
2H), 2.89 (br.  s, 1H), 1.69 (br.  s, 1H), 1.61-1.54 (br.  m, 2H), 1.40-1.29 (br.  m, 2H), 1.15 (br.  s, 
9H), 0.95-0.79 (br.  m, 5H); 
13
C NMR (125.76 MHz, DMSO-d6) δ ppm 171.3, 168.6, 137.5, 
129.1 (+), 128.0 (+, 2C), 126.7 (+, 2C), 49.9, 44.9 (br., -), 37.4 (br., +), 29.3 (-), 28.4 (+, 3C), 
25.7 (br., +), 19.5 (-), 15.8 (br., -),13.6 (+); FTIR (NaCl, film, cm-1): 3325, 292, 2930, 2872, 
1626, 1547, 1448, 1400, 1053, 791, 729, 702; HRMS (TOF ES): found 317.2245, calculated for 
C19H29N2O2 (M+H) 317.2229 (5.0 ppm). 
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N-Butyl-N-((1R,2R)-2-(tert-butylcarbamoyl)cyclopropyl)- 4-
chlorobenzamide (95aid): The reaction was performed 
according to the typical procedure, employing 
bromocyclopropane 70a (110 mg, 0.50 mmol) and Nbutyl- 4-chlorobenzamide (94id) (212 mg, 
1.00 mmol).  Flash column chromatography on Silica gel (eluent hexane/EtOAc 1:1) afforded 
two fractions.  The less polar one (Rf 0.44) was identified as non-reacted benzamide, and the 
more polar one (Rf 0.20) as the title compound, a colorless crystalline solid, mp 162-164 
o
C.  
Yield 142 mg (0.41 mmol, 81%).  
1
H NMR (500.13 MHz, CD3OD)δ ppm 7.44 (s, 4H), 3.85 (br.  
s, 1H), 3.27 (ddd, J = 13.7 Hz, 7.7 Hz, 5.7 Hz, 1H), 3.11 (br.  s, 1H), 1.76-1.66 (m, 2H), 1.53 (br.  
s, 1H), 1.48-1.42 (m, 2H), 1.20 (s, 9H), 1.14 (br.  s, 1H), 1.07 (br.  s, 1H), 1.01 (br.  s, 3H); 
13
C 
NMR (125.76 MHz, CD3OD) δ ppm 173.9, 171.5, 137.3, 136.9, 130.1 (+, 2C), 129.9 (+, 2C), 
52.0, 47.4 (-), 39.5 (+), 31.0 (-), 28.9 (+, 3C), 21.3 (-), 16.6 (-), 14.3 (+); FTIR (NaCl, film, cm-
1): 3333, 3065, 3053, 2966, 2932, 1668, 1630, 1553, 1435, 1418, 1315, 1256, 1225, 1209, 1090, 
843, 756, 636; HRMS (TOF ES): found 373.1644, calculated for C19H27ClN2O2Na (M+Na) 
373.1659 (4.0 ppm). 
 
N-Butyl-N-((1R*,2R*)-2-(tert-butylcarbamoyl)cyclopropyl)- 
4-cyanobenzamide (95ajd): The reaction was performed 
according to the typical procedure, employing 
bromocyclopropane 70a (110 mg, 0.50 mmol) and N-butyl-4-cyanobenzamide (94jd) (202 mg, 
1.00 mmol).  Flash column chromatography on Silica gel (eluent hexane/EtOAc 1:2) afforded 
two fractions.  The less polar one (Rf 0.73) was identified as non-reacted benzamide, and the 
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more polar one (Rf 0.47) as the title compound, a colorless crystalline solid, mp 136-140 
o
C.  
yield 136 mg (0.40 mmol, 80%).  
1
H NMR (500.13 MHz, CD3OD)δ ppm 7.81 (d, J = 8.2 Hz, 
2H), 7.61 (d, J = 8.2 Hz, 2H), 7.23 (br.  s, 1H), 3.86-3.79 (m, 1H), 3.34-3.28 (m, 1H), 3.09 (br.  
s, 1H), 1.78-1.66 (m, 2H), 1.53 (br.  s, 1H), 1.49-1.42 (m, 2H), 1.19 (s, 9H), 1.14-1.04 (m, 2H), 
1.02 (t, J = 7.3 Hz, 3H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 173.0, 171.4, 143.2, 133.8 (+, 
2C), 129.0 (+, 2C), 119.4, 114.7, 52.1, 47.4 (-), 39.3 (+), 30.9 (-), 29.0 (+, 3C), 28.7 (+), 21.3 (-), 
16.7 (-), 14.3 (+); FTIR (NaCl, film, cm-1): 3339, 2962, 2932, 2230, 1634, 1547, 1418, 1398, 
1310, 1258, 1275, 1225, 1207, 1107, 849, 764, 737; HRMS (TOF ES): found 342.2169, 
calculated for C20H28N3O2 (M+H) 342.2182 (3.8 ppm). 
 
N-Butyl-N-((1R*,2R*)-2-(tert-
butylcarbamoyl)cyclopropyl)-4-nitrobenzamide (95akd): 
The reaction was performed according to the typical 
procedure, employing bromocyclopropane 70a (110 mg, 0.50 mmol) and N-butyl-4-
nitrobenzamide (94kd) (222 mg, 1.00 mmol).  Flash column chromatography on Silica gel 
(eluenthexane/EtOAc 1:2) afforded two fractions.  The less polar one (Rf 0.77) was identified as 
non-reacted benzamide, and the more polar one (Rf 0.36) as the title compound, yellowish 
crystalline solid, mp 143-145 
o
C.  Yield 145 mg (0.40 mmol, 80%).  
1
H NMR (500.13 MHz, 
CD3OD)δ ppm 8.32 (d, J = 8.5 Hz, 2H), 7.68 (d, J = 8.5 Hz, 2H), 4.61 (br.  s, 1H), 3.86 (ddd, J = 
14.2 Hz, 7.6 Hz, 6.6 Hz, 1H), 3.10 (br.  s, 1H), 1.78-1.70 (m, 2H), 1.54 (br.  s, 1H), 1.50-1.44 (m, 
2H), 1.35-1.25 (m, 3H), 1.10 (s, 9H), 1.02 (t, J = 7.3 Hz, 3H); 
13
C NMR (125.76 MHz, CD3OD) δ 
ppm 172.8, 171.3, 149.9, 144.9, 129.4 (+, 2C), 125.1 (+, 2C), 51.9, 47.4 (-), 39.3 (+), 30.9 (-), 
29.1 (+), 28.9 (+, 3C), 21.3 (-), 16.6 (-), 14.3 (+); FTIR (NaCl, film, cm-1): 3335, 2961, 2928, 
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1634, 1524, 1456, 1348, 1312, 1259, 1105, 864, 735; HRMS (TOF ES): found 362.2068, 
calculated for C19H28N3O4 (M+H) 362.2080 (3.3 ppm). 
 
N-Butyl-N-((1R*,2R*)-2-(tert-
butylcarbamoyl)cyclopropyl)-4-
(trifluoromethyl)benzamide (94ald): The reaction was 
performed according to the typical procedure, employing bromocyclopropane 70aa (110 mg, 
0.50 mmol) and N-butyl(p-triflouromethyl)benzamide (94ld) (245 mg, 1.00 mmol).  Flash 
column chromatography on Silica gel (eluent hexane/EtOAc 1:1) afforded two fractions.  The 
less polar one (Rf 0.60) was identified as non-reacted benzamide, and the more polar one (Rf 
0.22) as the title compound, colorless crystalline solid, mp 158-161 
o
C.  Yield 163.5 mg (0.425 
mmol, 85%).  
1
H NMR (500.13 MHz, CD3OD)δ ppm 7.74 (d, J = 7.9 Hz, 2H), 7.64 (d, J = 7.9 
Hz, 2H), 4.04 (br.  s, 1H), 3.06 (br.  s, 1H), 1.96-1.84 (m, 4H), 1.75-1.70 (m, 2H), 1.60 (br.  s, 
1H), 1.44-1.29 (m, 3H), 1.19 (s, 9H), 1.07-1.02 (m, 2H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 
173.5, 171.9, 143.0, 132.6 (q, 
2
JCF = 32.1 Hz), 129.1 (+, 2C), 126.7 (q, 
3
JCF = 3.7 Hz, +, 2C), 
125.5 (q, 
1
JCF = 271.3 Hz), 52.1, 52.0 (-), 32.5 (+), 32.2 (-), 28.9 (+, 3C), 27.44 (+), 27.38 (-), 
27.0 (-), 17.5 (br, +); 
19
F NMR (376.50 MHz, CDCl3) δ ppm -62.6 (s, 3F); FTIR (NaCl, film, 
cm-1): 3335, 2928, 2854, 1628, 1549, 1323, 1167, 1130, 1067, 854, 737, 652, 592; HRMS (TOF 
ES): found 407.1941, calculated for C20H27F3N2O2Na (M+Na) 407.1922 (4.7 ppm).  
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N-Butyl-N-((1R*,2R*)-2-(tert-
butylcarbamoyl)cyclopropyl)-3,5-
bis(trifluoromethyl)benzamide (95amd): The reaction was 
performed according to the typical procedure, employing bromocyclopropane 70a (110 mg, 0.50 
mmol) and N-butyl-3,5-bis(triflouromethyl)benzamide (94md) (313 mg, 1.00 mmol).  Flash 
column chromatography on Silica gel (eluent hexane/EtOAc 1:2) afforded two fractions.  The 
less polar one (Rf 0.75) was identified as non-reacted benzamide, and the more polar one (Rf 
0.38) as the title compound, a colorless amorphous solid.  Yield 180 mg (0.40 mmol, 80%).  
1
H 
NMR (500.13 MHz, CD3OD)δ ppm 8.08 (s, 1H), 8.05 (s, 2H), 3.76-3.69 (m, 1H), 3.46-3.39 (m, 
1H), 3.18 (br.  s, 1H), 1.80-1.68 (m, 2H), 1.62 (br.  s, 1H), 1.50-1.42 (m, 2H), 1.14 (s, 9H), 1.11-
1.05 (m, 2H), 1.05-0.99 (m, 3H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 171.6, 171.2, 141.4, 
133.2 (q, 
2
JCF = 33.6 Hz, 2C), 128.8 (+, 2C), 124.6 (+), 124.6 (q, 
1
JCF =272.5 Hz), 52.0, 47.6 (-), 
39.2 (+), 30.9 (-), 28.9 (+, 3C), 28.4 (+), 21.4 (-), 17.3 (-), 14.3 (+); 
19
F NMR(376.50 MHz, 
CD3OD) δ ppm -65.4 (s, 6F); FTIR (NaCl, film, cm-1): 3344, 2966, 2933, 2876, 1643, 1545, 
1456, 1427, 1398, 1366, 1279, 1171, 1140, 903, 681; HRMS (TOF ES): found 475.1818, 
calculated for C21H26F6N2O2Na (M+Na) 475.1796 (4.6 ppm). 
 
N-((1R*,2R*)-2-(tert-Butylcarbamoyl)cyclopropyl)-
Nphenethyl-4-(trifluoromethyl)benzamide (95alg): The 
reaction was performed according to the typical procedure, 
employing bromocyclopropane 70a (110 mg, 0.50 mmol) and 
N-phenethyl-(p-triflouromethyl)- benzamide (94lg) (293 mg, 1.00 mmol).  Flash column 
chromatography on Silica gel (eluent hexane/EtOAc 1:1) afforded two fractions.  The less polar 
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one (Rf 0.68) was identified as non-reacted benzamide, and the more polar one (Rf 0.36) as the 
title compound, a colorless crystalline solid, mp 146-147 
o
C.  Yield 178 mg (0.41 mmol, 82%).  
1
H NMR (500.13 MHz, CD3OD)δ ppm 7.70 (d, J = 7.6 Hz, 2H), 7.42 (d, J = 7.6 Hz, 2H), 7.37-
7.33 (m, 3H) 7.28-7.24 (m, 2H), 4.10 (ddd, J = 13.3 Hz, 7.3 Hz, 6.6 Hz, 1H), 3.65 (ddd, J = 13.3 
Hz, 6.6 Hz, 6.3 Hz, 1H), 3.10-3.03 (m, 2H), 2.91 (br.  s, 1H), 1.56 (br.  s, 1H), 1.15 (s, 9H), 1.08-
0.96 (m, 2H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 173.5, 171.3, 142.3, 140.2, 132.6 (q, 
2
JCF 
= 31.8 Hz), 130.2 (+, 2C), 129.8 (+, 2C), 128.8 (+, 2C), 127.9 (+), 126.7 (+, 2C), 125.4 (q, 
1
JCF = 
271.6 Hz), 51.9, 49.2 (-), 39.5 (+), 34.8 (-), 28.9 (+, 3C), 28.5 (+), 16.8 (-); 
19
F NMR (376.50 
MHz, CD3OD) δ ppm - 65.2 (s, 3F); FTIR (NaCl, film, cm-1): 3337, 2970, 1639, 1547, 1454, 
1420, 1325, 1167, 1130, 1067, 851, 741, 700; HRMS (TOF ES): found 433.2113, calculated for 
C24H28F3N2O2 (M+H) 433.2103 (2.3 ppm). 
 
N-((1R*,2R*)-2-(tert-Butylcarbamoyl)cyclopropyl)-N-octyl- 
4-(trifluoromethyl)benzamide (95ale): The reaction was 
performed according to the typical procedure, employing 
bromocyclopropane 70a (110 mg, 0.50 mmol) and N-octyl-4-(triflouromethyl)benzamide (94le) 
(301 mg, 1.00 mmol).  Flash column chromatography on Silica gel (eluent hexane/EtOAc 3:1) 
afforded two fractions.  The less polar one (Rf 0.57) was identified as non-reacted benzamide, 
and the more polar one (Rf 0.15) as the title compound, a colorless amorphous solid.  Yield 187 
mg (0.43 mmol, 85%).  
1
H NMR (500.13 MHz, CD3OD)δ ppm 7.75 (d, J = 8.2 Hz, 2H), 7.64 (d, 
J = 8.2 Hz, 2H), 7.31 (br.  s, 1H), 3.83-3.77 (m, 1H), 3.38-3.32 (m, 1H), 3.14 (br.  s, 1H), 1.79-
1.69 (m, 2H), 1.60 (br.  s, 1H), 1.45-1.29 (m, 10H), 1.16 (s, 9H), 1.12-1.04 (m, 2H), 0.91 (t, J = 
7.3 Hz, 3H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 173.3, 171.5, 142.5, 132.6 (q, 
2
JCF = 32.7 
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Hz), 128.9 (+, 2C), 126.8 (q, 
3
JCF = 3.6 Hz, +, 2C), 125.5 (q, 
1
JCF = 271.6 Hz), 52.1, 47.7 (-), 
39.2 (+), 33.2 (-), 30.5 (-, 2C), 28.9 (+, 3C), 28.8 (-), 28.5 (+), 28.2 (-), 23.9 (-), 16.9 (-), 14.6 
(+); 
19
F NMR (376.50 MHz, CD3OD) δ ppm -65.2 (s, 3F); FTIR (NaCl, film, cm-1): 3337, 2961, 
2930, 2856, 1632, 1547, 1456, 1421, 1402, 1325, 1258, 1227, 1167, 1130, 851, 613; HRMS 
(TOF ES): found 463.2533, calculated for C24H35F3N2O2Na (M+Na) 463.2548 (3.2 ppm). 
 
N-Benzyl-N-((1R*,2R*)-2-(tert-
butylcarbamoyl)cyclopropyl)-4-
(trifluoromethyl)benzamide (95alf): The reaction was 
performed according to the typical procedure, employing bromocyclopropane 70a (110 mg, 0.50 
mmol) and N-benzyl-4-(triflouromethyl)benzamide (94lf) (279 mg, 1.00 mmol).  Flash column 
chromatography on Silica gel (eluent hexane/EtOAc 3:1) afforded two fractions.  The less polar 
one (Rf 0.40) was identified as non-reacted benzamide, and the more polar one (Rf 0.13) as the 
title compound, a colorless crystalline solid, mp 163-167 
o
C.  Yield 168 mg (0.40 mmol, 80%).  
1
H NMR (500.13 MHz, CD3OD)δ ppm 7.77 (d, J = 8.2 Hz, 2H), 7.67 (d, J = 8.2 Hz, 2H), 7.42-
7.36 (m, 4H), 7.34-7.30 (m, 1H), 4.88 (d, J = 14.2 Hz, 1H), 4.73 (d, J = 14.2 Hz, 1H), 2.96 (br.  s, 
1H), 1.67 (br.  s, 1H), 1.15 (s, 9H), 1.02 (br.  s, 1H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 
173.4, 171.4, 142.1, 138.6, 132.8 (q, 
2
JCF = 32.7 Hz), 130.1 (+, 2C), 129.3 (+, 2C), 128.9 (+, 2C), 
128.9 (+), 126.8 (q, 
3
JCF = 3.6 Hz, +, 2C), 125.5 (q, 
1
JCF = 271.6 Hz), 52.0, 51.3 (-), 39.4 (+), 
28.9 (+, 3C), 28.1 (+), 17.1 (-); 
19
F NMR (376.50 MHz, CD3OD) δ ppm -65.3 (s, 3F); FTIR 
(NaCl, film, cm-1): 2979, 2934, 1636, 1454, 1418, 1325, 1169, 1130, 1067, 851, 702; HRMS 
(TOF ES): found 419.1926, calculated for C23H26F3N2O2 (M+H) 419.1946 (4.8 ppm). 
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N-((1R*,2R*)-2-(tert-Butylcarbamoyl)cyclopropyl)-
Ncyclohexyl-4-(trifluoromethyl)benzamide (95alh): The 
reaction was performed according to the typical procedure, 
employing bromocyclopropane 70a (110 mg, 0.50 mmol) and N-cyclohexyl-4-
(triflouromethyl)benzamide (94lh) (271 mg, 1.00 mmol).  Flash column chromatography on 
Silica gel (eluent hexane/EtOAc 3:1) afforded two fractions.  The less polar one (Rf 0.58) was 
identified as non-reacted benzamide, and the more polar one (Rf 0.21) as the title compound, a 
colorless crystalline solid, mp 160-163 
o
C.  Yield 92 mg (0.225 mmol, 45%).  
1
H NMR (500.13 
MHz, CD3OD)δ ppm 7.74 (d, J = 8.2 Hz, 2H), 7.64 (d, J = 8.2 Hz, 2H), 4.06 (br.  s, 1H), 3.07 (br.  
s, 1H), 1.99- 1.83 (m, 6H), 1.78-1.69 (m, 2H), 1.60 (br.  s, 1H), 1.46-1.36 (m, 2H), 1.18 (s, 9H), 
1.10- 1.00 (m, 2H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 173.4, 171.9, 142.9, 132.6 (q, 
2
JCF = 
31.8 Hz), 129.1 (+, 2C), 126.7 (q, 
3
JCF = 3.6 Hz, +, 2C), 125.5 (q, 
1
JCF = 271.6 Hz), 60.6 (+), 
52.0, 37.2 (+), 32.5 (-), 32.1 (-), 28.9 (+, 3C), 27.7 (+), 27.44 (-), 27.38 (-), 27.0 (-), 17.5 (-); 
19
F 
NMR (376.50 MHz, CD3OD) δ ppm -65.3 (s, 3F); FTIR (NaCl, film, cm-1): 3337, 2934, 2858, 
1628, 1547, 1454, 1418, 1323, 1167, 1130, 1067, 854, 735; HRMS (TOF ES): found 417.2343, 
calculated for C22H29F3N2O2Li (M+Li) 417.2341 (0.5 ppm). 
 
N-((1R*,2R*)-2-(tert-Butylcarbamoyl)cyclopropyl)-N-
cyclohexyl- 3,5-bis(trifluoromethyl)benzamide (95amh): 
The reaction was performed according to the typical 
procedure, employing bromocyclopropane 70a (110 mg, 0.50 mmol) and N-cyclohexyl-3.5-
bis(triflouromethyl)- benzamide (94mh) (339 mg, 1.00 mmol).  Flash columnchromatography on 
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Silica gel (eluent hexane/EtOAc 5:1) afforded two fractions.  The less polar one (Rf 0.58) was 
identified as non-reacted benzamide, and the more polar one (Rf 0.19) as the title compound, a 
colorless crystalline solid, mp 140-141 
o
C.  Yield 198 mg (0.42 mmol, 83%).  
1
H NMR (500.13 
MHz, CD3OD)δ ppm 8.07 (s, 3H), 4.02 (br.  s, 1H), 3.09 (br.  s, 1H), 2.03-1.98 (m, 2H), 1.94-
1.84 (m, 3H), 1.76-1.70 (m, 2H), 1.66 (br.  s, 1H), 1.18 (s, 9H), 1.06-0.99 (m, 2H); 
13
C NMR 
(126 MHz, MeOD) δ ppm 171.7, 171.5, 141.8, 133.1 (q, 
2
JCF = 33.6 Hz, 2C), 129.0 (q, 
3
JCF = 2.7 
Hz, +, 2C), 124.5 (spt, 
3
JCF = 3.6 Hz, +), 124.7 (q, 
1
JCF = 272.5 Hz), 60.9 (+), 52.1, 37.2 (+), 32.3 
(-), 32.1 (-), 29.0 (+), 28.0 (+), 27.39 (-), 27.36 (-), 27.0 (-), 17.7 (-); 
19
F NMR (376.50 MHz, 
CD3OD) δ ppm -65.4 (s, 6F); FTIR (NaCl, film, cm-1): 3337, 2935, 2856, 1630, 1547, 1356, 
1281, 1184, 1138, 905, 683; HRMS (TOF ES): found 479.2122, calculated for C23H29F6N2O2 
(M+H) 479.2133 (2.3 ppm). 
 
N-((1R*,2R*)-2-(tert-butylcarbamoyl)cyclopropyl)-N-
isopropyl- 3,5-bis(trifluoromethyl)benzamide (95amc): The 
reaction was performed according to the typical procedure, 
employing bromocyclopropane 70a (110 mg, 0.50 mmol) and N-isopropyl-3,5-
bis(triflouromethyl)benzamide (94mc) (299 mg, 1.00 mmol).  Flash column chromatography on 
Silica gel (eluent hexane/ EtOAc 3:1) afforded two fractions.  The less polar one (Rf 0.58) was 
identified as non-reacted benzamide, and the more polar one (Rf 0.19) as the title compound, a 
colorless amorphous solid.  Yield 134 mg (0.31 mmol, 61%).  
1
H NMR (500.13 MHz, CD3OD)δ 
ppm 8.09 (s, 2H), 8.07 (s, 1H), 4.38 (br.  s, 1H), 3.10 (br.  s, 1H), 1.70-1.65 (m, 1H), 1.45 (d, J = 
6.9 Hz, 3H), 1.39 (d, J = 6.9 Hz, 3H), 1.17 (s, 9H), 1.06-1.02 (m, 2H); 
13
C NMR (125.76 MHz, 
CD3OD) δ ppm 171.8, 171.5, 141.8, 133.1 (q, 
2
JCF = 33.6 Hz, 2C), 129.0 (q, 
3
JCF = 2.7 Hz, +, 
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2C), 124.6 (spt, 
3
JCF = 3.6 Hz, +), 124.7 (q, 
1
JCF = 271.6 Hz, 2C), 52.4 (+), 52.1, 37.1 (+), 29.0 
(+, 3C), 27.7 (+), 21.3 (+), 21.0 (+), 17.4 (-); 
19
F NMR (376.50 MHz, CD3OD) δ ppm -65.4 (s, 
6F); FTIR (NaCl, film, cm-1): 3342, 2976, 2937, 2494, 1634, 1427, 1346, 1281, 1184, 1140, 
905, 681; HRMS (TOF ES): found 461.1618, calculated for C20H24F6N2O2Na (M+Na) 461.1640 
(4.8 ppm). 
 
N-((1R*,2R*)-2-(tert-Butylcarbamoyl)cyclopropyl)-N-
cyclopropyl- 3,5-bis(trifluoromethyl)benzamide (95ami): 
The reaction was performed according to the typical 
procedure, employing bromocyclopropane 70a (110 mg, 0.50 mmol) and N-cyclopropyl-3.5-
bis(triflouromethyl)- benzamide (94mi) (297 mg, 1.00 mmol).  Flash column chromatography on 
Silica gel (eluent hexane/ EtOAc 1:1) afforded two fractions.  The less polar one (Rf 0.51) was 
identified as non-reacted benzamide, and the more polar one (Rf 0.21) as the title compound, a 
colorless crystalline solid, mp 148-151 
o
C.  Yield 129 mg (0.30 mmol, 59%).  
1
H NMR (500.13 
MHz, CD3OD)δ ppm 8.14 (s, 2H), 8.09 (s, 1H), 7.42 (br.  s, 1H), 3.10 (br.  s, 1H), 2.79 (br.  s, 
1H), 1.78 (br.  s, 1H), 1.45-1.04 (m, 11H), 0.96-0.62 (m, 4H); 
13
C NMR (125.76 MHz, CD3OD) δ 
ppm 173.1, 171.8, 140.8, 132.9 (q, 
2
JCF = 33.6 Hz, 2C), 129.3 (+, 2C), 124.8 (+), 124.5 (q, 
1
JCF = 
272.5 Hz, 2C), 52.0, 51.9 (+), 39.4 (br.  s, +), 31.4 (br.  s, +),28.9 (+, 3C), 16.7 (br.  s, -), 9.3 (br.  
s, -, 2C); 
19
F NMR (376.50 MHz, CD3OD) δ ppm -65.5 (s, 6F); FTIR (NaCl, film, cm-1): 3340, 
2966, 2933, 1651, 1545, 1458, 1424, 1364, 1281, 1173, 1140, 905, 681; HRMS (TOF ES): found 
437.1661, calculated for C20H23F6N2O2 (M+H) 437.1664 (0.7 ppm). 
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N-Butyl-N-((1R*,2R*)-2-(morpholine-4-
carbonyl)cyclopropyl)- 3,5-bis(trifluoromethyl)benzamide 
(95emd): The reaction was performed according to the 
typical procedure, employing bromocyclopropane 70b (117 mg, 0.50 mmol) and N-butyl-3,5-
bis(triflouromethyl)- benzamide (94md) (313 mg, 1.00 mmol).  Flash chromatography on silica 
gel (eluent hexane/EtOAc 2:1) afforded two fractions.  The less polar one (Rf 0.72) was 
identified as non-reacted benzamide, and the more polar one (Rf 0.13) as the title compound, a 
white solid mp 69-71 
o
C.  Yield 171.7 mg (0.37 mmol, 74%); 
1
H NMR (400.13 MHz, CD3OD) δ 
ppm 8.14 (s, 1H) 8.10 (s, 2H), 3.84 (br.  s, 1H), 3.56-3.33 (m, 8H), 3.15 (br.  s, 1H), 3.04 (br.  s, 
1H), 2.08 (br.  s, 1H), 1.83-1.68 (m, 2H), 1.53-1.14 (5H), 1.05-0.98 (m, 3H), 0.80 (br.  s, 1H); 
13
C NMR (100.67 MHz, CD3OD) δ ppm 170.7, 170.6, 141.0, 133.0 (q, 
2
JCF = 32.3 Hz, 2C), 129.2 
(+, 2C), 124.7 (spt, 
3
JCF = 3.7 Hz, +), 124.6 (q, 
1
JCF = 272.2 Hz, 2C), 67.7 (-), 67.6 (-), 48.1 (-), 
47.0 (-), 43.7 (-), 40.5 (+), 30.9 (-), 24.4 (+), 21.4 (-), 18.8 (-), 14.3 (+); 
19
F NMR (376.50 MHz, 
CD3OD) δ ppm -65.4 (s, 6F); FTIR (NaCl, film, cm-1): 2962, 2932, 2862, 1645, 1464, 1448, 
1425, 1362, 1281, 1184, 1171, 1136, 1119, 905, 849, 757, 704, 681; HRMS (TOF ES): found 
466.1698, calculated for C21H24F6N2O3 (M+) 466.1691 (1.5 ppm). 
 
N-((1R*,2R*)-2-(Morpholine-4-carbonyl)cyclopropyl)- N-
phenethyl-3,5-bis(trifluoromethyl)benzamide (95bmg): 
The reaction was performed according to the typical 
procedure, employing bromocyclopropane 70b (117 mg, 0.50 
mmol) and N-phenethyl-3,5-bis(triflouromethyl)- benzamide (94mg) (313 mg, 1.00 mmol).  
Flash chromatography on silica gel (eluent hexane/EtOAc 2:1) afforded two fractions.  The less 
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polar one (Rf 0.69) was identified as non-reacted benzamide, and the more polar one (Rf 0.10) as 
the title compound, a colorless viscous oil.  Yield 195 mg (0.38 mmol, 76%); 
1
H NMR (500.13 
MHz, CD3OD)δ ppm 8.10 (s, 1H), 7.79 (s, 2H), 7.39- 7.32 (m, 4H), 7.28-7.23 (m, 1H), 4.15 (dt, J 
= 13.2 Hz, 6.6 Hz, 1H), 3.73-3.63 (m, 3H), 3.53-3.41 (m, 5H), 3.16-3.01 (m, 4H), 2.02 (br.  s, 
1H), 1.20-1.15 (m, 1H), 1.13-1.08 (m, 1H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 171.1, 
170.5, 140.9, 140.2, 133.0 (q, 
2
JCF = 33.6 Hz), 130.4 (+, 2C), 129.9 (+, 2C), 129.1 (+, 2C), 128.0 
(+), 124.7 (+, 2C), 124.6 (q, 
1
JCF = 271.6 Hz), 67.8 (-), 67.6 (-), 49.3 (-), 47.0 (-), 43.7 (-), 40.8 
(+), 34.6 (-), 24.4 (+), 18.9 (-); 
19
F NMR (376.50 MHz, CD3OD) δ ppm -65.5 (s, 6F); FTIR 
(NaCl, film, cm-1): 2924, 2890, 1645, 1456, 1423, 1366, 1280, 1236, 1177, 1136, 905, 752, 702; 
HRMS (TOF ES): found 515.1765, calculated for C25H25F6N2O3 (M+H) 515.1769 (0.8 ppm); 
 
N-Phenethyl-N-((1R*,2R*)-2-(piperidine-1-carbonyl)- 
cyclopropyl)-3,5-bis(trifluoromethyl)benzamide (95cmg): 
The reaction was performed according to the typical 
procedure, employing bromocyclopropane 70c (115 mg, 0.50 
mmol) and N-phenethyl-3,5-bis(triflouromethyl)- benzamide (94mg) (313 mg, 1.00 mmol).  
Flash chromatography on silica gel (eluent hexane/EtOAc 2:1) afforded two fractions.  The less 
polar one (Rf 0.69) was identified as non-reacted benzamide, and the more polar one (Rf 0.21) as 
the title compound, a colorless viscous oil.  Yield 195 mg (0.38 mmol, 76%); 
1
H NMR (500.13 
MHz, CD3OD)δ ppm 8.07 (s, 1H), 7.80 (s, 2H), 7.40- 7.33 (m, 4H), 7.29-7.24 (m, 1H), 4.16 (ddd, 
J = 12.9 Hz, 6.6 Hz, 6.3 Hz, 1H), 3.72-3.64 (m, 1H), 3.56-3.49 (m, 1H), 3.16-2.98 (m, 4H), 2.06-
2.00 (m, 1H), 1.75-1.50 (m, 4H), 1.44-1.33 (m, 4H), 1.18-1.12 (m, 1H), 1.10-1.05 (m, 1H); 
13
C 
NMR (125.76 MHz, CD3OD) δ ppm 171.2, 169.8, 140.9, 140.2, 132.9 (q, 
2
JCF = 33.6 Hz, 2C), 
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130.3 (+, 2C), 129.8 (+, 2C), 129.0 (+, 2C), 128.0 (+), 124.6 (+), 124.6 (q, 
1
JCF = 272.5 Hz, 2C), 
49.3 (- ), 47.7 (-), 44.5 (-), 40.6 (+), 34.6 (-), 27.8 (-), 26.6 (-), 25.5 (-), 24.5 (+), 18.6 (-); 
19
F 
NMR (376.50 MHz, CD3OD) δ ppm -65.5 (s, 6F); HRMS (TOF ES): found 519.2058, calculated 
for C26H26F6N2O2Li (M+Li) 519.2059 (0.2 ppm); 
 
N-Benzyl-N-((1R*,2R*)-2-(piperidine-1-
carbonyl)cyclopropyl)- 3,5-bis(trifluoromethyl)benzamide 
(95cmf): The reaction was performed according to the typical 
procedure, employing bromocyclopropane 70c (116 mg, 0.50 mmol) and N-benzyl-3,5-
bis(triflouromethyl)benzamide (94mf) (347 mg, 1.00 mmol).  Flash column chromatography on 
Silica gel (eluent hexane/ EtOAc 1:1) afforded two fractions.  The less polar one (Rf 0.61) was 
identified as non-reacted benzamide, and the more polar one (Rf 0.21) as the title compound, a 
colorless viscous oil.  Yield 170 mg (0.34 mmol, 68%).  
1
H NMR (500.13 MHz, CD3OD)δ ppm 
8.12 (s, 3H), 7.44-7.35 (m, 4H), 7.35-7.29 (m, 1H), 5.06 (d, J = 14.5 Hz, 1H), 4.58 (d, J = 14.5 
Hz, 1H), 3.49 (dt, J = 13.2 Hz, 5.0 Hz, 1H), 3.22 (br.  s, 1H), 3.07 (br.  s, 1H), 2.93 (br.  s, 1H), 
2.07 (br.  s, 1H), 1.63- 1.49 (m, 3H), 1.40-1.27 (m, 4H), 1.14 (br.  s, 1H), 1.03 (br.  s, 1H); 
13
C 
NMR (126 MHz, MeOD) δ ppm 171.1, 169.9, 140.6, 138.6, 133.0 (q, 
2
JCF = 33.6 Hz, 2C), 130.1 
(+, 4C), 129.2 (+, 2C), 128.9 (+), 124.8 (spt, 
3
JCF = 3.6 Hz, +), 124.6 (q, 
1
JCF = 272.5 Hz, 2C), 
52.0 (-), 47.6 (-), 44.5 (-), 40.6 (+), 27.8 (-), 26.6 (-), 25.5 (-), 24.1 (+), 18.5 (-); 
19
F NMR 
(376.50 MHz, CD3OD) δ ppm -65.4 (s, 6F); FTIR (NaCl, film, cm-1): 3088, 3064, 3032, 3009, 
2941, 2858, 1643, 1452, 1364, 1281, 1184,1138, 905, 849, 700, 681; HRMS (TOF ES): found 
499.1817, calculated for C25H25F6N2O2 (M+H) 499.1820 (0.6 ppm). 
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N-Cyclohexyl-N-((1R*,2R*)-2-(cyclohexylcarbamoyl) 
cyclopropyl)-3,5-bis(trifluoromethyl)benzamide 
(95dmh): The reaction was performed according to the 
typical procedure, employing bromocyclopropane 70d (123 mg, 0.50 mmol) and N-cyclohexyl-
3,5- bis(triflouromethyl)-benzamide (94mh) (339 mg, 1.00 mmol).  Flash chromatography on 
silica gel (eluent hexane/EtOAc 2:1) afforded two fractions.  The less polar one (Rf 0.78) was 
identified as non-reacted benzamide, and the more polar one (Rf 0.31) as the title compound, a 
colorless viscous oil.  Yield 166 mg (0.33 mmol, 66%); 
1
H NMR (500.13 MHz, CD3OD)δ ppm 
8.09 (s, 2H), 8.06 (s, 1H), 4.06 (br.  s, 1H), 3.48- 3.41 (m, 1H), 3.19 (br.  s, 1H), 2.04-1.97 (m, 
1H), 1.93-1.84 (m, 3H), 1.76-1.58 (m, 9H), 1.46-1.00 (m, 11H); 
13
C NMR (125.76 MHz, 
CD3OD) δ ppm 171.4 (2C), 141.5, 133.0 (q, 
2
JCF = 34.5 Hz, 2C), 129.2 (s, +, 2C), 124.7 (spt, 
3
JCF 
= 3.6 Hz, +), 124.7 (q, 
1
JCF = 271.6 Hz, 2C), 60.8 (+), 49.9 (+), 37.3 (+), 33.93 (-), 33.85 (-), 32.4 
(-), 32.1 (-), 27.5 (br.  s., +), 27.39 (-), 27.36 (-), 27.0 (-), 26.7 (-), 26.2 (-), 26.1 (-), 18.0 (-); 
19
F 
NMR (376.50 MHz, CD3OD) δ ppm -65.5 (s, 6F); FTIR (NaCl, film, cm-1): 3302, 2933, 2856, 
1632, 1547, 1454, 1427, 1352, 1278, 1182, 1138, 905, 681; HRMS (TOF ES): found 505.2287, 
calculated for C25H31F6N2O2 (M+H) 505.2290 (0.6 ppm). 
 
N-Benzyl-N-((1R*,2R*)-2-(methoxy(methyl)carbamoyl) 
cyclopropyl)-3,5-bis(trifluoromethyl)benzamide (95emf): 
The reaction was performed according to the typical 
procedure, employing bromocyclopropane 70e (104 mg, 0.50 mmol) and N-benzyl-3,5-
bis(trifluoromethyl) benzamide (94mf) (347 mg, 1.00 mmol).  Flash column chromatography on 
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Silica gel (eluent hexane/ EtOAc 2:1) afforded two fractions.  The less polar one (Rf 0.61) was 
identified as non-reacted benzamide, and the more polar one (Rf 0.31) as the title compound, a 
yelowish viscous oil.  
1
H NMR (500.13 MHz, CD3OD) δ ppm 8.09 (s, 3H), 7.45-7.38 (m, 4H), 
7.35-7.31 (m, 1H), 5.03 (d, J = 14.5 Hz, 1H), 4.63 (d, J = 14.5 Hz, 1H), 3.45 (br.  s, 3H), 3.17 
(br.  s, 1H), 2.93 (br.  s, 3H), 2.26 (br.  s, 1H), 1.28-1.21 (m, 1H), 1.11 (br.  s, 1H); 
13
C NMR 
(125.76 MHz, CD3OD) δ ppm 172.1, 171.3, 140.6, 138.5, 133.2 (q, 
2
JCF = 33.6 Hz, 2C), 130.1 (+, 
2C), 129.3 (+, 2C), 129.0 (q, 
3
JCF = 2.7 Hz, +, 2C), 129.0 (+), 124.8 (spt, 
3
JCF = 3.6 Hz, +), 124.6 
(q, 
1
JCF = 271.6 Hz, 2C), 62.2 (+), 51.9 (-), 40.8 (+), 32.4 (+), 23.6 (+), 18.3 (-); FTIR (teflon, 
film, cm-1): 2939, 1651, 1620, 1441, 1418, 1364, 1279, 1207, 1184, 1150, 1138, 1109, 1003, 
905, 756, 700, 681; HRMS (TOF ES): found 475.1457, calculated for C22H21F6N2O3 (M+H) 
475.1456 (0.2 ppm); 
N-Benzyl-N-((1R*,2R*)-2-(tert-
butylcarbamoyl)cyclopropyl)-4-nitrobenzamide (95akf):  
Typical Procedure I: An oven-dried 10 mL Weaton vial was 
charged with 2-bromo-N-(tert-butyl)cyclopropanecarboxamide 70a (110 mg, 0.5 mmol, 1.0 
equiv), 18-crown-6 (13.2 mg, 0.05 mmol, 10 mol%), KOH (98 mg, 1.75 mmol, 3.5 equiv), N-
benzyl-4-nitrobenzamide (94kf)
118
 (256 mg, 1.0 mmol, 2.0 equiv), and anhydrous THF (5 mL).   
The mixture was stirred at 85 
o
C for 12 hrs, then the reaction mixture was filtered into a 100 mL 
round bottom flask, both the reaction vessel and filter were rinsed consecutively with DCM (15 
mL) and EtOAc (15 mL), which were combined with filtrate.   The product was isolated by 
column chromatography in 24:1 DCM:MeOH  as a white solid (Rf 0.17, mp 146-150 
o
C).   Yield 
124.0 mg (0.32 mmol, 63%).   
1
H NMR (500.13 MHz, CD3OD) δ ppm 8.37 – 8.23 (m, 2H), 7.75 
– 7.64 (m, 2H), 7.39 (d, J = 5.6 Hz, 4H), 7.32 (d, J = 4.3 Hz, 1H), 7.19 (s, 1H), 4.90 (d, J = 14.6 
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Hz, 1H), 4.67 (d, J = 14.6 Hz, 1H), 3.01 – 2.86 (m, 1H), 1.33 (d, J = 4.1 Hz, 2H), 1.10 (s, 10H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 171.28, 169.70, 148.43, 142.98, 136.96, 128.56 (+, 2C), 
128.42 (+) 127.90 (+), 127.72 (+), 127.42 (+), 123.56 (+), 50.51, 49.70 (-), 37.99 (+), 27.45 (+, 
3C), 26.92 (+), 15.41 (-); FTIR (NaCl, cm
-1
): 3336, 2968, 2931, 1643, 1523, 1454, 1396, 1348, 
1267, 1155, 846, 702;  HRMS (TOF ES): found 394.1763, calculated for C22H24N3O4 (M-H) 
394.1767 (1.0 ppm). 
 
N-benzyl-N-((1R*,2R*)-2-(tert-butylcarbamoyl)cyclopropyl)-
4-cyanobenzamide (95ajf): This compound was synthesized 
according to Typical Procedure I employing 2-bromo-N-(tert-
butyl)cyclopropanecarboxamide (70a) (110 mg, 0.5 mmol), N-benzyl-4-cyanobenzamide 
(94jf)
119
 (236 mg, 1.0 mmol), 18-crown-6 (13.2 mg, 0.05 mmol) and KOH (56 mg, 1.75 mmol).  
The product was isolated by column chromatography (eluting with a ternary mixture 
Hexanes/Acetone/DCM 3:1:1) as a tan solid, (Rf 0.37, mp 79-82 
o
C).  Yield 177.0 mg (0.24 
mmol, 47%).   
1
H NMR (400.13 MHz, CD3OD) δ ppm 7.85 – 7.79 (m, 2H), 7.66 – 7.59 (m, 2H), 
7.39 (d, J = 4.5 Hz, 3H), 7.32 (q, J = 4.2 Hz, 1H), 7.26 (s, 1H), 4.88 (d, J = 14.6 Hz, 1H), 4.67 
(d, J = 14.6 Hz, 1H), 2.91 (ddd, J = 7.4, 4.2, 4.2 Hz, 1H), 1.62 (m, J = 8.5 Hz, 1H), 1.37 – 1.30 
(m, 1H), 1.18 (s, 9H), 1.02 (m, 1H); 
13
C NMR (125.76 MHz, CD3OD) δ ppm 171.54, 169.70, 
141.22, 136.96, 132.31 (+), 128.51 (+), 128.47 (+), 127.69 (+), 127.52 (+), 127.38 (+), 117.77, 
113.28, 50.50, 49.69 (-), 37.90 (+), 27.49 (+, 3C), 26.72 (+), 15.42 (-);  FTIR (NaCl, cm
-1
): 3339, 
2966, 2929, 2230, 1643, 1544, 1497, 1396, 1336, 1267, 1153, 849, 734;  HRMS (TOF ES): 
found 374.1867, calculated for C23H24N3O2 (M-H) 374.1869 (0.5 ppm). 
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 N-((1R*,2R*)-2-(tert-butylcarbamoyl)cyclopropyl)-4-nitro-
N-(thiophen-2-ylmethyl)benzamide (95akj):  This compound 
was synthesized according to Typical Procedure I employing 
2-bromo-N-(tert-butyl)cyclopropanecarboxamide (70a) (110 mg, 0.50 mmol), 4-nitro-N-
(thiophen-2-ylmethyl)benzamide (94kj) (262 mg, 1.00 mmol), 18-crown-6 (13.2 mg, 0.05 mmol) 
and KOH (56 mg, 1.75 mmol).  The product was isolated by column chromatography eluting 
with DCM:MeOH mixture (24:1) as a yellow solid (Rf 0.27, mp 150-152 
o
C).   Yield 104 mg 
(0.26 mmol, 52%).   
1
H NMR (500.13 MHz, CD3OD) δ ppm 8.31 (dd, J = 8.9, 2.2 Hz, 2H), 7.66 
(dd, J = 9.0, 2.3 Hz, 2H), 7.39 (d, J = 4.8 Hz, 1H), 7.21 (s, 1H), 7.13 (s, 1H), 7.01 (dd, J = 5.2, 
3.3 Hz, 1H), 5.08 (d, J = 15.0 Hz, 1H), 4.86 – 4.79 (d, J = 15.0, 1H), 3.04 – 2.97 (m, 1H), 1.68 – 
1.53 (m, 1H), 1.34 (s, 1H), 1.12 (s, 9H);  
13
C NMR (125.76 MHz, CD3OD) δ ppm 170.96, 
169.67, 148.45, 142.78, 139.26, 127.83 (+, 2C), 126.83 (+), 126.53 (+), 125.53 (+), 123.59 (+, 
2C), 50.43, 44.69 (-), 37.78 (+), 27.47 (+, 3C), 26.98 (+), 15.29 (-);  FTIR (NaCl, cm
-1
): 3348, 
2968, 2930, 1637, 1524, 1439, 1418, 1346, 1261, 856, 717; HRMS (TOF ES): found 401.1411, 
calculated for C22H24N3O4 (M+) 401.1409 (0.5 ppm). 
 
N-((1R*,2R*)-2-(tert-butylcarbamoyl)cyclopropyl)-4-cyano-
N-(furan-2-ylmethyl)benzamide (95ajk): This compound was 
synthesized according to Typical Procedure I employing 2-
bromo-N-(tert-butyl)cyclopropanecarboxamide (70a) (110 mg, 0.5 mmol), 4-cyano-N-(furan-2-
ylmethyl)benzamide (94jk) (226 mg, 1.0 mmol), 18-crown-6 (13.2 mg, 0.05 mmol) and KOH 
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(56 mg, 1.75 mmol).  The product was isolated by column chromatography on silica gel eluting 
with ternary mixture hexane/DCM/acetone 3:1:1 as a yellow solid, mp 126-130 
o
C, Rf 0.17.   
Yield 149 mg (0.41 mmol, 81%).   
1
H NMR (500.13 MHz, CD3OD) δ ppm 7.82 (s, 2H), 7.62 (d, 
J = 8.3 Hz, 2H), 7.52 (s, 1H), 7.21 (s, 1H), 6.42 (s, 2H), 4.87 (d, J = 12.8 Hz, 1H), 4.66 (d, J = 
14.2 Hz, 1H), 2.99 (s, 1H), 1.60 (s, 1H), 1.22 (s, 9H), 1.11 (s, 2H); 
13
C NMR (125.76 MHz, 
CD3OD) δ ppm 171.41, 169.72, 150.26, 142.48, 141.02 (+), 132.33 (+, 2C), 127.58 (+), 117.82, 
113.31, 110.21 (+), 108.48 (+), 50.51, 42.72 (-), 37.89 (+), 27.55 (+, 3S), 26.84 (+), 15.51 (-);  
FTIR (NaCl, cm
-1
): 3325, 2966, 2925, 2331, 1645, 1524, 1456, 1396, 1346, 1261, 1178, 862, 
700;  
 
HRMS (TOF ES): found 365.1740, calculated for C21H23N3O3 (M+) 365.1739 (0.3 ppm). 
 
3.5.5. Adducts Resulting from Nucleophilic Attack by Sulfonamides.    
 
(1R*,2R*)-N-(tert-Butyl)-2-(N-butyl-4-
fluorophenylsulfonamido)cyclopropanecarboxamide (98aid) (Typical 
Procedure II): An oven-dried 10 mL Weaton vial was charged with 
bromocyclopropane 70a (44 mg, 0.20 mmol, 1.5 equiv), 18-crown-6 (3.5 
mg, 13 μmol, 10 mol%), KOH (52 mg, 0.93 mmol, 7.0 equiv), N-butyl-
4-fluorobenzenesulfonamide (97jd)
120
 (31 mg,  0.13 mmol, 1.0 equiv), and anhydrous THF (8 
mL).  The mixture was stirred at 85 
o
C for 12 hrs, then filtered through a sintered funnel into a 
100 mL round bottom flask.   Both the reaction vessel and the filter were rinsed consecutively 
with EtOAc (15 mL), which was combined with filtrate.   Silica gel (2.0 g) was added to a 
filtrate, and then the solvent was removed by rotary evaporation.   The residue absorbed onto 
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silica gel was loaded on the top of the column packed with silica gel, which was eluted with 
hexane/EtOAc 3:1 to afford two fractions.   The major fraction (Rf = 0.30) contained the title 
product as a colorless solid, mp 112-113°C.   Yield 47 mg (96%, 0.127 mmol).   A second 
fraction (Rf = 0.07) contained minute amounts of (1R*,2S*)-isomer.   
1
H NMR (400.13 MHz, 
CDCl3) δ ppm 7.76 - 7.83 (m, 2H), 7.19 (t, J = 8.5 Hz, 2H), 5.87 (s, 1H), 3.19 (ddd, J = 13.6, 9.6, 
6.1 Hz, 1H), 3.02 (ddd, J = 13.6, 9.6, 5.6 Hz, 1H), 2.15 (ddd, J = 7.3, 4.3, 2.9 Hz, 1H), 1.99 (ddd, 
J = 9.2, 6.3, 2.8 Hz, 1H), 1.47 - 1.57 (m, 2H), 1.39 (s, 9H), 1.23 - 1.32 (m, 3H), 1.19 (dt, J = 9.3, 
4.9 Hz, 1H), 0.89 (t, J = 7.3 Hz, 3H);   
13
C NMR (100.67 MHz, CDCl3) δ ppm 169.4, 165.2 (d, J 
= 255.4 Hz), 133.3 (d, J = 2.9 Hz), 130.3 (+, d, J = 9.5 Hz, 2C), 116.4 (+, d, J = 22.7 Hz, 2C), 
51.5, 51.1 (-), 37.3 (+), 30.1 (-), 28.8 (+, 3C), 25.7 (+), 20.0 (-), 13.7 (+), 13.4 (-);  
19
F NMR 
(376.31 MHz, CDCl3) δ ppm -104.81 (tt, J = 8.1, 5.7 Hz, 1 F);  FT IR (KBr, cm
-1
): 3325, 2964, 
2934, 2874, 1651, 1593, 1493, 1456, 1229, 839;  HRMS (TOF ES): found 393.1621, calculated 
for C18H27N2O3SFNa (M+Na) 393.1624 (0.8 ppm).   
(1R*,2R*)-N-(tert-Butyl)-2-(N-butyl-4-
methylphenylsulfonamido)cyclopropanecarboxamide (98aad): The 
reaction was performed according to the Typical Procedure II, 
employing bromocyclopropane 70a (176 mg, 0.8 mmol, 1.2 equiv), 18-
crown-6 (18 mg, 0.067 mmol, 10 mol%), KOH (263 mg, 4.7 mmol, 7.0 
equiv) and N-butyl-4-methylbenzenesulfonamide (97ad)
121
 (151.4 mg, 0.67 mmol, 1.0 equiv).  
Column chromatography on Silica gel afforded the title compound as a white solid 
(diastereomeric mixture 16:1), mp 115-117°C   Rf 0.26 (eluent hexane/EtOAc 3:1).  Yield 216 
mg (0.60 mmol, 90%).   
1
H NMR (500.13 MHz, CDCl3) δ ppm 7.67 (m, J = 8.5 Hz, 2H), 7.30 
(m, J=8.2 Hz, 2H), 5.83 (s, 1H), 3.20 (ddd, J = 13.9, 9.8, 6.0 Hz, 1H), 3.00 (ddd, J = 13.6, 9.8, 
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5.7 Hz, 1H), 2.43 (s, 3H), 2.13 (ddd, J = 7.4, 4.6, 2.8 Hz, 1H), 1.99 (ddd, J = 9.1, 6.3, 2.8 Hz, 
1H), 1.43 - 1.58 (m, 2H), 1.41 (s, 9H), 1.22 - 1.33 (m, 3H), 1.16 (dt, J = 9.2, 4.7 Hz, 1H), 0.89 (t, 
J=7.3 Hz, 3H);  
13
C NMR (125.76 MHz, CDCl3) δ ppm 169.5, 143.7, 134.3, 129.6 (+, 2C), 127.6 
(+, 2C), 51.5, 51.1 (-), 37.4 (+), 30.3 (-), 28.9 (+, 3C), 25.8 (+), 21.5 (+), 20.1 (-), 13.7 (+), 13.1 
(-);  FT IR (KBr, cm
-1
): 3334, 2962, 2931, 1647, 1545, 1456, 1205, 1045, 816;  HRMS (TOF 
ES): found 366.1977, calculated for C19H30N2O3S (M
+
) 366.1977 (0.0 ppm).   
 
(1R*,2R*)-N-(tert-Butyl)-2-(N-butyl-4-
methoxyphenylsulfonamido)cyclopropanecarboxamide (98aed): The 
reaction was performed according to the Typical Procedure II, 
employing bromocyclopropane 70a (35 mg, 0.16 mmol, 1.2 equiv), 18-
crown-6 (3.5 mg, 0.013mmol, 10 mol%), KOH (52 mg, 0.93 mmol, 7.0 
equiv) and N-butyl-p-methoxybenzenesulfonamide (97ed)
122
 (32 mg, 0.133 mmol, 1.0 equiv).  
Column chromatography on Silica gel afforded the title compound as a white solid 
(diastereomeric mixture 11:1), mp 97-100°C, Rf 0.18 (eluent hexane/EtOAc 3:1).  Yield 51 mg 
(0.126 mmol, 95%).   
1
H NMR (400.13 MHz, CDCl3) δ ppm 7.72 (m, 2H), 6.97 (m, J = 8.8 Hz, 
2H), 5.85 (s, 1H), 3.87 (s, 3H), 3.19 (ddd, J = 13.6, 9.6, 6.1 Hz, 1H), 3.00 (ddd, J = 13.9, 9.6, 5.6 
Hz, 1H), 2.13 (ddd, J = 7.4, 4.5, 2.8 Hz, 1H), 1.98 (ddd, J = 9.1, 6.2, 2.9 Hz, 1H), 1.43 - 1.58 (m, 
2H), 1.41 (s, 9H), 1.23 - 1.32 (m, 3H), 1.17 (dt, J = 9.0, 4.7 Hz, 1H), 0.89 (t, J = 7.3 Hz, 3H);  
13
C NMR (100.67 MHz, CDCl3) δ ppm 169.6, 163.0, 129.6 (+, 2C), 128.7, 114.1 (+, 2C), 55.5 
(+), 51.4, 51.0 (-), 37.3 (+), 30.1 (-), 28.8 (+, 3C), 25.6 (+), 20.0 (-), 13.6 (+), 13.2 (-);  FT IR 
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(KBr, cm
-1
): 3325, 2962, 2934, 2872, 1653, 1541, 1443, 1259, 1092, 835;  HRMS (TOF ES): 
found 405.1834, calculated for C19H30N2O4SNa (M+Na) 405.1824 (2.5 ppm).   
 
 (1R*,2R*)-2-(N-Benzyl-4-methylphenylsulfonamido)-N-(tert-
butyl)cyclopropanecarboxamide (98aaf): The reaction was performed 
according to the Typical Procedure II, employing bromocyclopropane 
70a (35 mg, 0.16 mmol, 1.2 equiv), 18-crown-6 (3.5 mg, 0.013 mmol, 
10 mol%), KOH (52 mg, 0.93 mmol, 7.0 equiv) and N-benzyl-4-
methylbenzenesulfonamide (97ff)
123
  (35 mg, 0.133 mmol, 1.0 equiv).  Column chromatography on 
Silica gel afforded the title compound as a yellow oil (diastereomeric mixture 11:1), Rf 0.65 (eluent 
hexane/EtOAc 3:1).   Yield 40 mg (0.10 mmol, 75%).   
1
H NMR (500.13 MHz, CDCl3) δ ppm 7.71 (d, J 
= 8.2 Hz, 2H), 7.33 (d, J = 8.2 Hz, 2H), 7.34 - 7.36 (m, 5H), 5.16 (s, 1H), 4.42 (d, J = 13.9 Hz, 1H), 4.04 
(d, J = 13.6 Hz, 1H), 2.45 (s, 3H), 2.09 (ddd, J = 7.4, 4.6, 2.8 Hz, 1H), 1.32 - 1.37 (m, 1H), 1.30 (s, 9H), 
1.08 - 1.19 (m, 2H);  
13
C NMR (125.76 MHz, CDCl3) δ ppm 169.5, 143.9, 136.7, 133.8, 129.8 (+, 2C), 
129.1 (+, 2C), 128.5 (+, 2C), 127.8 (+), 127.7 (+, 2C), 55.4 (-), 51.3, 38.0 (+), 28.8 (+, 3C), 25.1 (+), 21.5 
(+), 13.5 (-);  FT IR (KBr, cm
-1
): 3334, 2966, 1651, 1599, 1537, 1456, 1256, 1028, 849;  HRMS (TOF 
ES): found 423.1717, calculated for C22H28N2O3SNa (M+Na) 423.1718 (0.2 ppm). 
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(1R*,2R*)-2-(N-Butyl-4-methylphenylsulfonamido)-N-
cyclohexylcyclopropanecarboxamide (98dad):  The reaction was 
performed according to the Typical Procedure II, employing 
bromocyclopropane 70d (39 mg, 0.16 mmol, 1.2 equiv), 18-crown-6 
(3.5 mg, 0.013 mmol, 10 mol%), KOH (52 mg, 0.93 mmol, 7.0 equiv) 
and N-butyl-4-methylbenzenesulfonamide (97ad)
121
 (30 mg, 0.133 mmol, 1.0 equiv).   Column 
chromatography on Silica gel afforded the title compound as a white solid (diastereomeric 
mixture 15:1) mp 118-120 °C; Rf 0.24 (eluent hexane/EtOAc 3:1).  Yield 46 mg (0.118 mmol, 
89%).   
1
H NMR (400.13 MHz, CDCl3) δ ppm 7.66 (d, J = 8.1 Hz, 2H), 7.30 (d, J = 8.3 Hz, 2H), 
5.89 (d, J = 8.1 Hz, 1H), 3.74 - 3.86 (m, 1H), 3.20 (ddd, J = 13.9, 9.9, 6.1 Hz, 1H), 3.01 (ddd, J = 
13.9, 9.9, 5.6 Hz, 1H), 2.43 (s, 3H), 2.17 (ddd, J = 7.2, 4.0, 2.9 Hz, 1H), 1.95 - 2.06 (m, 2H), 
1.91 (d, J = 12.4 Hz, 1H), 1.68 - 1.81 (m, 2H), 1.60 - 1.66 (m, 1H), 1.51 - 1.57 (m, 1H), 1.31 - 
1.49 (m, 4H), 1.16 - 1.30 (m, 6H), 0.89 (t, J = 7.3 Hz, 3H);  
13
C NMR (100.67 MHz, CDCl3) δ 
ppm 169.3, 143.7, 134.2, 129.7 (+, 2C), 127.6 (+, 2C), 51.1 (-), 48.5 (+), 37.5 (+), 33.4 (-), 33.0 
(-), 30.2 (-), 25.5 (-), 25.2 (+), 24.9 (-, 2C), 21.5 (+), 20.0 (-), 13.7 (+), 13.4 (-);  FT IR (KBr, cm
-
1
): 3296, 2932, 2854, 1639, 1599, 1548, 1450, 1346, 1165, 1090, 816;  HRMS (TOF ES): found 
392.2143, calculated for C21H32N2O3S (M
+
) 392.2134 (2.3 ppm).   
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(1R*,2R*)-N-(tert-butyl)-2-(N-(furan-2-ylmethyl)-4-
methylphenylsulfonamido)cyclopropanecarboxamide (98aak): The 
reaction was performed according to the Typical Procedure II, 
employing bromocyclopropane 70a (35 mg, 0.16 mmol, 1.2 equiv), 18-
crown-6 (3.5 mg, 0.013 mmol, 10 mol%), KOH (52 mg, 0.93 mmol, 7.0 
equiv) and 4-methyl-N-(furan-2-ylmethyl)benzenesulfonamide (97ak)
124
 (33 mg, 0.133 mmol, 
1.0 equiv).  Column chromatography on Silica gel afforded the title compound as a white solid 
(diastereomeric mixture 25:1) mp 108-110 
o
C, Rf 0.20 (eluent hexane/EtOAc 3:1).  Yield 43 mg 
(0.112 mmol, 84%).   
1
H NMR (400.13 MHz, CDCl3) δ ppm 7.64 (d, J = 8.3 Hz, 2H), 7.26 - 7.30 
(m, 3H), 6.28 (dd, J = 3.2, 1.9 Hz, 1H), 6.20 (d, J=3.3 Hz, 1H), 5.62 (s, 1H), 4.46 (d, J = 14.9 
Hz, 1H), 4.19 (d, J = 15.2 Hz, 1H), 2.42 (s, 3H), 2.17 (ddd, J = 7.3, 4.6, 2.8 Hz, 1H), 1.68 (ddd, J 
= 9.1, 6.3, 2.8 Hz, 1H), 1.37 (s, 9H), 1.25 - 1.30 (m, 1H), 1.16 (ddd, J = 9.3, 4.8 Hz, 1H); 
13
C 
NMR (100.67 MHz, CDCl3) δ ppm 169.5, 149.3, 143.8, 142.4 (+), 133.7, 129.6 (+), 127.8 (+), 
110.5 (+), 110.0 (+), 51.4, 47.1 (-), 37.0 (+), 28.9 (+), 25.6 (+), 21.5, 13.7 (-);  FT IR (KBr, cm
-
1
): 3384, 2968, 2929, 2872, 1666, 1599, 1504, 1456, 1350, 1227, 885, 656;  HRMS (TOF ES): 
found 413.1515, calculated for C24H32N2O3S (M
 
+ Na) 413.1511 (1.2 ppm).     
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 (1R*,2R*)-N-(tert-Butyl)-2-(N-
butylphenylsulfonamido)cyclopropanecarboxamide (98afd): The 
reaction was performed according to the Typical Procedure II, 
employing bromocyclopropane 70a (35 mg, 0.16 mmol, 1.2 equiv), 18-
crown-6 (3.5 mg, 0.013 mmol, 10 mol%), KOH (52 mg, 0.93 mmol, 7.0 
equiv) and N-butylbenzenesulfonamide (97fd)
125
 (28 mg, 0.133 mmol, 1.0 equiv).  Column 
chromatography on Silica gel afforded the title compound as a white solid (diastereomeric 
mixture 10:1) mp 65-68 °C.  Rf = 0.25 (eluent hexane/EtOAc 3:1).  Yield 34.2 mg (0.097 mmol, 
73%).    
1
H NMR (400.13 MHz, CDCl3) δ ppm 7.79 (d, J = 7.3 Hz, 2 H), 7.60 (t, J = 7.5 Hz, 
1H), 7.51 (t, J = 7.5 Hz, 2H), 5.85 (s, 1H), 3.21 (ddd, J = 13.7, 9.7, 5.9 Hz, 1H), 2.98 - 3.08 (m, 
1H), 2.15 (ddd, J = 7.3, 4.5, 2.8 Hz, 1H), 1.99 (ddd, J = 9.2, 6.3, 3.0 Hz, 1H), 1.43 - 1.57 (m, 
2H), 1.40 (s, 9H), 1.22 - 1.36 (m, 3H), 1.18 (dt, J = 9.2, 4.7 Hz, 1H), 0.88 (t, J = 7.5 Hz, 3H);  
13
C NMR (100.67 MHz, CDCl3) δ ppm 169.5, 137.1, 132.8 (+), 129.0 (+,  2C), 127.5 (+, 2C), 
51.5, 51.1 (-), 37.3 (+), 30.1 (-), 28.8 (+, 3C), 25.7 (+), 20.0 (-), 13.7 (+), 13.2 (-);  FT IR (KBr, 
cm
-1
):  3303, 2962, 2932, 2872, 1651, 1539, 1447, 1248, 1045, 887; HRMS (TOF ES): found 
353.1907, calculated for C18H29N2O3S (M+H) 353.1899 (2.3 ppm).    
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(1R*,2R*)-N-(tert-Butyl)-2-(N-butylnaphthalene-2-
sulfonamido)cyclopropanecarboxamide (98agd): The reaction was 
performed according to the Typical Procedure II, employing bromo-
cyclopropane 70a (35 mg, 0.16 mmol, 1.2 equiv), 18-crown-6 (3.5 mg, 
0.013mmol, 10 mol%), KOH (52 mg, 0.93 mmol, 7.0 equiv) and N-
butylnaphthalenesulfonamide (97gd) (34 mg, 0.133 mmol, 1.0 equiv).  Column chromatography 
on Silica gel afforded the title compound as a white solid (diastereomeric mixture 10:1) mp = 97-
99 °C, Rf 0.38 (eluent hexane/EtOAc 3:1).  Yield 44 mg (0.103 mmol, 78%).    
1
H NMR (400.13 
MHz, CDCl3) δ ppm 8.36 (s, 1H), 7.90 - 7.99 (m, 3H), 7.78 (dd, J = 8.6, 1.8 Hz, 1H), 7.59 - 7.69 
(m, 2H), 5.81 (s, 1H), 3.26 (ddd, J = 13.7, 9.8, 6.1 Hz, 1H), 3.09 (ddd, J = 13.7, 9.7, 5.7 Hz, 1H), 
2.27 (ddd, J = 7.4, 4.5, 2.8 Hz, 1H), 2.01 (ddd, J = 9.1, 6.3, 2.8 Hz, 1H), 1.45 - 1.58 (m, 2H), 
1.43 (s, 9H), 1.25 - 1.37 (m, 3H), 1.18 - 1.24 (m, 1H), 0.88 (t, J = 7.3 Hz, 3H);  
13
C NMR 
(100.67 MHz, CDCl3) δ ppm 169.5, 134.8, 134.4, 132.1, 129.2 (+, 2 C), 128.8 (+, 2 C), 127.9 
(+), 127.6 (+), 122.8 (+), 51.5, 51.1 (-), 37.3 (+), 30.3 (-), 28.9 (+, 3 C), 25.9 (+), 20.0 (-), 13.7 
(+), 13.2 (-);  FT IR (KBr, cm
-1
): 3377, 2961, 2930, 2870, 1649, 1589, 1541, 1456, 1259, 1132, 
1020, 860;  HRMS (TOF ES): found 403.2043, calculated for C22H31N2O3S (M+H) 403.2055 
(3.0 ppm).     
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 (1R*,2R*)-2-(N-Butylnaphthalene-2-sulfonamido)-N-
cyclohexylcyclopropanecarboxamide (98dgd): The reaction was 
performed according to the Typical Procedure II, employing 
bromocyclopropane 70d (39 mg, 0.16 mmol, 1.2 equiv), 18-crown-6 
(3.5 mg, 0.013mmol, 10 mol%), KOH (52 mg, 0.93 mmol, 7.0 equiv) 
and N-butylnaphthylsulfonamide (97gd) (35 mg, 0.133 mmol, 1.0 equiv).  Column 
chromatography on Silica gel afforded the title compound as a white solid (diastereomeric 
mixture 11:1), mp 110-113 °C; Rf = 0.41 (eluent hexane/EtOAc 2:1).  Yield 53 mg (0.125 mmol, 
94%).   
1
H NMR (400.13 MHz, CDCl3) δ ppm 8.33 - 8.40 (m, 1H), 7.90 - 8.00 (m, 3H), 7.78 (dd, 
J = 8.7, 1.9 Hz, 1H), 7.60 - 7.70 (m, 2H), 5.93 (d, J = 8.1 Hz, 1H), 3.77 - 3.89 (m, 1H), 3.27 
(ddd, J = 13.7, 9.8, 6.1 Hz, 1H), 3.12 (ddd, J = 13.8, 9.7, 5.6 Hz, 1H), 2.33 (ddd, J = 7.3, 4.5, 2.8 
Hz, 1H), 2.06 (tt, J = 6.1, 3.0 Hz, 2H), 1.89 - 1.97 (m, 1H), 1.70 - 1.84 (m, 2H), 1.53 - 1.68 (m, 
2H), 1.36 - 1.51 (m, 4H), 1.18 - 1.34 (m, 6H), 0.89 (t, J = 7.3 Hz, 3H);  
13
C NMR (100.67 MHz, 
CDCl3) δ ppm 169.3, 134.8, 134.4, 132.1, 129.3 (+), 129.2 (+), 128.8 (+, 2C), 127.9 (+), 127.6 
(+), 122.8 (+), 51.0 (-), 48.5 (+), 37.4 (+), 33.4 (-), 33.0 (-), 30.2 (-), 25.5 (-), 25.3 (+), 24.8 (-, 
2C), 20.0 (-), 13.7 (+), 13.5 (-);  FT IR (KBr, cm
-1
): 3321, 2932, 1637, 1541, 1535, 1450, 1269, 
1116, 1020, 858;  HRMS (TOF ES): found 428.2139, calculated for C24H32N2O3S (M
+
) 428.2134 
(1.2 ppm).   
 
 (1R*,2R*)-N-(tert-Butyl)-2-(N-
hexylmethylsulfonamido)cyclopropanecarboxamide (98ahe): The 
reaction was performed according to the Typical Procedure II, 
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employing bromocyclopropane 70a (44 mg, 0.2 mmol, 1.5 equiv), 18-crown-6 (3.5 mg, 
0.013mmol, 10 mol%), KOH (52 mg, 0.93 mmol, 7.0 equiv) and N-hexylmethanesulfonamide 
(97he)
126
 (39 mg,  0.133 mmol, 1.0 equiv).   Column chromatography on silica gel (eluent 
hexane/EtOAc 1:1) afforded two fractions.   The major fraction contained a title compound as a 
white solid mp 62-64 °C, Rf 0.52.   Yield 36.3 mg (0.114 mmol, 86%).   
1
H NMR (400.13 MHz, 
CDCl3) δ ppm 5.74 (br.  s, 1H), 3.15 - 3.31 (m, 2H), 2.88 (s, 3H), 2.58 (ddd, J = 7.3, 4.4, 2.9 Hz, 
1H), 1.90 (ddd, J = 9.2, 6.3, 2.9 Hz, 1H), 1.57 - 1.74 (m, 2H), 1.37 - 1.41 (m, 1H), 1.35 - 1.38 
(m, 9H), 1.26 - 1.33 (m, 6H), 1.21 (dt, J = 9.4, 4.8 Hz, 1H), 0.87 - 0.94 (m, 3H);  
13
C NMR 
(100.67 MHz, CDCl3) δ ppm 169.5, 51.4, 51.0 (-), 36.7 (+), 36.4 (+), 31.4 (-), 28.8 (+), 28.0 (+, 
3C), 26.5 (-), 25.8 (+), 22.5 (-), 14.0 (+), 13.6 (-);  FT IR (KBr, cm
-1
): 3331, 2960, 2932, 2858, 
1647, 1591, 1541, 1500, 1458, 1155, 883;  HRMS (TOF ES): found 341.1871, calculated for 
C15H30N2O3SNa (M+Na) 341.1875 (1.2 ppm).  The minor fraction (Rf 0.31) contained minute 
amounts (3.7 mg) of (1R*,2S*)-diastereomer.     
 
 (1R*,2R*)-2-(N-Benzylmethylsulfonamido)-N-(tert-
butyl)cyclopropanecarboxamide (98ahf): The reaction was performed 
according to the Typical Procedure II, employing bromocyclopropane 
70a (46 mg, 0.21 mmol, 1.5 equiv), 18-crown-6 (3.5 mg, 0.013mmol, 10 
mol%), KOH (52 mg, 0.93 mmol, 7.0 equiv) and N-benzylmethanesulfonamide (97hf)
127
 (26 mg, 
0.14 mmol, 1.0 equiv).  Column chromatography on Silica gel afforded the title compound as a 
white solid (diastereomeric mixture 15:1) mp 136-137 °C, Rf 0.28 (eluent hexane/EtOAc 3:2).   
Yield 37.8 mg (0.117 mmol, 83%).  
1
H NMR (400.13 MHz, CDCl3) δ ppm 7.31 - 7.42 (m, 5H), 
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5.36 (br.  s, 1H), 4.60 (d, J = 14.1 Hz, 1H), 4.21 (d, J = 14.1 Hz, 1H), 2.74 (s, 3H), 2.55 (ddd, J = 
7.4, 4.5, 2.8 Hz, 1H), 1.54 (ddd, J = 9.2, 6.3, 2.8 Hz, 1H), 1.33 - 1.38 (m, 1H), 1.31 (s, 9H), 1.20 
- 1.27 (m, 1H)  
13
C NMR (100.67 MHz, CDCl3) δ ppm 169.3, 135.5, 129.3 (+, 2C), 128.7 (+, 
2C), 128.2 (+), 54.8 (-), 51.4, 36.9 (+), 36.5 (+), 28.7 (+, 3C), 25.8 (+), 14.0 (-);  FT IR (KBr, 
cm
-1
): , 2964, 2929, 2972, 1651, 1537, 1456, 1258, 1049, 841;  HRMS (TOF ES): found 
325.1588, calculated for C16H25N2O3S (M+H) 325.1586 (0.6 ppm).    
 
 (1R*,2R*)-N-(tert-Butyl)-2-(N-
cyclohexylmethylsulfonamido)cyclopropanecarboxamide (98ahh):  
The reaction was performed according to the Typical Procedure II, 
employing bromocyclopropane 70a (35 mg, 0.16 mmol, 1.2 equiv), 18-crown-6 (3.5 mg, 0.013 
mmol, 10 mol%), KOH (52 mg, 0.93 mmol, 7.0 equiv) and N-cyclohexylmethanesulfonamide 
(97hh)
128
 (34 mg, 0.133 mmol, 1.0 equiv).  Column chromatography on Silica gel afforded the 
title compound as a yellow oil (diastereomeric mixture 9:1) Rf 0.28 (eluent hexane/EtOAc 2:1).  
Yield 28 mg (0.089 mmol, 67%).  
1
H NMR (400.13 MHz, CDCl3) δ ppm 5.83 (br.  s, 1H), 3.67 
(tt, J = 12.1, 3.3 Hz, 1H), 2.87 (s, 3H), 2.49 (ddd, J = 7.4, 4.5, 3.0 Hz, 1H), 1.92 (ddd, J = 9.2, 
6.3, 2.9 Hz, 1H), 1.75 - 1.87 (m, 4H), 1.49 - 1.74 (m, 3H), 1.36 - 1.41 (m, 1H), 1.35 (s, 9H), 1.24 
- 1.32 (m, 3H), 1.00 - 1.15 (m, 1H);  
13
C NMR (100.67 MHz, CDCl3) δ ppm 169.8, 60.2 (+), 
51.4, 37.9 (+), 32.8 (+), 32.7 (-), 31.1 (-), 28.8 (+, 3C), 26.2 (-), 26.1 (-), 25.4 (-), 25.3 (+), 14.0 (-
);  FT IR (KBr, cm
-1
): 3373, 2964, 2934, 2856, 1651, 1547, 1454, 1256, 1084, 893;  HRMS 
(TOF ES): found 339.1721, calculated for C15H28N2O3SNa (M+Na) 339.1718 (0.9 ppm). 
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 (1R*,2R*)-2-(N-Butyl-4-fluorophenylsulfonamido)-N-
cyclohexylcyclopropanecarboxamide (98did): The reaction was 
performed according to the Typical Procedure II, employing 
bromocyclopropane 70d (39 mg, 0.16 mmol, 1.2 equiv), 18-crown-6 
(3.5 mg, 0.013mmol, 10 mol%), KOH (52 mg, 0.93 mmol, 7.0 equiv) 
and N-butyl-4-fluorobenzenesulfonamide (97id)
120
 (31 mg, 0.133 mmol, 1.0 equiv).   Column 
chromatography on Silica gel afforded the title compound as a white solid (diastereomeric 
mixture 10:1) mp 91-93 °C, Rf 0.29 (eluent hexane/EtOAc 3:1).  Yield 51.3 mg (0.129 mmol, 
97%).   
1
H NMR (400.13 MHz, CDCl3) δ ppm 7.75 - 7.84 (m, 2H), 7.20 (t, J = 8.6 Hz, 2H), 5.90 
(d, J = 8.1 Hz, 1H), 3.73 - 3.86 (m, 1H), 3.19 (ddd, J = 13.7, 9.8, 5.8 Hz, 1H), 3.04 (ddd, J = 
13.9, 9.9, 5.6 Hz, 1H), 2.21 (ddd, J = 7.3, 4.5, 2.8 Hz, 1H), 1.86 - 2.07 (m, 3H), 1.75 (td, J = 8.0, 
3.8 Hz, 2H), 1.63 (dt, J = 12.8, 3.6 Hz, 1H), 1.49 - 1.57 (m, 1H), 1.34 - 1.48 (m, 4H), 1.16 - 1.32 
(m, 6H), 0.89 (t, J = 7.3 Hz, 3H); 
13
C NMR (100.67 MHz, CDCl3) δ 169.3, 165.2 (d, J = 255.4 
Hz), 133.4 (d, J = 2.9 Hz), 130.3 (+, d, J = 8.8 Hz, 2C), 116.4 (+, d, J = 22.7 Hz, 2C), 51.1 (-), 
48.6 (+), 37.4 (+), 33.5 (-), 33.0 (-), 30.2 (-), 25.5 (-), 25.3 (+), 24.89 (-), 24.88 (-), 20.1 (-), 13.7 
(+), 13.6 (-);  
19
F NMR (376.46 MHz, CDCl3) δ ppm -104.8 (tt, J = 8.6, 4.7 Hz, 1F);  FT IR 
(KBr, cm
-1
): 3302, 2932, 2855, 1639, 1593, 1545, 1492, 1450, 1350, 1292, 1116, 1043, 872;  
HRMS (TOF ES): found 419.1799, calculated for C20H29N2O3SFNa (M+Na) 419.1781 (4.3 
ppm).  
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N-Butyl-4-fluoro-N-((1R*,2R*)-2-(morpholine-4-
carbonyl)cyclopropyl)benzenesulfonamide (98bid): The reaction was 
performed according to the Typical Procedure II, employing (2-
bromocyclopropyl)(morpholino)methanone (70b) (37 mg, 0.16 mmol, 
1.2 equiv), 18-crown-6 (3.5 mg, 0.013mmol, 10 mol%), KOH (52 mg, 
0.93 mmol, 7.0 equiv) and N-butyl-4-fluorobenzenesulfonamide (97id)
120
 (31 mg, 0.133 mmol, 
1.0 equiv).  Column chromatography on Silica gel afforded the title compound as a colorless oil 
(11:1 mixture of diastereomers), Rf = 0.25 (eluent EtOAc:Hexane 2:1).  Yield 36 mg (0.11 
mmol, 71%).   
1
H NMR (400.13 MHz, CDCl3) δ 7.82 (ddd, J = 8.7, 5.0, 1.4 Hz, 2H), 7.23 (t, J = 
8.5 Hz, 2H), 3.89 (m, 1H), 3.85 – 3.64 (m, 7H), 3.55 (ddd, J = 12.6, 7.1, 2.9 Hz, 1H), 3.21 – 3.02 
(m, 2H), 2.51 – 2.41 (m, 2H), 1.64 – 1.49 (m, 1H), 1.50 – 1.19 (m, 5H), 0.95 – 0.84 (m, 3H).  
13
C 
NMR (100.67 MHz, CDCl3) δ 169.25 , 165.25 (d, J = 255.3 Hz), 133.54 , 130.23 (d, J = 9.1 Hz, 
2C), 116.46 (d, J = 22.5 Hz, 2C), 67.06 , 66.95 , 46.15 , 42.61 , 38.61 , 30.23 , 21.36 , 20.06 , 
14.97 , 13.70 .  
19
F NMR (376.46 MHz, CDCl3) δ -104.67 – -104.78 (m); FT IR (NaCl, cm
-1
): 
3331, 3087, 2962, 2872, 1645, 1585, 1547, 1475, 1454, 1392, 1294, 1225, 1205, 1167, 1094 
HRMS found C18H24FN2O4S (M-H)
+
 383.1441 (0.5 ppm).   
 
(1R
*
,2R
*
)-N-(tert-butyl)-2-(4-fluoro-N-(furan-2-
ylmethyl)phenylsulfonamido)cyclopropanecarboxamide (98aik): The 
reaction was performed according to the Typical Procedure II, 
employing bromocyclopropane 70a (35 mg, 0.16 mmol, 1.2 equiv), 18-
crown-6 (3.5 mg, 0.013 mmol, 10 mol%), KOH (52 mg, 0.93 mmol, 7.0 
175 
 
equiv) and 4-fluoro-N-(furan-2-ylmethyl)benzenesulfonamide (97ik) (34 mg, 0.133 mmol, 1.0 
equiv).  Column chromatography on Silica gel afforded the title compound as a white solid 
(diastereomeric mixture 25:1) mp 121-124 
o
C, Rf 0.17 (eluent hexane/EtOAc 3:1).  Yield 49 mg 
(0.123 mmol, 93%).   
1
H NMR (400.13 MHz, CDCl3) δ ppm 7.74 (dd, J = 5.1, 8.8 Hz, 2H), 7.25 
(dd, J = 0.9, 1.9 Hz, 1H), 7.14 (dd, J = 8.6 Hz, 2H), 6.27 (dd, J = 1.9, 3.2 Hz, 1H), 6.21 (d, J = 
3.0 Hz, 1H), 5.66 (s, 1H), 4.52 (d, J = 15.4 Hz, 1H), 4.20 (d, J = 15.4 Hz, 1H), 2.25 (ddd, J = 2.8, 
4.5, 7.4 Hz, 1H), 1.74 - 1.78 (m, 1H), 1.38 (s, 9H), 1.31 - 1.35 (m, 1H), 1.20 (ddd, J = 4.8, 9.4 
Hz, 1H);  
13
C NMR (100.67 MHz, CDCl3) δ ppm 169.3, 165.20 (d, J = 259.40 Hz, 1C), 148.9, 
142.5 (+) , 132.97 (d, J = 2.93 Hz, 1C), 130.45 (+, d, J = 8.78 Hz, 1C), 116.16 (+, d, J = 22.69 
Hz, 1C), 110.5 (+), 110.2 (+), 51.5, 47.0 (-), 36.9 (+), 28.9 (+), 25.9 (+), 13.9 (-); 
19
F NMR (376 
MHz, CDCl3) δ ppm -104.73 (tt, J = 8.0, 5.7 Hz, 1F);  FT IR (KBr, cm
-1
): 3387, 3021, 2969, 
2867, 1645, 1593, 1493, 1337, 1155, 885, 734;  HRMS (TOF ES): found 401.1535, calculated 
for C24H32N2O3S (M
 
+ Li) 401.1523 (3.0 ppm).   
 
(1R*,2R*)-N-(tert-butyl)-2-(N-butyl-4-
chlorophenylsulfonamido)cyclopropanecarboxamide (98ajd): The 
reaction was performed according to the Typical Procedure II, 
employing bromocyclopropane 70a (35 mg, 0.16 mmol, 1.2 equiv), 18-
crown-6 (3.5 mg, 0.013 mmol, 10 mol%), KOH (52 mg, 0.93 mmol, 7.0 
equiv) and N-butyl-4-chlorobenzenesulfonamide (97jd)
129
 (33 mg, 0.133 mmol, 1.0 equiv).  
Column chromatography on Silica gel afforded the title compound as a white solid 
(diastereomeric mixture 11:1) mp 109-112 °C.  Major: Rf 0.47 (major), 0.17 (minor), eluent 
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hexane/EtOAc 3:1.   Yield 48 mg (0.126 mmol, 95%).   
1
H NMR (400.13 MHz , CDCl3) δ ppm 
7.73 (d, J = 8.6 Hz, 2H), 7.50 (d, J = 8.8 Hz, 2H), 5.82 (s, 1H), 3.21 (ddd, J = 6.1, 9.6, 13.6 Hz, 
1H), 3.04 (ddd, J = 5.6, 9.5, 13.7 Hz, 1H), 2.16 (ddd, J = 2.8, 4.5, 7.4 Hz, 1H), 2.00 (ddd, J = 
2.8, 6.3, 9.2 Hz, 1H), 1.46 - 1.63 (m, 2H), 1.42 (s, 9H), 1.25 - 1.37 (m, 3H), 1.21 (ddd, J = 4.8, 
9.4 Hz, 1H), 0.91 (t, J = 7.3 Hz, 3H);  
13
C NMR (100.67 MHz, CDCl3) δ ppm 169.3, 139.7, 
136.2, 129.5 (+, 2C), 129.1 (+, 2C), 128.6 (+, 2C), 128.0 (+.  2C), 55.4 (-), 51.4, 37.9 (+), 28.8 
(+), 25.2 (+), 13.7;  FT IR (KBr, cm
-1
): 3386, 3087, 2962, 2871, 1645, 1547, 1475, 1352, 1259, 
829, 739;  HRMS (TOF ES): found 387.1506, calculated for C24H32N2O3S (M
 
+ H) 387.1509 
(0.8 ppm). 
 
(1R*,2R*)-2-(N-benzyl-4-chlorophenylsulfonamido)-N-(tert-
butyl)cyclopropanecarboxamide (98ajf): The reaction was performed 
according to the Typical Procedure II, employing bromocyclopropane 
70a (35 mg, 0.16 mmol, 1.2 equiv), 18-crown-6 (3.5 mg, 0.013 mmol, 
10 mol%), KOH (52 mg, 0.93 mmol, 7.0 equiv) and N-benzyl-4-
chlorobenzenesulfonamide (97jf)
130
 (38 mg, 0.133 mmol, 1.0 equiv).  
Column chromatography on Silica gel afforded the title compound as a white solid 
(diastereomeric mixture 25:1) mp 88-92 
o
C, Rf = 0.17 (eluent hexane/EtOAc 3:1).  Yield 41 mg 
(0.096 mmol, 72%).   
1
H NMR (400.13 MHz, CDCl3) δ ppm 7.75 (d, J = 8.6 Hz, 2H), 7.52 (d, J 
= 8.8 Hz, 2H), 7.30 - 7.37 (m, J = 2.5 Hz, 5H), 5.16 (s, 1H), 4.48 (d, J = 13.9 Hz, 1H), 4.05 (d, J 
= 13.9 Hz, 1H), 2.13 (ddd, J = 2.8, 4.7, 7.5 Hz, 1H), 1.36 - 1.40 (m, 1H), 1.32 (s, 9H), 1.14 - 1.24 
(m, 2H); 
13
C NMR (100.67 MHz, CDCl3) δ ppm 169.4, 139.5, 135.7, 129.4 (+), 129.0 (+), 51.6, 
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51.2 (-), 37.3 (+), 30.2 (-), 28.9 (+), 25.7 (+), 20.1 (-), 13.7 (+), 13.4 (-);  FT IR (KBr, cm
-1
): 
3332, 3031, 2966, 2867, 1645, 1546, 1496, 1336, 827, 739;  HRMS (TOF ES): found 421.1341, 
calculated for C24H32N2O3S (M
 
+ H) 421.1353 (2.8 ppm).    
 
 (1R*,2R*)-2-(4-Bromo-N-butylphenylsulfonamido)-N-(tert-
butyl)cyclopropanecarboxamide (98akd):  The reaction was performed 
according to the Typical Procedure II, employing bromocyclopropane 
70a (35 mg, 0.16 mmol, 1.2 equiv), 18-crown-6 (3.5 mg, 0.013mmol, 10 
mol%), KOH (52 mg, 0.93 mmol, 7.0 equiv) and N-butyl-4-
bromobenzenesulfonamide (97kd)
131
 (39 mg,  0.13 mmol, 1.0 equiv).  Column chromatography 
on Silica gel (eluent hexane/EtOAc 3:1) afforded two fractions.   The major fraction (Rf 0.44) 
contained the title compound as a white solid, mp 101-103 °C.   Yield 47.8 mg (0.11 mmol, 
85%).   Minor fraction (Rf 0.16) contained minute amounts (4.5 mg) of (1R*,2S*)-diastereomer.    
1
H NMR (400.13 MHz, CDCl3) δ ppm 7.65 (s, 4 H), 5.82 (s, 1 H), 3.19 (ddd, J = 13.7, 9.8, 6.1 
Hz, 1 H), 3.03 (ddd, J = 13.6, 9.6, 5.6 Hz, 1 H), 2.15 (ddd, J = 7.5, 4.5, 2.9 Hz, 1 H), 1.98 (ddd, J 
= 9.2, 6.3, 2.8 Hz, 1 H), 1.44 - 1.57 (m, 2 H), 1.40 (s, 9 H), 1.23 - 1.34 (m, 3 H), 1.15 - 1.23 (m, 
1 H), 0.89 (t, J = 7.3 Hz, 3 H);  
 13
C NMR (100.61 MHz, CDCl3) δ ppm 169.3, 136.1, 132.4 (+, 
2C), 129.1 (+, 2C), 128.0, 51.5, 51.2 (-), 37.3 (+), 30.2 (-), 28.9 (+, 3C), 25.7 (+), 20.0 (-), 13.7 
(+), 13.3 (-);   FT IR (KBr, cm
-1
): 3325, 2962, 2931, 2871, 1654, 1535, 1388, 1259, 1087, 821, 
570;  HRMS (TOF ES): found 453.0827, calculated for C18H27N2O3SBrNa (M+Na) 453.0823 
(0.9 ppm).  
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3.5.6. Aniline Adducts 
 
 
(1R*,2R*)-N-(tert-Butyl)-2-(methyl(4-
nitrophenyl)amino)cyclopropanecarboxamide (100ab), Typical Procedure 
IV: 10 mL Wheaton vial equipped with a magnetic stir bar, under dry 
nitrogen atmosphere was charged with THF (5 mL), powdered KOH (112 
mg, 2.00 mmol), N-methyl-4-nitroaniline (99b) (228 mg, 1.50 mmol), 18-crown-6 (13 mg, 0.050 
mmol) and 2-bromo-N-(tert-butyl)cyclopropanecarboxamide (70a) (110 mg, 0.50 mmol).  This 
solution was stirred at 55 
o
C for 12h, then filtered through a fritted funnel and concentrated in 
vacuum.  Purification by flash chromatography on silica gel (eluent hexane:EtOAc 3:1) afforded 
the title compound as yellow solid (Rf 0.18), yield 142 mg (0.49 mmol, 98%).   
1
H NMR (400.13 
MHz, CDCl3) δ ppm 8.07 (d, J = 9.4 Hz, 2H), 6.76 (d, J = 9.4 Hz, 2H), 5.86 (s, 1H), 3.09 (s, 
3H), 3.06 (ddd, J = 7.6, 4.8, 3.1 Hz, 1H), 1.56 (m, 2H), 1.44 (s, 9H), 1.22 (ddd, J = 4.4, 4.9, 9.4 
Hz, 1H); 
13
C NMR (CDCl3, 100.61 MHz) δ 169.5, 154.6, 138.1, 125.6 (+, 2C), 111.8 (+, 2C), 
51.7, 40.6 (+), 38.0 (+), 29.0 (+, 3C), 27.1  (+), 16.3 (-);  FT IR (NaCl, cm
-1
): 3325, 2966, 2930, 
2874, 1643, 1547, 1493, 1396, 1315, 1113, 831, 754;  HRMS (TOF ES): found 290.1504, 
calculated for C15H20N3O3 (M-H) 290.1505 (0.3 ppm).    
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(1R*,2R*)-2-(Benzyl(4-cyanophenyl)amino)-N-(tert-
butyl)cyclopropanecarboxamide (100ac): This compound was 
synthesized according to the typical procedure employing 2-bromo-N-
(tert-butyl)cyclopropanecarboxamide (70a) (22 mg, 0.10 mmol), KOH 
(22 mg, 0.40 mmol), 18-crown-6 (2.6, 0.01 mmol), THF (1 mL), N-
benzyl-4-cyanoaniline (99c)
132
 (62 mg, 0.3 mmol).   Column chromatography on silica gel 
eluting with hexane/EtOAc (3:1) afforded the title compound as pale yellow oil, Rf 0.28.   Yield 
32 mg (0.092 mmol, 92%).   
1
H NMR (400.13 MHz, CDCl3) δ ppm 7.43 (d, J = 9.0 Hz, 2H), 
7.35 (m, 3H), 7.11 (d, J = 6.9 Hz, 2H), 6.83 (d, J = 9.0 Hz, 2H), 5.69 (s, 1H) 4.71 (d, J = 17.2 
Hz, 1H) 4.62 (d, J = 17.2 Hz, 1H), 3.15 (ddd, J = 6.7, 4.8, 3.2 Hz, 1H), 1.55 (m, 2H), 1.41 (s, 
9H), 1.20 (ddd, J = 8.7, 4.3, 3.4 Hz, 1H); 
13
C NMR (CDCl3, 100.61 MHz) δ ppm 169.6, 152.2, 
137.9, 133.3 (+, 2C), 128.9 (+, 2C), 127.4 (+), 126.0 (+, 2C), 113.7 (+, 2C), 99.7, 55.2 (-), 51.6, 
40.3 (+), 29.0 (+, 3C), 26.9 (+), 16.0 (-).  FT IR (NaCl, cm
-1
): ν= 3338, 2964, 2927, 2871, 2216, 
1644, 1605, 1546, 1435, 1383, 821, 737; HRMS (TOF ES): found 347.1993, calculated for 
C22H25N3O (M+H) 347.1998 (1.4 ppm). 
 
(1R*,2R*)-2-(benzyl(4-(trifluoromethyl)phenyl)amino)-N-(tert-
butyl)cyclopropanecarboxamide (100ad): This compound was 
synthesized according to the typical procedure employing 2-bromo-N-
(tert-butyl)cyclopropanecarboxamide (70a)  (22 mg, 0.1 mmol), KOH 
(22 mg, 0.40 mmol), 18-crown-6 (2.6 mg, 0.01 mmol), THF (1 mL), N-
benzyl-4-trifluoroaniline (99d)
132
 (75 mg, 0.30 mmol).   Column chromatography on silica gel 
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eluting with hexane/ EtOAc (3:1) afforded the title compound as white solid, mp 125-128 
o
C, Rf 
0.45.   Yield 25 mg (0.064 mmol, 65%).   
1
H NMR (400.13 MHz, CDCl3) δ ppm 7.46 (m, 2H), 
7.33 (m, 2H), 7.29 (m, 1H), 7.16 (m, 2H), 6.89 (d, J = 8.6 Hz, 2H), 5.54 (s, 1H), 4.72 (d, J = 
17.1 Hz, 1H), 4.61 (d, J = 17.0 Hz, 1H), 3.14 (ddd, J = 7.7, 4.7, 3.1 Hz, 1H), 1.53 (m, 2H), 1.42 
(s, 9H), 1.20 (m, 1H);  
13
C NMR (CDCl3, 100.61 MHz) δ 169.8 , 151.6 , 138.6 , 130.9 , 128.8 (+, 
2C), 127.2 (+), 126.3 (+, q, 
3
J = 3.9 Hz, 2C), 126.2 (2C), 124.9 (q, 
1
J = 270.3 Hz), 119.6 (q, 
2
J = 
32.5 Hz), 113.4 (+, 2C), 55.7 (-), 51.6 , 40.4 (+), 29.0 (+, 3C), 27.1 (+), 16.0 (-).  FT IR (NaCl, 
cm
-1
): 3315, 2964, 2929, 1730, 1643, 1556, 1454, 1393, 1325, 1226, 1111, 823, 725 cm;  HRMS 
(TOF ES): found 391.2001, calculated for C22H26N2OF3 (M+H) 391.1997 (1.0 ppm). 
 
((1R*,2R*)-2-(benzyl(4-
nitrophenyl)amino)cyclopropyl)(morpholino)methanone (100be): 
This compound was synthesized according to the typical procedure 
employing (2-bromocyclopropyl)(morpholino)methanone (70b) (23 
mg, 0.10 mmol), KOH (22 mg, 0.40 mmol), 18-crown-6 (2.6, 0.01 
mmol), THF (1 mL), and N-benzyl-4-nitroaniline (99e)
133
 (68 mg, 0.3 mmol).   Column 
chromatography on silica gel eluting with hexane/EtOAc (1:1) afforded the title compound as 
pale yellow oil, Rf 0.13.   Yield 27 mg (0.071 mmol, 71%).   
1
H NMR (400.13 MHz, CDCl3) δ 
ppm 8.12 (d, J = 9.3 Hz, 2H), 7.36 (m, 2H), 7.31 (d, J = 7.2 Hz, 1H), 7.13 (d, J = 7.5 Hz, 2H), 
6.84 (d, J = 9.3 Hz, 2H), 4.81 (d, J = 17.3, 1H) 4.69 (d, J = 17.3, 1H), 3.78-3.63 (m, 6H), 3.53 
(m, 2H), 3.37 (ddd, J = 2.9, 4.8, 7.6 Hz, 1H), 2.01 (ddd, J = 2.9, 5.8, 9.1 Hz, 1H), 1.65 (ddd, J = 
5.39, 5.39, 7.20 1H), 1.35 (td, J = 5.0, 9.6 Hz, 1H); 
13
C NMR (100.61 MHz, CDCl3) δ ppm 
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169.0, 154.1, 138.9, 137.6, 129.0 (+, 2C), 127.6 (+), 125.8 (+, 2C), 125.7 (+, 2C), 112.7 (+, 2C), 
66.9 (-), 66.8 (-), 55.6 (-), 46.1 (-), 42.6 (-), 41.3 (+), 22.2 (+), 17.3 (-);  HRMS (TOF ES): found 
382.1784, calculated for C21H24N3O4 (M+H) 382.1767 (4.4 ppm).   
 
(1R*,2R*)-2-(Benzyl(3-nitrophenyl)amino)-N-(tert-
butyl)cyclopropanecarboxamide (100af): This compound was 
synthesized according to the typical procedure employing 2-bromo-N-
(tert-butyl)cyclopropanecarboxamide (70a) (22 mg, 0.10 mmol), KOH 
(22 mg, 0.40 mmol), 18-crown-6 (2.6 mg, 0.01 mmol), THF (1 mL), N-benzyl-3-nitroaniline 
(99e)
134
 (68 mg, 0.30 mmol).   Column chromatography on silica gel eluting with hexane/EtOAc 
(3:1) afforded the title compound as yellow oil, Rf 0.26.   Yield 18 mg (0.049 mmol, 50%).   
1
H 
NMR (400.13 MHz, CDCl3) δ ppm 7.79 (t, J = 2.4 Hz, 1H), 7.61 (dd, J = 7.9, 2.0 Hz, 1H), 7.33 
(m, 3H), 7.29 (m, 1H), 7.16 (d, J = 7.4 Hz, 2H), 7.03 (dd, J = 8.4, 2.5 Hz, 1H), 5.65 (s, 1H), 4.75 
(d, J = 17.0 Hz, 1H), 4.62 (d, J = 17.1 Hz, 1H), 3.12 (m, 1H), 1.59 (m, 2H), 1.45 (s, 9H), 1.20 
(m, 1H);  
13
C NMR (CDCl3, 100.61 MHz) δ 169.3, 149.9, 138.0, 129.6 (+, 2C), 128.9 (+, 2C), 
127.3 (+), 126.2 (+, 2C), 119.6 (+), 112.5 (+), 108.1 (+), 55.7 (-), 51.8, 40.4 (+), 29.0 (+, 3C), 
27.4 (+), 15.7 (-);   FT IR (KBr, cm
-1
): 3336, 2964, 2929, 2869,  1642, 1605, 1549, 1447, 1381, 
821, 736;  HRMS (TOF ES): found 347.1993, calculated for C22H25N3O (M+) 347.1998 (1.4 
ppm).    
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(1R*,2R*)-N-(tert-Butyl)-2-
(diphenylamino)cyclopropanecarboxamide (100ag): This compound 
was synthesized according to the typical procedure employing 2-
bromo-N-(tert-butyl)cyclopropanecarboxamide (70a) (55 mg, 0.25 mmol), powedered KOH (56 
mg, 1.0 mmol), 18-crown-6 (6.6 mg, 0.025 mmol), THF (5 mL), and diphenyl amine (99g) (126 
mg, 0.75 mmol).   Crude mixture (dr 1.1:1) was concentrated in vacuum and treated with 
potassium tert-butoxide (112 mg, 1.0 mmol) in anhydrous THF (5 mL) at 80 
o
C for 12h, to 
improve the dr to 25:1.   Flash column chromatography on silica gel afforded the title compound 
as white solid, mp 111.3 
o
C, Rf 0.27 (hexane/EtOAc 6:1).   Yield 74 mg (0.24 mmol, 96%).   
1
H 
NMR (400.13 MHz, CDCl3) δ ppm 7.36 – 7.29 (m, 4H), 7.08 – 6.99 (m, 6H), 5.50 (s, 1H), 3.20 
(ddd, J = 7.5, 4.8, 2.9 Hz, 1H), 1.04 (ddd, J = 8.6, 4.8 Hz, 1H), 1.43 – 1.39 (m, 9H), 1.53 (ddd, J 
= 7.2, 5.4 Hz, 1H), 1.50 – 1.46 (m, 1H);  
13
C NMR (100.61 MHz, CDCl3) δ 170.1, 147.3, 129.2 
(+, 4C), 122.3 (+, 2C), 121.4 (+, 4C), 51.5, 40.6 (+), 29.0 (+, 3C), 27.6 (+), 16.5 (-).   FT IR 
(NaCl, cm
-1
): 3325, 3057, 3044, 2966, 2930, 1647, 1591, 1500, 1456, 1394, 1364, 1313, 1248, 
1224, 748; HRMS (TOF ES): found 308.1880, calculated for C20H24N2O (M+) 308.1889 (2.9 
ppm). 
 
 (1R*,2R*)-N-(tert-butyl)-2-(10H-phenothiazin-10-
yl)cyclopropanecarboxamide (100ah): This compound was prepared 
according to the typical procedure employing 2-bromo-N-(tert-
butyl)cyclopropanecarboxamide (70a) (55 mg, 0.25 mmol), powdered KOH (56 mg, 1.0 mmol), 
18-crown-6 (6.6 mg, 0.025 mmol), THF (5 mL), and 10H-phenothiazine (99h) (149 mg, 0.75 
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mmo l).  Crude reaction mixture (dr 3.5:1) was concentrated in vacuum and treated with 
potassium tert-butoxide (112 mg, 1.00 mmol) in anhydrous THF (5 mL) at 80 
o
C for 12h to 
improve dr to 49:1.   Purification by flash chromatography on silica gel (eluent hexane:EtOAc 
8:1) afforded the title compound as white solid, mp 187-188 
o
C, Rf 0.52.   Yield 50 mg (0.148 
mmol, 59%).   
1
H NMR (400.13 MHz, CDCl3) δ ppm 7.24 – 7.12 (m, 4H), 6.98 (t, J = 8.0 Hz, 
2H), 5.57 (s, 1H), 3.29 (ddd, J = 7.2, 4.7, 2.9 Hz, 1H), 1.83 (ddd, J = 6.7, 5.8, 4.9 Hz, 1H), 1.57 
(ddd, J = 5.8, 2.9 Hz, 1H), 1.20 (ddd, J = 9.3, 4.8 Hz, 1H).   
13
C NMR (100.61 MHz, CDCl3) δ 
ppm 169.8, 127.2, 127.1, 122.93, 51.6, 35.4, 29.0, 28.5, 18.1;  FT IR (NaCl, cm
-1
): 3358, 2992, 
2961, 1649, 1542, 1461, 1374, 1367, 1250, 1129, 825, 750;  HRMS (TOF ES): found 339.1528, 
calculated for C20H23N2OS (M+H) 339.1531 (0.9 ppm). 
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Appendix 
A.1. Assignment of Relative Configurations by 
1
H NMR 
 
The relative configuration of compound 94abd was assigned based on analysis of the 
coupling constants in the multiplet at 2.75 ppm.   Albeit severe broadening of the resonance lines 
complicated the analysis, careful optimization of the sample temperature allowed for obtaining 
of an acceptable resolution in DMSO-d6 at 370 K (97 
o
C).   Further improvement of the line 
resolution was achieved by applying Lorentzian-Gaussian Windows Function (LB = -1, GF = 
0.5) prior to the Fourier Transform.  Coupling constant values were determined by multiplete 
simulation using ACD/SpecManager 11.01.   The observation of two trans-
3
J coupling constants 
(3.15 Hz, 4.89 Hz) and only one cis-
3
J coupling constant (7.72 Hz) allowed for unambiguous 
assignment of the trans-configuration to product 94abd.   
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A.2. Crystallographic Data 
 
 Colorless parallelepiped-shaped crystals of C25H24F6N2O3 are, at 100(2) K, monoclinic, 
space group P21/c – C2h
5
 (No.  14)
135
 with a = 15.679(9) Å, b = 16.496(10) Å, c = 8.969(5) Å,  
= 95.185(11), V = 2310(2) Å
3
 and Z = 4 molecules {dcalcd = 1.479 g/cm
3
; a(MoK) = 0.130 
mm
-1
}.    A full hemisphere of diffracted intensities (1850 10-second frames with a  scan width 
of 0.30) was measured for a 2-domain specimen using graphite-monochromated MoK 
radiation (= 0.71073 Å) on a Bruker SMART APEX CCD Single Crystal Diffraction System.
136
 
The second domain accounted for 41% of the crystal volume and was rotated by 180 about the a 
axis of the unit cell for the major domain.   X-rays were provided by a fine-focus sealed x-ray 
tube operated at 50 kV and 30 mA.   Lattice constants were determined with the Bruker SAINT 
software package using peak centers for 3072 reflections.   A total of 3875 unique integrated 
reflection intensities having 2((MoK)< 50.00 and a coverage which was 95.1% complete 
were produced using the Bruker program SAINT;
137
 27.4% of the reflections had two twin 
components and the rest had just one.  The data were corrected empirically for variable 
absorption effects using equivalent reflections; the relative transmission factors ranged from 
0.914 to 1.000.   The Bruker software package SHELXTL was used to solve the structure using 
“direct methods” techniques.   All stages of weighted full-matrix least-squares refinement were 
conducted using Fo
2
 data with the SHELXTL Version 6.10 software package.
138
 The final 
structural model took the 2-domain twinning into account and incorporated anisotropic thermal 
parameters for all nonhydrogen atoms and isotropic thermal parameters for all hydrogen atoms.   
All hydrogen atoms were included in the structural model as idealized atoms (assuming sp
2
- or 
sp
3
-hybridization of the carbon atoms and C-H bond lengths of 0.95 – 1.00 Å).   The isotropic 
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thermal parameters of all hydrogen atoms were fixed at values 1.2 times the equivalent isotropic 
thermal parameter of the carbon atom to which they are covalently bonded.    A total of 326 
parameters were refined using no restraints, 3875 data and weights of w = 1/[
2
(F
2
) + (0.1314P)
2
 
+ 1.8112P], where P = [Fo
2
 + 2Fc
2
]/3.   Final agreement factors at convergence are:  
R1(unweighted, based on F) = 0.089 for 2972 independent absorption-corrected “observed” 
reflections having 2(MoK) <  50.00 and I > 2(I);  R1(unweighted, based on F) = 0.113 and 
wR2(weighted, based on F
2
) = 0.244 for 3875 independent absorption-corrected reflections 
having 2(MoK) < 50.00.   The largest shift/s.u.  was 0.000 in the final refinement cycle.   The 
final difference map had maxima and minima of 0.85 and  -0.61 e
-
/Å
3
, respectively.    
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Table 14 Atomic coordinates (Å) and equivalent isotopic factors (Å
2
) for diamide 95bmg.   
U(eq) is defined as one third of the trace of the orthogonalized U
ij
 tensor. 
 Atom  x  y  z  U(eq) 
 
F1   0.03357(15)  0.29620(15)  0.3107(5)  0.0911(12)  
F2   0.1009(3)  0.30901(18)  0.1232(4)  0.1169(16)  
F3   0.16018(15)  0.25784(14)  0.3149(4)  0.0724(9)  
F4  0.00448(19)  0.60552(18)  0.1745(3)  0.0730(9)  
F5   -0.0232(2)  0.60032(19)  0.3928(4)  0.0831(10)  
F6  0.07646(18)  0.67539(14)  0.3336(6)  0.144(2)  
O1  0.13519(14)  0.55382(14)  -0.2558(3)  0.0315(6)  
O2  0.28798(15)  0.72017(13)  0.1247(3)  0.0357(6)  
O3  0.35411(14)  0.44771(14)  0.6035(3)  0.0333(6)  
N1  0.37900(16)  0.56393(16)  0.4826(3)  0.0264(6)  
N2   0.22643(19)  0.61286(16)  0.0056(3)  0.0313(7)  
C1  0.3620(2)  0.62182(19)  0.3643(4)  0.0270(7)  
H1  0.3336   0.6733   0.3918   0.032  
C2  0.4281(2)  0.6297(2)  0.2565(4)  0.0310(8)  
H2A  0.4780   0.5928   0.2687   0.037  
H2B  0.4407   0.6847   0.2203   0.037 
C3  0.3419(2)  0.59320(19)  0.2052(4)  0.0260(7)  
H3  0.3391   0.5335   0.1866   0.031  
C4  0.2827(2)  0.64657(19)  0.1094(4)  0.0273(7)  
C5  0.2018(2)  0.52773(19)  -0.0082(4)  0.0298(7)  
H5A  0.1467   0.5193   0.0353   0.036  
H5B  0.2457   0.4937   0.0479   0.036  
C6  0.1930(2)  0.5029(2)  -0.1699(4)  0.0304(7)  
H6A  0.2498   0.5054   -0.2098   0.036  
H6B  0.1725   0.4462   -0.1782   0.036  
C7  0.1646(2)  0.6352(2)  -0.2485(4)  0.0327(8)  
H7A  0.1248   0.6698   -0.3124   0.039  
H7B  0.2218   0.6383   -0.2870   0.039  
C8  0.1702(2)  0.6655(2)  -0.0902(4)  0.0376(9)  
H8A  0.1929   0.7215   -0.0861   0.045  
H8B  0.1124   0.6663   -0.0541   0.045  
C9  0.4561(2)  0.5791(2)  0.5853(4)  0.0306(8)  
H9A  0.5004   0.6052   0.5295   0.037  
H9B  0.4794   0.5267   0.6248   0.037  
C10  0.4368(2)  0.6329(2)  0.7147(4)  0.0296(8)  
H10A  0.4129   0.6852   0.6760   0.035  
H10B  0.3937   0.6065   0.7727   0.035  
C11  0.51772(19)  0.64782(18)  0.8143(3)  0.0234(7)  
C12  0.5330(2)  0.60544(19)  0.9452(4)  0.0285(7)  
H12   0.4911   0.5686   0.9746   0.034  
C13  0.6087(2)  0.6156(2)  1.0351(4)  0.0351(8)  
H13  0.6188   0.5859   1.1257   0.042  
C14  0.6698(2)  0.6696(2)  0.9919(4)  0.0375(9)  
H14  0.7224   0.6762   1.0521   0.045  
C15  0.6545(2)  0.7131(2)  0.8635(4)  0.0347(8)  
H15  0.6957   0.7510   0.8354   0.042  
C16   0.5793(2)  0.7021(2)  0.7741(4)  0.0296(7)  
H16  0.5694   0.7321   0.6838   0.036  
C17  0.3309(2)  0.49846(19)  0.5094(3)  0.0249(7)  
C18  0.24389(19)  0.48842(19)  0.4250(3)  0.0237(7)  
C19  0.2176(2)  0.41142(19)  0.3843(4)  0.0268(7)  
H19  0.2561   0.3672   0.4017   0.032  
C20  0.1365(2)  0.39775(19)  0.3190(4)  0.0254(7)  
C21  0.0784(2)  0.46126(19)  0.2954(3)  0.0263(7)  
H21  0.0220   0.4516   0.2509   0.032  
C22  0.10391(19)  0.5380(2)  0.3375(3) 0.0263(7)  
C23  0.18691(19)  0.55252(19)  0.4007(3)  0.0240(7)  
H23  0.2045   0.6061   0.4272   0.029  
C24  0.1083(2)  0.3150(2)  0.2666(5)  0.0400(9)  
C25  0.0431(2) 0.6063(2)  0.3113(4)  0.0326(8)  
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Figure 9.   ORTEP drawing of diamide 95bmg molecule, showing the atom numbering scheme; 
50% probability amplitude displacement ellipsoids are shown. 
 
Figure 10.   Packing of diamide 95bmg molecules in the crystalline lattice cell. 
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